WO2004061090A1 - Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same - Google Patents

Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same Download PDF

Info

Publication number
WO2004061090A1
WO2004061090A1 PCT/JP2004/000003 JP2004000003W WO2004061090A1 WO 2004061090 A1 WO2004061090 A1 WO 2004061090A1 JP 2004000003 W JP2004000003 W JP 2004000003W WO 2004061090 A1 WO2004061090 A1 WO 2004061090A1
Authority
WO
WIPO (PCT)
Prior art keywords
fraction
organic solvent
barley
insoluble
natural killer
Prior art date
Application number
PCT/JP2004/000003
Other languages
French (fr)
Japanese (ja)
Inventor
Toshiro Omori
Yasufumi Umemoto
Yoshifumi Furuta
Hideki Hokazono
Mihoko Furutera
Hideki_____________________________________- Ohba
Original Assignee
Sanwa Shurui Co., Ltd.
Barley Fermentation Technologies, Inc.
National Institute Of Advanced Industrial Science And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Shurui Co., Ltd., Barley Fermentation Technologies, Inc., National Institute Of Advanced Industrial Science And Technology filed Critical Sanwa Shurui Co., Ltd.
Priority to JP2005507954A priority Critical patent/JPWO2004061090A1/en
Publication of WO2004061090A1 publication Critical patent/WO2004061090A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0646Natural killers cells [NK], NKT cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998Hordeum (barley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Definitions

  • the present invention relates to a composition having an action of activating natural killer cells and a method for producing the same, and a composition containing natural killer cells activated using the composition and a method for producing the same.
  • the present invention obtains a liquid component by solid-liquid separation of a barley shochu distillation residue (hereinafter abbreviated as “barley shochu distillation residue”) by-produced in the production of shochu using barley as a raw material,
  • barley shochu distillation residue a barley shochu distillation residue
  • the fraction that has not been adsorbed to the synthetic adsorbent which has been collected by exhausting the fraction or subjecting the liquid to an adsorption separation treatment using a synthetic adsorbent, is subjected to ion exchange treatment using an ion exchange resin.
  • the fraction that is not adsorbed on the ion exchange resin is fractionated, and the fraction that is not adsorbed on the ion exchange resin is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane.
  • the present invention also includes a composition containing a natural killer cell and a natural killer cell activated by using a composition comprising a natural killer cell and a fraction insoluble in the organic solvent, and a method for producing the same.
  • Natural killer cells are found in the lymphoid tissues of animals (humans, mice, hamsters, rats, chickens, pigs, etc.). These sputum cells are morphologically somewhat large lymphocytes (LGLs) that contain azul granules in the cytoplasm, occupying a few percent of lymphocytes, and without immune memory. It is thought that it plays a part in the defense mechanism of the body against tumor development because it can destroy non-specific tumor cells (mainly hematopoietic tumors).
  • LGLs lymphocytes
  • sputum cells play an important role in non-antigen-specific innate immunity that acts at the very beginning of the immune response. Even though it does not have a sputum cell receptor, it can accurately identify self and non-self and can cause necrosis of virus-infected cells and tumor cells without prior antigen sensitization. Are known.
  • Patent Document 1 describes a filamentous fungus of the genus Aspergillus or Basidiomycetus as a plant tissue raw material of rice bran, bran, rice straw or bagasse. Describes a method for producing hemicellulose having an immunostimulatory action, characterized by being assimilated in the culture medium.
  • the hemicellulose having an immunostimulatory effect obtained through the production method is described as having main components xylose and arabinose and having an average molecular weight of 550,000 or 600,000.
  • the bran, rice straw, or bagasse is the residue of barley shochu that is a by-product of the distillation of the whitened grains that have undergone whitening to remove the hulls of barley grains, followed by distillation after alcohol fermentation. It is completely different from liquid.
  • water-soluble polysaccharides are obtained by preparing water-soluble polysaccharides of plant tissues such as gramineous plants, especially rice bran.
  • An immunity enhancing substance obtained by preparing an extracellular enzyme of a filamentous fungus to obtain an enzyme complex, mixing the water-soluble polysaccharide and the enzyme complex, and reacting at a predetermined pH for a predetermined time, It is described that it has an effect of activating NK cells. Further, it is described that the substance for enhancing immunity has an average molecular weight of 600,000 or 650,000, and main components are xylose and arabinose.
  • the rice bran in Patent Document 2 is a by-product generated when whitening the threshed brown rice, and after subjecting the whitened grains that have been whitened to remove the hulls of barley grains to alcohol fermentation, distillation is performed. It is completely different from the barley shochu distillation residue, which is a distillation residue produced as a by-product during the production of shochu.
  • Patent Document 3 an aqueous extract of sake lees produced as a by-product when rice is subjected to alcoholic fermentation to produce sake is activated by NK cell activation. It is described to have
  • the sake lees in Patent Document 3 is a solid content which is a residue after separating the liquid obtained by subjecting rice to alcoholic fermentation and then squeezing it as a sake product. Therefore, the sake lees in Patent Document 3 is a distillation residue produced as a by-product in producing shochu by subjecting the refined grains that have undergone whitening to remove the hulls of barley grains to alcohol fermentation and then distilling them. It is completely different from a barley shochu distillation residue.
  • Patent Document 4 describes an immunostimulation comprising a water extract of rice bran and comprising an extract having a molecular weight of about 30000 to 40000. A composition for use is described. Patent Document 4 describes that the composition has mitogenic activity and excellent NK cell activation action. Patent The rice bran in Ref. 4 is a by-product generated when whitening the threshed brown rice, and the whitened grains that have undergone whitening to remove the hulls of barley grains are subjected to alcoholic fermentation followed by distillation to produce shochu. It is completely different from the barley shochu distillation residue, which is a by-product distillation residue.
  • Patent Document 5 discloses a partial decomposition of a hemicell mouthpiece obtained from corn hull, which is commercially available under the trade name “Celuse”. An antitumor composition containing the product as an active ingredient is described. According to Patent Document 5, the partial degradation product of hemicellulose has an average molecular weight of 20,000 to 200,000, and NK cell activity is significantly increased in colon26 cancer-bearing mice administered with the partial degradation product. Furthermore, it is described that the ability to produce cytokines (IL-2 and INF-a) is also significantly increased.
  • cytokines IL-2 and INF-a
  • Non-Patent Document 1 a partially decomposed product of hemicellulose obtained from corn hull marketed under the trade name “Cel Ace” described in Patent Document 5 contains arabinose and It is mainly composed of arabinoxylan consisting of xylose and has a composition of 40.32% xylose, 27.76% arabinose, 11.86% uronic acid, 5.91% galactose and 2.30% glucose. It is described that there is.
  • the corn hull which is the source of the “partial degradation product of hemicellulose obtained from corn hull” described in Patent Document 5
  • There is a barley shochu distillation residue that is a distillation residue by-produced when producing white spirits by subjecting the whitened grains that have undergone whitening to remove the hulls of barley grains to alcohol fermentation and then distilling them.
  • Patent Document 6 The barley shochu distillation residue (i.e., obtained from the distillation residue produced as a by-product in producing shochu by subjecting the whitened grains that had undergone whitening to remove the hull of barley grains to alcohol fermentation and then performing distillation) A composition having a fatty liver inhibitory action different from the activating action on M cells is described, that is, Patent Document 6 obtains a liquid component by solid-liquid separation of the barley shochu distillation residue. Then, Al force is added to the obtained liquid to fractionate the Al force soluble fraction, and the fraction obtained is neutralized with an acid to obtain a neutral soluble fraction.
  • Patent Document 6 A composition having a fatty liver inhibitory action obtained by adding ethanol to the neutral soluble fraction is described in Patent Document 6.
  • Patent Document 6 describes the composition described above. , which contains a molecular weight of 3000 or less as a main component, and the composition contains hemicellulose It is described that the constituent element is xylose, and therefore, in any of the above-mentioned known documents, whether or not the barley shochu distillation residual liquid contains a component having an activating action on M cells. It is clear that there is no suggestion about this.
  • the present invention further provides a barley shochu distillation residue (hereinafter referred to simply as “barley shochu distillation residue”) produced as a by-product when producing barley shochu.
  • barley shochu distillation residue hereinafter referred to simply as “barley shochu distillation residue”
  • An object of the present invention is to provide a composition having a significant activating effect on natural killer cells (hereinafter abbreviated as “NK cells”) collected from a barley shochu distillation residue and a method for producing the same. There is.
  • NK cells natural killer cells
  • Another object of the present invention is to provide a composition containing NK cells activated using the composition having a significant activating effect on NK cells, and a method for producing the same.
  • the composition having a significant activating effect on NK cells of the present invention includes the following two embodiments.
  • the composition having a significant activating effect on NK cells of the first aspect is obtained by solid-liquid separation of a barley shochu distillation residual liquid to obtain a liquid component, and the liquid component is subjected to an ion exchange treatment using an ion exchange resin.
  • the fraction that is not adsorbed on the ion-exchange resin is fractionated, and the fraction that is not adsorbed on the ion-exchange resin that has been collected is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane.
  • a concentrated solution and a fraction insoluble in the organic solvent fractionated by adding an organic solvent to the concentrated solution, and the fraction insoluble in the organic solvent substantially contains uronic acid. It contains polysaccharides consisting of xylose, arabinose, and glucose.
  • the molecular weight distribution is 5% for 100,000 or more, 18% for 30,000 to 100,000, 23% for 10,000 to 30,000, 000 to 10,000 is 31%, 1,000 to 3,000 is 11%, 500 to 1,000 is 3%, and 500 or less is 9%. Has an activating effect.
  • the fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of total arabinose and xylose derived from polysaccharide, about 4.2% by weight of crude protein, organic acid Has a component composition consisting of about 0.3% by weight and about 1.2% by weight of free sugars.
  • the composition having a significant activating effect on NK cells according to the second aspect is obtained by subjecting the barley shochu distillation residue to solid-liquid separation to obtain a liquid component, which is then subjected to an adsorption separation process using a synthetic adsorbent. And fractionating a non-adsorbed fraction on the synthetic adsorbent, and subjecting the non-adsorbed fraction to the fractionated synthetic adsorbent to an ion exchange treatment using an ion exchange resin. A non-adsorbed fraction is fractionated, and the non-adsorbed fraction is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution.
  • the fraction insoluble in the organic solvent fractionated by adding an organic solvent to the organic solvent is substantially free of uronic acid and consists of xylose, arabinose and glucose.
  • uronic acid consists of xylose, arabinose and glucose.
  • composition having an activating effect on NK cells according to the first and second aspects of the present invention is very remarkable for NK cells, comparable to IL-2 which is a known NK cell activator. It has an activating effect and can be used very suitably for the treatment of cancer including leukemia as a pharmaceutical.
  • composition containing the activated NK cell of the present invention includes the following two embodiments.
  • the composition containing activated NK cells according to the first aspect contains activated NK cells using the composition having a significant activation action on the NK cells according to the first aspect. It is a cell-containing composition.
  • the composition containing activated NK cells according to the second aspect contains NK cells activated using the composition having a significant activating effect on the M cells according to the second aspect. It is a cell-containing composition.
  • the activated NK cell-containing composition containing activated NK cells according to the first and second aspects of the present invention can be used very suitably for the treatment of cancer including leukemia as a pharmaceutical. .
  • the present invention has been completed based on the facts obtained by the present inventors through experiments. The experiment conducted by the present invention will be described below.
  • the present inventors obtained a liquid component by solid-liquid separation of a barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and an organic solvent (preferably ethanol) was added to the liquid component.
  • an organic solvent preferably ethanol
  • the collected fraction insoluble in the organic solvent contains polysaccharide as one of its main components
  • the polysaccharide contained in the fraction insoluble in the organic solvent contains NK cells.
  • components other than polysaccharides contained in the fraction insoluble in the organic solvent that is, amino acid, peptide, protein, organic acid, or barley-derived
  • various ion exchange resins are prepared, and the liquid components obtained by solid-liquid separation of the barley shochu distillation residual liquid are ion exchange treatments using these ion exchange resins individually.
  • a fraction insoluble in the organic solvent collected by fractionation is obtained, and whether each of the obtained fractions insoluble in the organic solvent has an NK cell activation effect or not, has an NK cell activation effect.
  • the following experiment was conducted to clarify the degree of the NK cell activation effect. Barley shochu was produced for the purpose of the following Experiment 1 to Experiment 14. Barley (70% refined) was used as a raw material.
  • Steamed barley was produced by absorbing 40% by weight of barley, steaming for 40 minutes, and allowing to cool to 40 ° C.
  • the first preparation add 3.6 ml of water and lkg (wet weight) of cultured cells of shochu yeast as yeast to the barley koji (3 tons as barley) produced by the method described above to obtain primary mash.
  • the obtained primary moromi was subjected to 5 days of fermentation (1st stage fermentation).
  • 11.4 kiloliters of water and 7% ton of steamed barley (7 tons of barley) produced by the method described above were added to the primary mash that had been subjected to the first stage fermentation. (Stage fermentation).
  • the fermentation temperature was 25 ° C for both the first and second charge.
  • the second mash after the second stage fermentation was subjected to simple distillation by a conventional method to obtain 10 kiloliters of barley shochu and 15 kiloliters of barley shochu distillation residue.
  • the obtained barley shochu distillation residue was Used for Experiment 1 to Experiment 14.
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, the Brix of the obtained liquid component is adjusted to 10, and the liquid component adjusted to BrixlO is adjusted to 1 L. Ethanol is added so that the concentration becomes 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin to collect a fraction insoluble in an organic solvent (ethanol). The obtained fraction is lyophilized. 11.8 g of a freeze-dried product was obtained.
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged at 8000 rpm and lOmin to obtain a liquid component. After adjusting the liquid component to BrixlO, 1 ml of the liquid component adjusted to BrixlO is stored in a volume of 500 ml. The fraction not adsorbed on the ion exchange resin was fractionated through a column packed with Amberlite IRC76 (weakly acidic cation exchange resin) manufactured by Organo Co., Ltd., and the obtained fraction was converted to Brix60.
  • Amberlite IRC76 weakly acidic cation exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component. After adjusting the obtained liquid component to Brixl O, 1 ml of the liquid component adjusted to BrixlO was added to 500 ml. Through a column packed with Amberlite IRA67 (weakly acidic anion exchange resin) manufactured by Organo Co., Ltd., fractions not adsorbed on the ion exchange resin were collected, and the obtained fractions were combined with Brix60.
  • Amberlite IRA67 weakly acidic anion exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component. After the liquid component thus obtained is adjusted to BrixlO, 1 L of the liquid component adjusted to BrixlO is added to a 500 ml organopolyester. Pass through a column packed with Amberlite 200CT (Strongly Acidic Cation Exchange Resin), and collect fractions not adsorbed on the ion exchange resin, and adjust the resulting fractions to Brix60.
  • Amberlite 200CT Shortly Acidic Cation Exchange Resin
  • NK cell activity ie, activation effect on NK cells was performed in the same manner as described in the Examples below. ) was measured.
  • the present inventors obtain a liquid component by solid-liquid separation of the barley shochu distillation residual liquid by-produced in the production of shochu using barley as a raw material, and add an organic solvent (preferably ethanol) to the liquid component.
  • an organic solvent preferably ethanol
  • the polysaccharides contained in the fraction insoluble in the organic solvent activate M cells. Further studies were conducted through experiments to clarify whether or not they are involved in the process. That is, the following experiments were conducted for the purpose of removing amino acids, peptides, proteins, organic acids, polyphenols derived from barley, etc., which are components other than polysaccharides contained in the fraction insoluble in the organic solvent. .
  • the liquid content obtained by solid-liquid separation of the barley shochu distillation residue was synthesized for the purpose of removing polyphenol derived from barley contained in the liquid content of the barley shochu distillation residue.
  • a fraction that is not adsorbed to the synthetic adsorbent is separated by an adsorption separation process using an adsorbent, and then the amino acids and peptides contained in the fraction that is not adsorbed to the synthesized adsorbent.
  • the ion-exchange resin is obtained by subjecting the non-adsorbed fraction to the synthetic adsorbent to ion exchange treatment using various ion-exchange resins.
  • Barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” above From the above, a fraction insoluble in an organic solvent was collected by the method shown below. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, the Brix of the obtained liquid component is adjusted to 10, and the liquid component adjusted to BrixlO is adjusted to 1 L. Ethanol is added so that the concentration is 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin to collect a fraction insoluble in the organic solvent (ethanol), and the resulting fraction is freeze-dried. As a result, 11.8 g of a freeze-dried product was obtained.
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was packed with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. The fraction that was not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability with respect to the synthetic adsorbent of the column was fractionated.
  • the obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column packed with 500 ml of Amberlite IRC76 (weakly acidic cation exchange resin) manufactured by Organo Corporation. The fraction not adsorbed on the ion exchange resin is collected, and the resulting fraction is adjusted to Brix60. Ethanol is added to a final concentration of 75% by volume, followed by centrifugal separation under the conditions of 8000 rpm and lOmin. A fraction insoluble in an organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 5.3 g of a lyophilized product.
  • Amberlite IRC76 weakly acidic cation exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was placed in a column packed with Synthetic Adsorbent Amperai® XAD-16 manufactured by Organo Corporation. The fraction adsorbed on the synthetic adsorbent consisting of a flow-through liquid exhibiting non-adsorbability to the synthetic adsorbent of the column was fractionated by subjecting it to an adhesion separation treatment.
  • the obtained fraction Adjust to BrixlO, and pass 1 L of this adjusted fraction to BrixlO through a column packed with 500 ml of Amberlite IRA67 (weakly acidic anion exchange resin) manufactured by Organo Corp. After the fraction was adjusted to Brix60, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged at 8000 rpm and lOmin to obtain the organic solvent (ethanol). The insoluble fraction was collected, and the obtained fraction was freeze-dried to obtain 5.9 g of a freeze-dried product.
  • Amberlite IRA67 weakly acidic anion exchange resin
  • the barley shochu distillation residue obtained in the above-mentioned “Production of barley shochu and barley shochu distillation residue” fractions insoluble in an organic solvent were collected by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 kg, lOmin to obtain a liquid component, and the obtained liquid component was applied to a column packed with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated.
  • the obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite IR120B (strongly acidic cation exchange resin) manufactured by Organo Corporation. Fraction that is not adsorbed on the ion exchange resin is collected, and the resulting fraction is adjusted to Brix 60. Ethanol is added to a final concentration of 75% by volume, followed by centrifugation at 8000 rpm and lOmin. A fraction insoluble in an organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 5.6 g of a freeze-dried product.
  • Amberlite IR120B strongly acidic cation exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was applied to a column filled with synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated.
  • the obtained fraction The fraction 1 L adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corp., and the fraction not adsorbed to the ion exchange resin. After fractionation, the fraction obtained was adjusted to Brix 60, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged at 8000 rpm and lOmin, and insoluble in the organic solvent (ethanol). The fraction was collected, and the obtained fraction was freeze-dried to obtain 4.1 g of a freeze-dried product.
  • Amberlite 200CT strongly acidic cation exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged under the conditions of 8000 n> m and lOmin to obtain a liquid, and the resulting liquid was filled with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. By passing through a column and subjecting to an adsorption separation treatment, a fraction that was not adsorbed to the synthetic adsorbent consisting of a flow-through liquid that showed non-adsorbability to the synthetic adsorbent of the column was fractionated.
  • the obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite IRA402BL (strongest basic anion exchange resin) manufactured by Organo Corp. Fraction that is not adsorbed on the exchange resin, the resulting fraction is adjusted to Brix60, ethanol is added to a final concentration of 75% by volume, and the organic material is centrifuged at 8000 rpm and lOmin. The fraction insoluble in the solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 2.3 g of a freeze-dried product.
  • Amberlite IRA402BL strongest basic anion exchange resin
  • a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was applied to a column filled with synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated.
  • the obtained fraction The fraction 1 L adjusted to Br ixlO was adjusted to 350 ml of Amberlite IRC76 (weakly acidic cation exchange resin) by Organo Co., Ltd. and 150 ml of Amberlite IRA67 (organo Co., Ltd.) A weakly basic anion exchange resin) is passed through a column packed with a mixed bed ion exchange resin, and a fraction not adsorbed on the mixed bed ion exchange resin is collected. After adjustment to Brix60, ethanol was added to a final concentration of 75 volumes, and the mixture was centrifuged under the conditions of 8000 rpiii, lOmin, and the fraction insoluble in the organic solvent (ethanol) was collected. By subjecting the portion to freeze-drying, 1.9 g of a freeze-dried product was obtained.
  • the NK cell activity (ie, the activation action on M cells) was performed in the same manner as described in the Examples below. ) was measured.
  • the polysaccharide content and the total content of arabinose and xylose derived from the polysaccharide were measured by the following methods. That is, the fraction insoluble in each organic solvent obtained in Experiment 1 to Experiment 14 (lyophilized product) was dissolved by adding 0.5 ml of ion-exchanged water to 0.05 g, and 200 l of concentrated hydrochloric acid was added thereto to obtain 95 ° C. C.
  • the M cell activity exhibited by NK cells cultured separately by adding each of the fractions (lyophilized product) insoluble in the organic solvent obtained in Experiment 1 to Experiment 14 is the fraction insoluble in the organic solvent. It was revealed that the content was increased in proportion to the total content of arabinose and xylose derived from the polysaccharide contained in the minute. The correlation coefficient between the NK cell activity and the total content of arabinose and xylose derived from polysaccharide was found to be 0 ⁇ 961.
  • Shodex standard P-82 (molecular weight 1300 to 1660000) and maltotriose (molecular weight 504) manufactured by Showa Denko Co., Ltd. were separately dissolved in O. lmol / L sodium nitrate solution. A standard solution of 0.05 W / V agricultural power was obtained, and the standard solution was injected into a high performance liquid chromatograph to prepare a calibration curve. Next, prepare 0.02 g of the fraction insoluble in each organic solvent (lyophilized product) obtained in Experiment 1 to Experiment 10, and add 10 ml of O.
  • the barley shochu distillation residue obtained in the above-mentioned “Manufacture of barley shochu and barley shochu distillation residue” was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the liquid obtained After adjusting the volume to Brixl O, 1 L of the liquid volume adjusted to Brixl O was passed through a column packed with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation. Fraction that is not adsorbed on the exchange resin is obtained, and the obtained fraction is subjected to concentration treatment with an ultrafiltration membrane UFP-30-E-4MA (fraction molecular weight 30,000) manufactured by A / G Technology.
  • Amberlite 200CT strongly acidic cation exchange resin
  • the total content of polysaccharide-derived arabinose and xylose was measured by the method described in “Measurement of Polysaccharide Content” above. As a result, it was found that the total content of polysaccharide-derived arabinose and xylose increased to about 54.4 wt.
  • the molecular weight distribution of the fraction insoluble in the organic solvent was 100,000 to 5%, 30,000 to 100,000 are 18%, 10,000 to 30,000 are 23%, 3,000 to 10,000 are 31%, 1,000 From 3,000 to 11%, 500 to 1,000 was found to be 3%, and 500 or less was found to be 9%. From the results of the chromatogram obtained, it was revealed that the chromatogram of the fraction insoluble in the organic solvent had the highest peak in the molecular weight range of 3,000 to 10,000.
  • the NK cell activity of NK cells cultured by adding a fraction insoluble in the organic solvent was measured by the method described in the Examples below.
  • the NK cell activation action of the fraction insoluble in the organic solvent was extremely strong, and was comparable to the positive control IL-2.
  • the NK cell activation action of the fraction insoluble in the organic solvent fractionated from the liquid fraction of the barley shochu distillation residue is contained in the fraction insoluble in the organic solvent, arabinose and xylose.
  • a composition containing a significant amount of such polysaccharides mainly composed of arabinose and xylose is derived from a polysaccharide mainly composed of arabinose.
  • the liquid is subjected to solid-liquid separation to obtain a liquid component, which is subjected to an ion exchange treatment using an ion exchange resin to fractionate a fraction not adsorbed on the ion exchange resin, and the resulting ion exchange is obtained.
  • a fraction that is not adsorbed to the resin is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrate, and an organic solvent is added to the concentrate to obtain a fraction insoluble in the organic solvent. It was found that it can be sorted as .
  • the fraction insoluble in the organic solvent contains about 84.1% by weight of polysaccharide, about 4.2% by weight of crude protein, and about 0.3% by weight of organic acid. About 1.2% by weight The fraction was found to contain polysaccharides as the main component.
  • the barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” above was used.
  • the liquid is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, and the obtained liquid component is passed through a column filled with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation for adsorption separation treatment.
  • a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation for adsorption separation treatment.
  • Obtained fraction was adjusted to Brixl O, and then 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation.
  • Fractionated non-adsorbed fraction is subjected to concentration treatment with ultrafiltration membrane UFP-30-E-4MA (fractional molecular weight 30,000) manufactured by A / G Technology.
  • the resulting concentrate is adjusted to Brix20, ethanol is added to a final concentration of 75% by volume, and the mixture is centrifuged at 8000 n) m and lOmin, and the organic solvent (ethanol) is obtained.
  • Fraction-insoluble fraction was collected, and the obtained fraction was freeze-dried to obtain 1.3 g of a freeze-dried product.
  • the total content of polysaccharide-derived arabinose and xylose was measured by the method described in “Measurement of Polysaccharide Content” above. As a result, it was found that the total content of arabinose and xylose derived from polysaccharides increased to about 58.6% by weight.
  • the molecular weight distribution of the fraction (lyophilized product) insoluble in the obtained organic solvent was measured by the method described in “Measurement of molecular weight distribution” above, the fraction insoluble in the organic solvent was obtained.
  • the molecular weight distribution is 11% for 100,000 or more, 29% for 30,000 to 100,000, 24% for 10,000 to 30,000, 21% for 3,000 to 10,000, 1,000 to 3 , 000 was found to be 6%, 500 to 1,000 was 2%, and 500 or less was 7%. From the results of the obtained chromatogram, it was revealed that the chromatogram of the fraction insoluble in the organic solvent had the highest peak in the molecular weight range of 30,000 to 100,000. Therefore, the NK cell activity of NK cells cultured by adding a fraction insoluble in the organic solvent was measured by the method described in Examples below. As a result, the NK cell activation action of the fraction insoluble in the organic solvent was extremely remarkable, and was comparable to that of IL-2 as a positive control.
  • the NK cell activation action of the fraction insoluble in the organic solvent fractionated from the liquid content of the barley shochu distillation residue by the above-described method is the arabinose contained in the fraction insoluble in the organic solvent
  • the main composition of arabinose and xylose in this way A composition containing a significant amount of polysaccharide as an element is obtained by solid-liquid separation of the barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and this liquid is used as a synthetic adsorbent.
  • a fraction that is non-adsorbed on the synthetic adsorbent is obtained by subjecting it to an adsorption separation treatment, and the obtained fraction is subjected to an ion exchange treatment using an ion exchange resin to obtain a fraction that is not adsorbed on the ion exchange resin.
  • an ion exchange treatment using an ion exchange resin to obtain a fraction that is not adsorbed on the ion exchange resin.
  • the fraction insoluble in the organic solvent is about 78.5% by weight of polysaccharide, about 3.3% by weight of crude protein, about 0.2% by weight of organic acid, and free. It was found that the saccharide contained about 1.5% by weight, and the fraction contained polysaccharide as a main component.
  • the hemicellulos described in Patent Document 1 is similar to the composition having the action of activating NK cells of the present invention in that the main constituents are xylose and arabinose.
  • the hemicellulose has an average molecular weight of 550,000 or 600,000, it is clearly different from the composition having an action of activating NK cells of the present invention.
  • the immunity enhancing substance described in Patent Document 2 is similar to the composition having an action of activating M cells of the present invention in that the main components are xylose and arabinose. Since the force-enhancing substance has an average molecular weight of 600,000 or 650,000, it is clearly different from the composition having the action of activating NK cells of the present invention.
  • Patent Document 3 describes that an aqueous extract of sake lees produced as a by-product in sake production produced using rice as a raw material only through fermentation has an NK cell activation effect. However, Patent Document 3 does not describe the component composition of the aqueous extract at all, and does not specifically describe the component involved in the NK cell activation action.
  • Patent Document 4 describes an aqueous extract of rice bran from a fraction having a molecular weight of about 30,000 to 40,000. It is described that the composition for immunostimulation comprising the extract as described above has mitogenic activity and excellent NK cell activation action. However, Patent Document 4 does not describe the component composition of the immunostimulatory composition at all, and does not specifically describe the component involved in the immunostimulatory action. Patent Document 5 discloses that hemicellulose obtained by alkali extraction of the residue obtained by removing starch and protein from corn hull, which is marketed under the name of “Cel Ace”, is treated with xylanase.
  • Non-Patent Document 1 includes “Celace” (partially decomposed hemicellulose obtained from corn hulls) described in Patent Document 5 containing xylose, arabinose, uronic acid, galactose, and glucose. It is described that it is. Therefore, Patent Document 5 and Non-Patent Document 1 relate to the same “partially decomposed product of hemicellulose obtained from corn hulls”, that is, commercially available “Cell Ace”.
  • the composition having an action of activating NK cells of the present invention produces barley koji and steamed barley using barley as a raw material, and the starch contained in the obtained barley koji and steamed barley is added to the barley koji. Saccharified, and then subjected to alcoholic fermentation with yeast to obtain shochu-ripened mash, and the resulting shochu-ripened mash is subjected to distillation to produce shochu, that is, a by-product distillation residue, that is, barley shochu mash distillation residue It is obtained from the liquid. That is, the source for obtaining the composition having the effect of activating NK cells of the present invention is barley shochu distillation residue.
  • the acquisition source of “cell ace”, a partial degradation product of hemicellulose described in Patent Document 5 is corn hull, that is, hull of corn kernel that is removed when corn kernel is refined.
  • both sources are completely different.
  • the composition having the action of activating NK cells of the present invention is obtained by a production method completely different from the method for producing a partially decomposed product of hemicellulose described in Patent Document 5.
  • the NK cells of the present invention The composition having an activating effect contains arabinose, xylose and glucose, but does not substantially contain uronic acid.
  • the partially decomposed product of hemicellulose described in Patent Document 5 contains a relatively large amount of uronic acid. In this respect both
  • the composition having the effect of activating the M cells of the present invention is clearly distinguished from the partially decomposed product of hemicellulose (trade name Cellace) obtained from corn hull described in Patent Document 5. Obviously it is different.
  • the average molecular weight of the partially degraded hemicellulose is preferably 20,000 to 200,000, more preferably 20,000 to 100,000, and 20,000 to 40,000.
  • the experimental data that led to the determination of the average molecular weight is not described at all, and a specific example of obtaining a partially decomposed product of hemicellulose having such an average molecular weight is as follows. It is not described at all.
  • Patent Document 5 a partially decomposed product of hemicellulose is marketed under the trade name “Cel Ace” (manufactured by Nippon Shokuhin Kako Co., Ltd.).
  • Cellace was obtained, and the molecular weight distribution of Cellace was measured by the method described in“ Measurement of molecular weight distribution ”described above.
  • the molecular weight distribution of Cell Ace is 1% for 1 million or more, 9% for 300,000 to 1 million, 30% for 100,000 to 300,000, 30% for 30,000 to 100,000, and 10,000 to 30,000.
  • the molecular weight distribution of the composition having the effect of activating the M cells of the present invention is only 5% or 11% of 100,000 or more, and has a molecular weight of 3,000 to 100,000.
  • Components with molecular weight distribution in the range account for 72% or 74% of the total.
  • the highest peaks observed in the chromatogram are molecular weights of 3,000 to 10,000, respectively. Is present in the molecular weight range of 30,000 to 100,000.
  • the molecular weight distribution of the composition having the action of stimulating NK cells of the present invention is “cell suspension”, that is, a composition comprising a partial degradation product of hemicellulose obtained from corn hulls. It is completely different from the molecular weight distribution. Therefore, it is clear that the composition having the effect of activating NK cells of the present invention is different from the partial degradation product of hemicellulose described in Patent Document 5.
  • Patent Document 6 describes a composition having an action to suppress fat dryness from a barley shochu distillation residue.
  • the source of the composition having an action to suppress fatty liver is barley shochu distillate as in the case of the composition having an action to activate NK cells of the present invention. It is different from the action to become.
  • the main component of the composition described in Patent Document 6 has a molecular weight of 3000 or less, and the micelle mouth contained in the composition contains xylose as a main component. It is a distinct distinction from a composition that has the effect of activating cells.
  • the composition having the effect of activating the M cells of the present invention is produced as follows. That is, Step A to obtain a liquid component by solid-liquid separation of the barley shochu distillation residue that is a by-product in the production of distilled liquor using barley, and the obtained liquid component is subjected to an ion exchange treatment using an ion exchange resin. Step B 1 for obtaining a non-adsorbed fraction on the ion exchange resin, and subjecting the obtained non-adsorbed fraction to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane. It is produced by sequentially performing Step C for obtaining a concentrated solution and Step D for fractionating a fraction insoluble in the organic solvent by adding an organic solvent to the obtained concentrated solution.
  • the composition having an action of activating NK cells of the present invention is produced as follows. That is, Step A to obtain a liquid component by solid-liquid separation of a barley shochu distillation residue, which is a by-product in the production of distilled liquor using barley, and the obtained liquid component using a synthetic adsorbent. Step E to obtain a fraction that is not adsorbed to the synthetic adsorbent by subjecting it to an adsorption separation treatment, and the fraction that is not adsorbed to the synthetic adsorbent thus obtained is subjected to an ion exchange treatment using an ion exchange resin.
  • Step B 2 for obtaining a non-adsorbed fraction on the ion exchange resin, and subjecting the obtained non-adsorbed fraction to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane.
  • the step C is obtained by sequentially performing the step C for obtaining a concentrated liquid and the step D for fractionating a fraction insoluble in the organic solvent by adding an organic solvent to the obtained concentrated liquid.
  • the barley shochu distillation residue used in the present invention typically comprises barley koji and steamed barley using barley or polished barley as a raw material, and the starch contained in the barley koji and steamed barley obtained is When saccharifying with barley koji, subjecting them to alcoholic fermentation with yeast to obtain shochu-ripened mash, and distilling the obtained shochu-ripened mash with a single distillation apparatus such as vacuum distillation or atmospheric distillation Means a by-product as a distillation residue, that is, a distillation residue of barley shochu.
  • the barley koji used for the production of barley shochu may be produced under the koji-making conditions used in normal barley shochu production.
  • the Aspergillus kawachi i generally used in the production of barley shochu is preferable.
  • Aspergi lus genus strains such as Aspergillus awamori used in awamori manufacture and Aspergi lus oryzae used in sake production and the like can also be used.
  • various yeasts for brewing shochu can be used as the yeast used in the production of barley shochu.
  • the step A for obtaining a liquid component by solid-liquid separation of the barley shochu distillation residue obtained in the distillation step in the production of barley shochu is made from raw barley or barley koji derived from the barley shochu distillation residue.
  • the purpose is to remove SS components such as water-insoluble fermentation residues.
  • the solid-liquid separation in step A can be performed by screw press or -Preliminary separation is performed by a solid-liquid separation method using the Ler press method or using a filter-press type solid-liquid separator, and then using a centrifuge, a diatomaceous earth filter, a ceramic filter, or a filter-press
  • the solid-liquid separation process that can be performed according to the present invention is performed.
  • the step E of obtaining a non-adsorbed fraction on the synthetic adsorbent by subjecting the liquid content of the barley shochu distillation residue obtained in the step A to an adsorption separation process using a synthetic adsorbent is a barley shochu distillation
  • the purpose is to remove components such as polyphenol contained in the liquid content of the residual liquid.
  • an aromatic, aromatic modified, or methacrylic synthetic adsorbent can be used.
  • Preferable specific examples of the synthetic adsorbent used in Step E include Amberlay XAD-4, Amberlay XAD-16, Amberlite XAD-1180 and Amperlite XAD-2000 manufactured by Organo Corporation.
  • Aromatic (or styrene) synthetic adsorbents such as Sepabeads SP850 and Diaion HP20 manufactured by Mitsubishi Chemical Co., Ltd. Amperlite XAD-7 manufactured by Organo Co., Ltd. and Diamond manufactured by Mitsubishi Chemical Co., Ltd. Examples include methacrylic (or acrylic) synthetic adsorbents such as Ion HP2MG. In addition to these, aromatic modified synthetic adsorbents such as Sepapies SP207 manufactured by Mitsubishi Chemical Corporation may be used in some cases.
  • step B2 in which the fraction adsorbed on the synthetic adsorbent obtained in E is subjected to an ion exchange treatment using an ion exchange resin to obtain a fraction not adsorbed on the ion exchange resin, the liquid fraction or Components other than the above-mentioned polysaccharides contained in the non-adsorbed fraction of the synthetic adsorbent, that is, amino acids, peptides, proteins, organic acids, or barley-derived polyphenols are removed using an ion exchange resin.
  • the ion exchange resin used in Step B1 and Step B2 includes a cation exchange resin, an anion exchange resin, or a mixed bed ion in which both are mixed.
  • Exchange resins can be used.
  • a cation exchange resin either a strong acid cation exchange resin or a weak acid cation exchange resin can be used.
  • an anion exchange resin a strong base anion exchange resin and a weak base are used. Any sex anion exchange resin can be used.
  • a mixed bed ion exchange resin the above-described cation exchange resin and anion exchange resin can be freely combined and used at a predetermined ratio.
  • ion exchange resins include strong acid cation exchange resins such as Amberlite 200CT and Amberlite IR120B manufactured by Organo Corp., weak acid cation exchange resins such as Amberly MRC76, and amperite. Strongest basic anion exchange resin such as IRA402BL, weak basic anion exchange measurement such as Amberlite IRA67, or both the weak acid cation exchange resin and the weak basic anion exchange resin at a predetermined ratio A mixed bed type ion exchange resin obtained by mixing can be used.
  • strong acid cation exchange resins such as Amberlite 200CT and Amberlite IR120B manufactured by Organo Corp.
  • weak acid cation exchange resins such as Amberly MRC76
  • Strongest basic anion exchange resin such as IRA402BL, weak basic anion exchange measurement such as Amberlite IRA67, or both the weak acid cation exchange resin and the weak basic anion exchange resin at a predetermined ratio
  • a mixed bed type ion exchange resin obtained by mixing can be used.
  • the weak acid cation exchange resin Amberlite IRC76 and the above-mentioned weak It is particularly preferable to use a mixed bed type ion exchange resin obtained by mixing both basic anion exchange resin ampere lye IRA67 at a predetermined ratio, or Amberlite 200CT, a strongly acidic cation exchange resin. preferable.
  • the purpose is to concentrate a polysaccharide mainly composed of arabinose and xylose, which are components involved in NK cell activation, using an ultrafiltration membrane.
  • the ultrafiltration membrane used in Step C any membrane material and membrane module type can be used, and the molecular weight cut-off is preferably 3000 or more, particularly preferably 10,000 to 50,000. Can be used.
  • the concentration rate of ultrafiltration to preferably 2 times or more, particularly preferably 5 times or more, a polysaccharide composed of arabinose and xylose.
  • a composition having an effect of activating the M cells of the present invention containing a significant amount of can be obtained.
  • step D in which an organic solvent is added to the concentrate obtained in step C to fractionate a fraction insoluble in the organic solvent, an appropriate organic solvent is added until a predetermined final concentration is reached.
  • an organic solvent is optimal as the organic solvent, but the organic solvent is not limited to this.
  • the final concentration of the organic solvent affects the production efficiency of the components, and the optimum final concentration of the organic solvent is preferably 5 volume% or more, more preferably 30 to 75 volume%.
  • the composition having the action of activating NK cells of the present invention obtained as described above is obviously of course administered directly as it is, as is apparent from the results of test examples in the examples described later.
  • the desired NK cell activation effect can also be obtained by dispersing the composition in a suitable carrier such as physiological saline and administering it to a patient by intravenous injection.
  • the present invention also provides a composition containing NK cells activated with the composition having an action of activating NK cells (hereinafter referred to as an activated NK cell-containing composition).
  • the activated NK cell-containing composition collects blood from an affected person such as leukemia, separates the obtained blood into lymphocytes and serum composed of immune cells such as NK cells, and the lymphocytes are separated into the NK cells.
  • the activated NK cell-containing composition obtained in this way is washed with a drip physiology Can be suspended in saline and administered via intravenous infusion.
  • Such activated NK cell-containing composition has the effect of necrotizing K562 cells. Therefore, the activated NK cell-containing composition can be used as a therapeutic agent for (myeloid) leukemia.
  • UFP-30-E-4MA fractional molecular weight 30,000
  • the resulting concentrated solution is adjusted to Brix20, and the final concentration is 75 volumes. Ethanol was added so that the concentration of the lyophilized product was 10%. Centrifugation was performed at 8000 rpm and lOmin, and a fraction insoluble in the organic solvent (ethanol) was collected. 2. 5g was obtained. The lyophilized product was powdered to obtain a grayish white, tasteless and odorless composition.
  • the barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” was centrifuged at 8000 rpm and lOmin to obtain a liquid content of the barley shochu distillation residue.
  • a column filled with a synthetic adsorbent amperite XAD-16 manufactured by Co., Ltd. By passing through a column filled with a synthetic adsorbent amperite XAD-16 manufactured by Co., Ltd. and subjecting it to an adsorption separation treatment, the above-mentioned flow-through liquid that exhibits non-adsorbability to the synthetic adsorbent of the column is used. The fraction not adsorbed on the synthetic adsorbent was collected.
  • the fraction that was not adsorbed to the resulting synthetic adsorbent was adjusted to Br ixlO, and 1 L of the fraction adjusted to Br ixlO was added to 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation.
  • a fraction that is not adsorbed to the ion exchange resin is obtained, and the obtained fraction is filtered with an ultrafiltration membrane UFP-30-E-4MA manufactured by A / G Technology (fractionated molecular weight 3
  • the resulting concentrate is adjusted to Brix20, ethanol is added to a final concentration of 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin.
  • a fraction insoluble in the organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 1.3 g of a lyophilized product.
  • the freeze-dried product was powdered to obtain an off-white, tasteless and odorless composition.
  • Example 2 In order to clarify whether the compositions obtained in Example 2 and Comparative Example 1 have an activating effect on NK cells, the following Test Example 1 was performed.
  • heparin-added peripheral blood was collected from healthy humans, diluted twice with physiological saline, and the diluted blood was overlaid on Lymphosepar I (manufactured by Immune Biology Laboratories) at room temperature. After centrifugation at 1500 ⁇ for 30 minutes, the plasma was removed using a pipette to obtain a fraction of peripheral blood mononuclear cells ( ⁇ C). Next, the PBMC fraction obtained to obtain a S t emSep NK cell fraction Ri by the subjecting (manufactured by Veritas), the NK cell fraction obtained 5% C0 2 atmosphere at 37 ° C for Culture was performed to obtain a NK cell culture solution.
  • the obtained M cell culture solution was centrifuged at 1000 rpm for 5 minutes to collect NK cells.
  • the number of NK cells collected was adjusted to IX cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain an NK cell suspension.
  • K562 cells chronic myeloid leukemia cells obtained by subculture are centrifuged to separate the K562 cells, which are then washed with PBS (Phosphat e-bufered saline).
  • PBS Phosphat e-bufered saline
  • NK cell culture solution thus obtained was centrifuged at 1000 rpm for 5 minutes to collect NK cells.
  • the number of NK cells collected was adjusted to IX cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain effect cells.
  • the target cells adjusted to the optimum concentration were dispensed 100 1 into a 96-well V-bottom plate, and the effector cells were mixed separately. Plate mixing said target cell and said effector cells are, 800 rpm, centrifuged for 2 minutes, 5% C0 2 atmosphere, after 4 hours at 37 ° C, each culture 100 1 were taken, respectively, Measure the K562 cell viability using the following formula, using the CeilTiter-Glo Luminescent Cel 1 Vi ab i 1 i Assay Assay kit (Promega), and determine the NK cells of each sample. It was used as an index of activation ability.
  • K562 cell viability ⁇ (Luminescence of [NK cells + K562 cells treated with each sample]) 1 (Luminescence of NK cells only) ⁇ / (Luminescence of K562 cells treated with PBS) X 100
  • Table 1 shows the measurement results of NK cell activity against K562 cells. The following facts were found from the results shown in Table 1. That is, NK cells obtained by adding a predetermined amount of the composition obtained in Comparative Example 1 and subjecting it to culture are more than NK cells obtained by adding the predetermined amount of IL-2 and subjecting it to culture. Slightly low NK cell activity was shown. On the other hand, NK cells obtained by adding a predetermined amount of the composition obtained in Example 1 and Example 2 and subjecting them to culture are obtained by adding the predetermined amount of IL-2 and subjecting them to culture. It was revealed that the cells have extremely remarkable NK cell activation ability comparable to that of M cells.
  • NK cells By the way, in afflicted patients such as malignant tumors, the activity of NK cells is reduced.
  • the cytotoxic activity against tumor cells caused by the NK cells is also extremely low. Therefore, the following tests were conducted for the purpose of more practically evaluating the NK cell activation by the fraction insoluble in the organic solvent and the resulting cytotoxic activity against tumor cells.
  • heparin-added peripheral blood was collected from healthy humans, diluted twice with physiological saline, and the diluted blood was overlaid on Lymphosepar I (manufactured by Immune Biology Laboratories) at room temperature. After centrifugation at 1500 rpm for 30 minutes, plasma was removed using a pipette to obtain a fraction of peripheral blood mononuclear cells (IC). Then, the resulting: PBMC fraction to obtain a StemSep NK cell fraction Ri by the subjecting (manufactured by Veritas), and the NK cell fraction obtained 5% C0 2 atmosphere, the culture at 37 ° C for The NK cell culture solution was obtained.
  • Lymphosepar I manufactured by Immune Biology Laboratories
  • the obtained NK cell culture solution was centrifuged at 1000 rpm for 5 minutes to collect NK cells.
  • the number of cells of each collected NK cell was adjusted to IX 10 6 cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain an NK cell suspension.
  • K562 cells chronic myeloid leukemia cells obtained by subculture are centrifuged to separate the K562 cells and washed twice with PBS (Phosphate-buf fered saline). Subsequently, the cells were further washed with RPMI-1640 medium supplemented with CS, to obtain target cells consisting of K562 cells.
  • the NK cell suspension was dispensed into a 96-well V-bottom plate at a rate of 1001, and the target cells adjusted to the optimum concentration were added at a rate of 100 U.
  • the cells were cultured for 4 hours at 37 ° C. in a 5% CO 2 atmosphere.
  • 100 L of the target cells adjusted to the optimal concentration was added to another M cell suspension 100 1, and then the RPMI-1640 medium with 10% FCS was added to 22 ⁇ 1. The same treatment was applied to the material to which the slag was added.
  • the target cell 100 ⁇ ⁇ adjusted to the optimal concentration was added to another ⁇ cell suspension 100 1, and then the RPMI-1640 medium supplemented with 10% FCS was used.
  • IL-2 water prepared to a concentration of lmg / ml The same treatment was applied to the solution to which 22 1 was added.
  • 100 1 of each culture was collected, and the amount of ATP was measured using CelTiter-Glo Luminescent Cell Viability Assay Kit (Promega), and the survival rate of K562 cells was calculated using the following formula.
  • K562 cell viability (%) ⁇ ([Luminescence of [NK cells + K562 cells treated in each sample])]
  • Table 2 shows the measurement results of the cytotoxic activity when the lyophilized product obtained in Comparative Example 1 was added to the mixture of M cells and K562 cells.
  • the following facts were found from the results shown in Table 2. That is, when the lyophilized product obtained in Comparative Example 1 was added to the mixture of NK cells and K562 cells in the predetermined amount, it was clearer than the case where the predetermined amount of IL-2 was added to the mixture. Showed low cytotoxic activity. On the other hand, when the predetermined amount of the lyophilized product obtained in Example 1 and Example 2 was added to the mixture of NK cells and K562 cells, it was comparable to the case where the predetermined amount of IL-2 was added to the mixture. It was found to exhibit extremely strong cytotoxic activity.
  • Example 1 and Example 2 when the lyophilized product of Example 1 and Example 2 is added to a mixture of NK cells and K562 cells, it not only significantly activates NK cells but also suppresses the proliferation of K562 cells. From the above, it was revealed that there is an excellent leukemia treatment effect.
  • Example 2 In order to clarify the in vivo NK cell activation action of the freeze-dried fraction insoluble in the organic solvent obtained in Example 1 and Example 2, the following test was performed. That is, C57BL / 6 mice (3 weeks old, 10 mice per group) were fed with a diet (control group) that did not contain the composition having the effect of activating NK cells of the present invention, and the organic obtained in Example 1 Diet containing 0.5% and 1.0% of lyophilized fraction insoluble in solvent (test group 1), and lyophilized fraction insoluble in organic solvent obtained in Example 2 of 0. 5% and 1.0% diet (Test group 2) was ingested, and after 5 weeks, the spleens were removed from both groups of mice, the number of cells was counted and NK fine Cell activity was measured as follows.
  • spleen cells were suspended in C-RMI medium, and cell-labeled with fluorescein isothiocyanate (FITC) -conjugated anti-mouse IL-2 / 3 receptor antibody and phycoerythrin 0PE) -conjugated anti-mouse CD3 antibody,
  • FITC fluorescein isothiocyanate
  • the NK cell fraction was measured by flow cytometry, and the CD3-IL-2 ⁇ + fraction was identified as M cells.
  • NK cell activity (%) was calculated from the following formula using a scintillation counter.
  • NK cell activity (%) [(experimental release-spontaneous release) / (maximum release-spontaneous release)] X 100
  • Table 3 shows the results of measurement of the number of spleen cells, NK cell fraction, and spleen cell-derived NK cell activity.
  • test group 1 ingesting a diet containing 0.5% and 1.0% of the composition having the effect of activating NK cells obtained in Example 1, and the organic solvent obtained in Example 2 above.
  • the spleen cell-derived NK cell activity in test group 2 that received diets containing 0.5% and 1.0% lyophilized fractions insoluble in erythrocyte significantly increased compared to the control group, respectively. It has been found.
  • the number of spleen cells and NK cell fraction there was no significant difference between the three groups consisting of test group 1, test group 2 and control group. From these results, it became clear that the composition having an action of activating NK cells of the present invention activates NK cells even in vivo.
  • the M cells of the present invention which are mainly composed of polysaccharides consisting of alapinose and xylose, obtained from the barley shochu distillation residue, are activated. It has been found that a composition having an action has an excellent activation effect on NK cells.
  • composition having the effect of activating NK cells of the present invention has a very remarkable NK cell activation effect comparable to IL-2, which is a known NK cell activator, so leukemia is repelled. It is extremely suitable for the treatment of cancer.
  • NK cell activity (3 ⁇ 4) 2.70 ⁇ 0.25 18.8 ⁇ 2.97 21.6 ⁇ 5.18 20.2 ⁇ 4.31 22.8 ⁇ 3.75 fl Number of base cells (x10 a ) 1.17 ⁇ 0.31 1.18 ⁇ 0.16 1.08 + 0.61 1.22 ⁇ 0.38 1.09 ⁇ 0.45 NK cell fraction ( .81 ⁇ 0.14 62 ⁇ 0.71 4.43 ⁇ 0.29 4,29 ⁇ 0.87 4.58 ⁇ 1.27

Abstract

A composition capable of activating natural killer cells comprising a fraction which is substantially free from uronic acid, contains polysaccharides comprising xylose, arabinose and glucose and is insoluble in an organic acid solvent. This fraction is obtained by subjecting barley shochu (distilled spirit) stillage to solid-liquid separation to give a liquid, subjecting this liquid to an ion exchange treatment using an ion exchange resin to give a fraction (a) not adsorbed by the ion exchange resin, or subjecting the above-described liquid to an adsorption separation treatment using a synthetic adsorbent to give a fraction (b) not adsorbed by the synthetic adsorbent, then subjecting this fraction (b) to an ion exchange treatment using an ion exchange resin to give the above-described fraction (a), concentrating the thus obtained fraction (a) by ultrafiltration using an ultrafiltration membrane to give a liquid concentrate, and adding the above-described organic solvent to the liquid concentrate. A composition containing natural killer cells having been inactivated with the use of the above composition.

Description

明 細 書  Specification
ナチュラルキラー細胞を賦活化する作用を有する組成物及びその製造方法、及び 前記組成物を使用して賦活化したナチュラルキラ一細胞を含有する組成物 及びその製造方法 技術分野 TECHNICAL FIELD The present invention relates to a composition having an action of activating natural killer cells and a method for producing the same, and a composition containing natural killer cells activated using the composition and a method for producing the same.
本発明は、大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液(以 下、 "大麦焼酎蒸留残液" と略称する) を固液分離して液体分を取得し、 前記液 体分をその ί尽か、或いは前記液体分を合成吸着剤を使用する吸着分離処理に付す ことにより分取した前記合成吸着剤に非吸着の画分を、イオン交換樹脂を使用す るイオン交換処理に付して前記イオン交換樹脂に非吸着の画分を分取し、分取し た前記イオン交換樹脂に非吸着の画分を限外濾過膜を使用する限外濾過による 濃縮処理に付して濃縮液を得、該濃縮液に有機溶媒を添加することにより分取し た、ナチュラルキラー細胞を賦活化する作用を有する前記有機溶媒に不溶の画分 からなる組成物及びその製造方法に関する。 本発明は、 また、 ナチュラルキラー 細胞と前記有機溶媒に不溶の画分からなる組成物を使用して賦活化したナチュ ラルキラ一細胞を含有する組成物及びその製造方法を包含する。 背景技術  The present invention obtains a liquid component by solid-liquid separation of a barley shochu distillation residue (hereinafter abbreviated as “barley shochu distillation residue”) by-produced in the production of shochu using barley as a raw material, The fraction that has not been adsorbed to the synthetic adsorbent, which has been collected by exhausting the fraction or subjecting the liquid to an adsorption separation treatment using a synthetic adsorbent, is subjected to ion exchange treatment using an ion exchange resin. The fraction that is not adsorbed on the ion exchange resin is fractionated, and the fraction that is not adsorbed on the ion exchange resin is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane. It is related with the composition which consists of a fraction insoluble in the said organic solvent which has the effect | action which activates a natural killer cell collected by adding an organic solvent to this concentrated liquid, and its manufacturing method, and its manufacturing method. The present invention also includes a composition containing a natural killer cell and a natural killer cell activated by using a composition comprising a natural killer cell and a fraction insoluble in the organic solvent, and a method for producing the same. Background art
ナチュラルキラ一細胞 (以下、 "ΝΚ細胞" と呼称する) は、 動物 (ヒト、 マウ ス、 ハムスター、 ラット、 ニヮトリ、 ブタなど) のリンパ組織中に見出されてい る。 そうした ΝΚ細胞は、 形態学的には、 細胞質内にァズ一ル顆粒を含有するやや 大型のリンパ球 (LGL) で、 リンパ球中の数%を占めており、 免疫的記憶なしに、 ある種の腫瘍細胞(主として造血器系腫瘍) を非特異的に破壊することができる ことから、腫瘍発生に対する生体の防御機構の一翼を担っていると考えられてい る。更に、 B細胞や T細胞が抗原特異的な獲得免疫を司るのに対して、 ΝΚ細胞は免 疫反応の極く初期に働く抗原非特異的な自然免疫に重要な役割を果たし、 Β細胞 レセプ夕—や Τ細胞レセプ夕一を有さないにもかかわらず、 自己と非自己を正確 に識別し、事前の抗原の感作なしにウィルス感染細胞や腫瘍細胞を壊死に至らし めることが知られている。 Natural killer cells (hereinafter referred to as “spider cells”) are found in the lymphoid tissues of animals (humans, mice, hamsters, rats, chickens, pigs, etc.). These sputum cells are morphologically somewhat large lymphocytes (LGLs) that contain azul granules in the cytoplasm, occupying a few percent of lymphocytes, and without immune memory. It is thought that it plays a part in the defense mechanism of the body against tumor development because it can destroy non-specific tumor cells (mainly hematopoietic tumors). The Furthermore, whereas B cells and T cells are responsible for antigen-specific acquired immunity, sputum cells play an important role in non-antigen-specific innate immunity that acts at the very beginning of the immune response. Even though it does not have a sputum cell receptor, it can accurately identify self and non-self and can cause necrosis of virus-infected cells and tumor cells without prior antigen sensitization. Are known.
ところで、 近年、 がん ·糖尿病をはじめとする難病 (生活習慣病) の治療など において、合成医薬に依存する治療方法では、克服し難い副作用の問題が往々に してあることから、そうした合成医薬による副作用のない治療方法として、人間 に本来備わっている免疫力 (自己治癒力) を天然素材を原料とする薬効食品など を使って増強させる所謂代替医療による治療方法が注目されている。そうした代 替医療は患者主体の治療方法であり、副作用の心配が少ないことから、特にァメ リカでは、 全体の 60%の医師が患者に代替医療をすすめ、 がん患者の約半数以上 が代替医療を行っていることが報告されている。 日本国内でも、 1998年 2月に初 めての 「代替医療」 に関する学術合議が日本国内で開催されたこともあって、 代 替医療への関心が高まっている。 こうしたことから、 各種の天然物に由来する ΝΚ 細胞を賦活化する物質が、免疫力増強物質の一つとして医薬品や薬効食品として 徐々に使用されるようになっており、将来的には、その使用は一般に普及するも のと思われる。  By the way, in recent years, in the treatment of intractable diseases (lifestyle-related diseases) such as cancer and diabetes, the treatment methods that depend on synthetic drugs often have problems of side effects that cannot be overcome. As a treatment method that does not have side effects caused by the above, a so-called alternative medicine treatment method that enhances the immunity (self-healing power) inherent in humans by using medicinal foods made from natural materials is attracting attention. Because such alternative medicine is a patient-centered treatment and there are few concerns about side effects, 60% of doctors recommend alternative medicine to patients, especially in the United States, and more than half of cancer patients substitute. It is reported that medical care is provided. In Japan as well, interest in alternative medicine has increased as the first academic council on “alternative medicine” was held in February 1998 in Japan. For these reasons, substances that activate す る cells derived from various natural products are gradually being used as pharmaceuticals and medicinal foods as one of the immunity enhancing substances, and in the future, Use seems to be popular.
そうした天然物に由来する ΝΚ細胞を賦活化する物質としては、以下に述べるよ うに幾つか知られている。 例えば、 日本国特許公報第 2532899号 (以下、 "特許 文献 1" と呼称する) には、 米糠、 ふすま、 稲わら又はバガスの植物組織原料を ァスペルギルス属またはバシディォマイセトス属である糸状菌の培養液中で資 化することを特徴とする免疫賦活作用を有するへミセルロースの製造方法が記 載されている。そして、 該製造方法を介して得られる免疫賦活作用を有するへミ セルロースは、主たる構成要素がキシロース及びァラビノースであり、平均分子 量が 55万又は 60万である旨記載されている。 尚、 特許文献 1に於ける前記米糠、 ふすま、稲わら又はバガスは、大麦穀粒の外皮を除去する精白を行った精白粒を アルコール発酵に付した後蒸留を行って焼酎を製造する際に副生する蒸留残渣 である大麦焼酎蒸留残液とは全く異なるものである。 As described below, several substances that activate sputum cells derived from such natural products are known. For example, Japanese Patent Publication No. 2532899 (hereinafter referred to as “Patent Document 1”) describes a filamentous fungus of the genus Aspergillus or Basidiomycetus as a plant tissue raw material of rice bran, bran, rice straw or bagasse. Describes a method for producing hemicellulose having an immunostimulatory action, characterized by being assimilated in the culture medium. The hemicellulose having an immunostimulatory effect obtained through the production method is described as having main components xylose and arabinose and having an average molecular weight of 550,000 or 600,000. In addition, the rice bran in Patent Document 1, The bran, rice straw, or bagasse is the residue of barley shochu that is a by-product of the distillation of the whitened grains that have undergone whitening to remove the hulls of barley grains, followed by distillation after alcohol fermentation. It is completely different from liquid.
特開平 9-23895号公報 (以下、 "特許文献 2 " とする) には、 イネ科植物、 特に米糠などの植物組織水溶性多糖を調製して水溶性多糖体を取得し、これとは 別に糸状菌の細胞外酵素を調製して酵素複合体を取得し、前記水溶性多糖体と前 記酵素複合体とを混合し、所定 PHで所定時間反応させることにより得られる免疫 力増強物質が、 NK細胞を賦活化する作用を有することが記載されている。 また、 該免疫力増強物質は、平均分子量が 60万または 65万であり、主たる構成要素がキ シロース及びァラビノースであることが記載されている。尚、特許文献 2に於け る前記米糠は、脱穀した玄米を精白する際に生ずる副産物であり、大麦穀粒の外 皮を除去する精白を行った精白粒をアルコール発酵に付した後蒸留を行って焼 酎を製造する際に副生する蒸留残渣である大麦焼酎蒸留残液とは全く異なるも のである。  In JP 9-23895 (hereinafter referred to as “Patent Document 2”), water-soluble polysaccharides are obtained by preparing water-soluble polysaccharides of plant tissues such as gramineous plants, especially rice bran. An immunity enhancing substance obtained by preparing an extracellular enzyme of a filamentous fungus to obtain an enzyme complex, mixing the water-soluble polysaccharide and the enzyme complex, and reacting at a predetermined pH for a predetermined time, It is described that it has an effect of activating NK cells. Further, it is described that the substance for enhancing immunity has an average molecular weight of 600,000 or 650,000, and main components are xylose and arabinose. In addition, the rice bran in Patent Document 2 is a by-product generated when whitening the threshed brown rice, and after subjecting the whitened grains that have been whitened to remove the hulls of barley grains to alcohol fermentation, distillation is performed. It is completely different from the barley shochu distillation residue, which is a distillation residue produced as a by-product during the production of shochu.
特開平 10-146166号公報 (以下、 "特許文献 3" とする) には、 米をアルコー ル発酵に付して清酒を製造する際に副生する酒粕の水抽出液が NK細胞活性化作 用を有することが記載されている。 尚、 特許文献 3に於ける酒粕は、 米をアルコ —ル発酵に付した後搾りに掛けて得られる液体分を清酒製品として分取した後 の残渣である固体分である。 従って、 特許文献 3に於ける酒粕は、 大麦穀粒の外 皮を除去する精白を行った精白粒をアルコール発酵に付した後蒸留を行って焼 酎を製造する際に副生する蒸留残渣である大麦焼酎蒸留残液とは全く異なるも のである。  In Japanese Patent Laid-Open No. 10-146166 (hereinafter referred to as “Patent Document 3”), an aqueous extract of sake lees produced as a by-product when rice is subjected to alcoholic fermentation to produce sake is activated by NK cell activation. It is described to have In addition, the sake lees in Patent Document 3 is a solid content which is a residue after separating the liquid obtained by subjecting rice to alcoholic fermentation and then squeezing it as a sake product. Therefore, the sake lees in Patent Document 3 is a distillation residue produced as a by-product in producing shochu by subjecting the refined grains that have undergone whitening to remove the hulls of barley grains to alcohol fermentation and then distilling them. It is completely different from a barley shochu distillation residue.
特開 2002-255843号公報 (以下、 "特許文献 4" と呼称する) には、 米糠の水 抽出物であって、分子量 30000乃至 40000程度の画分からなる抽出物を含有してな る免疫賦活用組成物が記載されている。 また、 特許文献 4には、 前記組成物はマ ィトジェン活性及び優れた NK細胞の活性化作用を有する旨記載されている。特許 文献 4に於ける米糠は、 脱穀した玄米を精白する際に生ずる副産物であり、 大麦 穀粒の外皮を除去する精白を行った精白粒をアルコール発酵に付した後蒸留を 行って焼酎を製造する際に副生する蒸留残渣である大麦焼酎蒸留残液とは全く 異なるものである。 Japanese Unexamined Patent Publication No. 2002-255843 (hereinafter referred to as “Patent Document 4”) describes an immunostimulation comprising a water extract of rice bran and comprising an extract having a molecular weight of about 30000 to 40000. A composition for use is described. Patent Document 4 describes that the composition has mitogenic activity and excellent NK cell activation action. Patent The rice bran in Ref. 4 is a by-product generated when whitening the threshed brown rice, and the whitened grains that have undergone whitening to remove the hulls of barley grains are subjected to alcoholic fermentation followed by distillation to produce shochu. It is completely different from the barley shochu distillation residue, which is a by-product distillation residue.
特開 2002-338475号公報 (以下、 "特許文献 5" と呼称する) には、 「セルェ —ス」 の商品名で市販されている、 トウモロコシ外皮から得られたへミセル口一 スの部分分解物を有効成分として含有する抗腫瘍組成物が記載されている。特許 文献 5には、前記へミセルロースの部分分解物は、平均分子量が 2万乃至 20万であ り、 該部分分解物を投与した colon26担癌マウスにおいては、 NK細胞活性が有意 に上昇し、 更にサイトカイン (IL- 2及び INF -ァ) 産生能も有意に上昇することが 記載されている。  Japanese Unexamined Patent Publication No. 2002-338475 (hereinafter referred to as “Patent Document 5”) discloses a partial decomposition of a hemicell mouthpiece obtained from corn hull, which is commercially available under the trade name “Celuse”. An antitumor composition containing the product as an active ingredient is described. According to Patent Document 5, the partial degradation product of hemicellulose has an average molecular weight of 20,000 to 200,000, and NK cell activity is significantly increased in colon26 cancer-bearing mice administered with the partial degradation product. Furthermore, it is described that the ability to produce cytokines (IL-2 and INF-a) is also significantly increased.
平成 3年 3月 (社) 菓子総合技術センター発行 「農林水産省食品流通局委託事 業 No. 8飲食料品用作用性素材有効利用技術シリーズ 水溶性コーンファイバ 一(ァラビノキシラン) 」 3頁 (以下、 "非特許文献 1" と呼称する) には、 特 許文献 5に記載の 「セルエース」 の商品名で市販されているトウモロコシ外皮か ら得られたへミセルロースの部分分解物が、ァラビノース及びキシロースからな るァラビノキシランを主成分とし、 キシロース 40. 32%、 ァラビノース 27. 76%、 ゥ ロン酸 11. 86%、 ガラク 1 ス 5. 91%、及びグルコース 2. 30%の組成を有するもので あることが記載されている。  March 1991 (Company) Confectionery Technology Center, published by the Ministry of Agriculture, Forestry and Fisheries, Food Distribution Bureau, Contracted Business No. 8 Effective Use Technology Series for Active Materials for Food and Drink, Water-soluble Corn Fiber I (Arabinoxylan), page 3 (below) (Referred to as “Non-Patent Document 1”), a partially decomposed product of hemicellulose obtained from corn hull marketed under the trade name “Cel Ace” described in Patent Document 5 contains arabinose and It is mainly composed of arabinoxylan consisting of xylose and has a composition of 40.32% xylose, 27.76% arabinose, 11.86% uronic acid, 5.91% galactose and 2.30% glucose. It is described that there is.
ところで、 特許文献 5に記載の "トウモロコシ外皮から得られたへミセルロー スの部分分解物"の取得源であるトウモロコシ外皮は、 要するに、 トウモロコシ 穀粒を精白する際に除かれるトウモロコシ穀粒の外皮であり、 これは、大麦穀粒 の外皮を除去する精白を行った精白粒をアルコール発酵に付した後蒸留を行つ て焼酎を製造する際に副生する蒸留残渣である大麦焼酎蒸留残液とは全く異な るものである。  By the way, the corn hull, which is the source of the “partial degradation product of hemicellulose obtained from corn hull” described in Patent Document 5, is basically the corn hull that is removed when the corn kernel is refined. There is a barley shochu distillation residue that is a distillation residue by-produced when producing white spirits by subjecting the whitened grains that have undergone whitening to remove the hulls of barley grains to alcohol fermentation and then distilling them. Are completely different.
以上とは別に、 特開 2001-145472号公報 (以下、 "特許文献 6 " と呼称する) には、 大麦焼酎蒸留残液 (即ち、 大麦穀粒の外皮を除去する精白を行った精白粒 をアルコール発酵に付した後蒸留を行って焼酎を製造する際に副生する蒸留残 から取得した、 M細胞に対する賦活化作用とは異なる脂肪肝抑制作用を有す る組成物が記載されている。 即ち、 特許文献 6には、 前記大麦焼酎蒸留残液を固 液分離して液体分を取得し、得られた前記液体分にアル力リを添加してアル力リ 可溶性画分を分取し、分取した前記アル力リ可溶性画分を酸で中和して中性可溶 性画分を取得し、前記中性可溶性画分にェタノ一ルを添加することにより得られ た脂肪肝抑制作用を有する組成物が記載されている。 また、 特許文献 6には、 前 記組成物は、分子量 3000以下を主たる成分として含有し、該組成物が含有するへ ミセルロースの主たる構成要素はキシロースであることが記載されている。 してみるに、上述した何れの公知文献にも、大麦焼酎蒸留残液が M細胞に対す る賦活化作用を有する成分を含有するか否かについては示唆すらもないことは 明白である。 発明の要約 Apart from the above, JP 2001-145472 A (hereinafter referred to as “Patent Document 6”) The barley shochu distillation residue (i.e., obtained from the distillation residue produced as a by-product in producing shochu by subjecting the whitened grains that had undergone whitening to remove the hull of barley grains to alcohol fermentation and then performing distillation) A composition having a fatty liver inhibitory action different from the activating action on M cells is described, that is, Patent Document 6 obtains a liquid component by solid-liquid separation of the barley shochu distillation residue. Then, Al force is added to the obtained liquid to fractionate the Al force soluble fraction, and the fraction obtained is neutralized with an acid to obtain a neutral soluble fraction. A composition having a fatty liver inhibitory action obtained by adding ethanol to the neutral soluble fraction is described in Patent Document 6. In addition, Patent Document 6 describes the composition described above. , Which contains a molecular weight of 3000 or less as a main component, and the composition contains hemicellulose It is described that the constituent element is xylose, and therefore, in any of the above-mentioned known documents, whether or not the barley shochu distillation residual liquid contains a component having an activating action on M cells. It is clear that there is no suggestion about this.
本発明は、上述した従来技術の状況に鑑みて、大麦焼酎を製造する際に副生さ れる大麦焼酎蒸留残液 (以下、 これを単に "大麦焼酎蒸留残液" と呼称する) の 更なる有効利用を図るべく鋭意検討の結果完成に至ったものである。  In view of the above-mentioned state of the art, the present invention further provides a barley shochu distillation residue (hereinafter referred to simply as “barley shochu distillation residue”) produced as a by-product when producing barley shochu. As a result of intensive studies to achieve effective use, it has been completed.
本発明の目的は、 大麦焼酎蒸留残液より分取した、 ナチュラルキラー細胞 (以 下、 "NK細胞" と略称する) に対し顕著な賦活化作用を有する組成物及びその製 造方法を提供することにある。  An object of the present invention is to provide a composition having a significant activating effect on natural killer cells (hereinafter abbreviated as “NK cells”) collected from a barley shochu distillation residue and a method for producing the same. There is.
本発明の他の目的は、前記 NK細胞に対し顕著な賦活化作用を有する組成物を用 いて賦活化した NK細胞を含有する組成物及びその製造方法を提供することにあ る。  Another object of the present invention is to provide a composition containing NK cells activated using the composition having a significant activating effect on NK cells, and a method for producing the same.
本発明の NK細胞に対し顕著な賦活化作用を有する組成物は、以下に述べる二つ の態様を包含する。 第一の態様の NK細胞に対し顕著な賦活化作用を有する組成物は、大麦焼酎蒸留 残液を固液分離して液体分を得、該液体分をイオン交換樹脂を使用するイオン交 換処理に付して前記イオン交換樹脂に非吸着の画分を分取し、分取した前記ィォ ン交換樹脂に非吸着の画分を限外濾過膜を使用する限外濾過による濃縮処理に 付して濃縮液を得、該濃縮液に有機溶媒を添加することにより分取した前記有機 溶媒に不溶の画分からなり、該有機溶媒に不溶の画分は、 ゥロン酸を実質的に含 有せず、 キシ口一ス、 ァラビノース及びグルコースからなる多糖類を含有し、 分 子量分布が 10万以上が 5%、 3万乃至 10万が 18%、 1万乃至 3万が 23%、 3, 000乃至 1 万が 31%、 1, 000乃至 3, 000が 11%、 500乃至 1, 000が 3%、 500以下が 9%であり、 NK細 胞に対し顕著な賦活化作用を有する。前記有機溶媒に不溶の画分は、多糖類が約 84. 1重量%、多糖類由来のァラビノース及びキシロースの合計含量が約 54. 4重量% 、 粗タンパクが約 4. 2重量 %、 有機酸が約 0. 3重量%、 及び遊離糖類が約 1. 2重量% からなる成分組成を有する。 The composition having a significant activating effect on NK cells of the present invention includes the following two embodiments. The composition having a significant activating effect on NK cells of the first aspect is obtained by solid-liquid separation of a barley shochu distillation residual liquid to obtain a liquid component, and the liquid component is subjected to an ion exchange treatment using an ion exchange resin. The fraction that is not adsorbed on the ion-exchange resin is fractionated, and the fraction that is not adsorbed on the ion-exchange resin that has been collected is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane. To obtain a concentrated solution, and a fraction insoluble in the organic solvent fractionated by adding an organic solvent to the concentrated solution, and the fraction insoluble in the organic solvent substantially contains uronic acid. It contains polysaccharides consisting of xylose, arabinose, and glucose. The molecular weight distribution is 5% for 100,000 or more, 18% for 30,000 to 100,000, 23% for 10,000 to 30,000, 000 to 10,000 is 31%, 1,000 to 3,000 is 11%, 500 to 1,000 is 3%, and 500 or less is 9%. Has an activating effect. The fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of total arabinose and xylose derived from polysaccharide, about 4.2% by weight of crude protein, organic acid Has a component composition consisting of about 0.3% by weight and about 1.2% by weight of free sugars.
第二の態様の NK細胞に対し顕著な賦活化作用を有する組成物は、大麦焼酎蒸留 残液を固液分離して液体分を得、該液体分を合成吸着剤を使用する吸着分離処理 に付して前記合成吸着剤に非吸着の画分を分取し、分取した前記合成吸着剤に非 吸着の画分をイオン交換樹脂を使用するイオン交換処理に付して前記イオン交 換樹脂に非吸着の画分を分取し、分取した前記イオン交換樹脂に非吸着の画分を 限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得、該濃縮液に 有機溶媒を添加することにより分取した前記有機溶媒に不溶の画分からなり、前 記有機溶媒に不溶の画分は、 ゥロン酸を実質的に含有せず、 キシロース、 ァラビ ノース及びグルコースからなる多糖類を含有し、分子量分布が 100, 000以上が 11% 、 30, 000乃至 100, 000が 29 10, 000乃至 30, 000が 24 、 3, 000乃至 10, 000が 21%、 1, 000乃至 3, 000が 6%、 500乃至 1, 000が 2%、 500以下が 7%であるものであり、 NK細 胞に対し顕著な賦活化作用を有する。前記有機溶媒に不溶の画分は、多糖類が約 78. 5重量 °ん多糖類由来のァラビノース及びキシロースの合計含量が約 58. 6重量% 、 粗タンパクが約 3. 3重量%、 有機酸が約 0. 2重量%、 及び遊離糖類が約 1. 5重量% からなる成分組成を有する。 The composition having a significant activating effect on NK cells according to the second aspect is obtained by subjecting the barley shochu distillation residue to solid-liquid separation to obtain a liquid component, which is then subjected to an adsorption separation process using a synthetic adsorbent. And fractionating a non-adsorbed fraction on the synthetic adsorbent, and subjecting the non-adsorbed fraction to the fractionated synthetic adsorbent to an ion exchange treatment using an ion exchange resin. A non-adsorbed fraction is fractionated, and the non-adsorbed fraction is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution. The fraction insoluble in the organic solvent fractionated by adding an organic solvent to the organic solvent, and the fraction insoluble in the organic solvent is substantially free of uronic acid and consists of xylose, arabinose and glucose. Contains polysaccharides, molecular weight distribution over 100,000 is 11%, 30,000 to 100, 000 is 29, 10,000 to 30,000, 24, 3,000 to 10,000 is 21%, 1,000 to 3,000 is 6%, 500 to 1,000 is 2%, 500 or less is 7% Some have a significant activation effect on NK cells. In the fraction insoluble in the organic solvent, the total content of arabinose and xylose derived from polysaccharide is about 58.6% by weight. It has a component composition consisting of about 3.3% by weight of crude protein, about 0.2% by weight of organic acid, and about 1.5% by weight of free sugars.
本発明の第一の態様及び第二の態様の NK細胞に対し賦活化作用を有する組成 物は、公知の NK細胞賦活化剤である IL- 2に匹敵する極めて顕著な、 NK細胞に対す る賦活化作用を有し、医薬用として白血病をはじめとするガンの治療に極めて好 適に使用することができる。  The composition having an activating effect on NK cells according to the first and second aspects of the present invention is very remarkable for NK cells, comparable to IL-2 which is a known NK cell activator. It has an activating effect and can be used very suitably for the treatment of cancer including leukemia as a pharmaceutical.
本発明の陚活化した NK細胞を含有する組成物は、以下に述べる二つの態様を包 含する。  The composition containing the activated NK cell of the present invention includes the following two embodiments.
第一の態様の賦活化した NK細胞を含有する組成物は、上記第一の態様の NK細胞 に対し顕著な賦活化作用を有する組成物を用いて賦活化した NK細胞を含有する 賦活化 NK細胞含有組成物である。  The composition containing activated NK cells according to the first aspect contains activated NK cells using the composition having a significant activation action on the NK cells according to the first aspect. It is a cell-containing composition.
第二の態様の賦活化した NK細胞を含有する組成物は、上記第二の態様の M細胞 に対し顕著な賦活化作用を有する組成物を用いて賦活化した NK細胞を含有する 賦活化 NK細胞含有組成物である。  The composition containing activated NK cells according to the second aspect contains NK cells activated using the composition having a significant activating effect on the M cells according to the second aspect. It is a cell-containing composition.
本発明の第一の態様及び第二の態様の賦活化した NK細胞を含有する賦活化 NK 細胞含有組成物は、医薬用として白血病をはじめとするガンの治療に極めて好適 に使用することができる。  The activated NK cell-containing composition containing activated NK cells according to the first and second aspects of the present invention can be used very suitably for the treatment of cancer including leukemia as a pharmaceutical. .
本発明は、本発明者らが実験を介して得た事実に基づいて完成せしめたもので ある。 以下に本発明らが行った実験について述べる。  The present invention has been completed based on the facts obtained by the present inventors through experiments. The experiment conducted by the present invention will be described below.
本発明者らは、大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液 を固液分離して液体分を得、 該液体分に有機溶媒 (好ましくはエタノール) を添 加することにより分取した前記有機溶媒に不溶の画分には、その主たる成分の 1 つとして多糖類が含まれていることに鑑み、前記有機溶媒に不溶の画分に含まれ る多糖類が NK細胞の賦活化に関与しているか否かを明らかにするために実験を 介して鋭意検討を行った。即ち、 前記有機溶媒に不溶の画分に含まれる多糖類以 外の成分、 即ち、 アミノ酸、 ペプチド、 タンパク質、 有機酸、 或いは大麦由来の ポリフエノール等を除去することを目的として、種々のイオン交換樹脂を用意し 、大麦焼酎蒸留残液を固液分離することにより得た液体分をそれらイオン交換樹 脂を個々に使用するイオン交換処理に付すことにより、それぞれのイオン交換樹 脂に非吸着の画分を取得し、得られた複数のイオン交換樹脂に非吸着の画分のそ れぞれについて、有機溶媒を添加することによる分画処理により分取した前記有 機溶媒に不溶の画分を得、得られた有機溶媒に不溶の画分のそれぞれが NK細胞賦 活化作用を有するか否か、 また NK細胞賦活化作用を有する場合、その NK細胞賦活 化作用はどの程度のものであるかを明らかにするために以下の実験を行った。 以下の実験 1乃至実験 14に供する目的で大麦焼酎の製造を行った。 原料として は、 大麦 (70%精白) を用いた。 The present inventors obtained a liquid component by solid-liquid separation of a barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and an organic solvent (preferably ethanol) was added to the liquid component. In view of the fact that the collected fraction insoluble in the organic solvent contains polysaccharide as one of its main components, the polysaccharide contained in the fraction insoluble in the organic solvent contains NK cells. In order to clarify whether or not it is involved in activation, we conducted intensive studies through experiments. That is, components other than polysaccharides contained in the fraction insoluble in the organic solvent, that is, amino acid, peptide, protein, organic acid, or barley-derived For the purpose of removing polyphenols, etc., various ion exchange resins are prepared, and the liquid components obtained by solid-liquid separation of the barley shochu distillation residual liquid are ion exchange treatments using these ion exchange resins individually. To obtain a non-adsorbed fraction on each ion-exchange resin, and add an organic solvent to each of the non-adsorbed fractions on the obtained plurality of ion-exchange resins. A fraction insoluble in the organic solvent collected by fractionation is obtained, and whether each of the obtained fractions insoluble in the organic solvent has an NK cell activation effect or not, has an NK cell activation effect. In this case, the following experiment was conducted to clarify the degree of the NK cell activation effect. Barley shochu was produced for the purpose of the following Experiment 1 to Experiment 14. Barley (70% refined) was used as a raw material.
[麹の製造] [Manufacture of firewood]
大麦を 40重量%吸水させ、 40分間蒸した後、 40°Cまで放冷し、 大麦トンあたり lkgの種麹 (白麹菌) を接種し、 38°C、 RH95¾で 24時間、 32°C、 RH92%で 20時間保 持することにより、 大麦麹を製造した。  40% barley water was absorbed, steamed for 40 minutes, allowed to cool to 40 ° C, inoculated with 1 kg of seed perilla (birch) per ton of barley, 38 ° C, RH95¾ for 24 hours, 32 ° C, Barley straw was produced by holding at RH92% for 20 hours.
[蒸麦の製造] [Manufacture of steamed barley]
大麦を 40重量 %吸水させ、 40分間蒸した後、 40°Cまで放冷することにより、 蒸 麦を製造した。  Steamed barley was produced by absorbing 40% by weight of barley, steaming for 40 minutes, and allowing to cool to 40 ° C.
[大麦焼酎及び大麦焼酎蒸留残液の製造]  [Production of barley shochu and barley shochu distillation residue]
1次仕込みでは前述の方法で製造した大麦麹 (大麦として 3トン) に、 水 3. 6キ 口リットル及び酵母として焼酎酵母の培養菌体 lkg (湿重量) を加えて 1次もろみ を得、 得られた 1次もろみを 5日間の発酵 (1段目の発酵) に付した。 次いで、 2 次仕込みでは、 上記 1段目の発酵を終えた 1次もろみに、 水 11.4キロリットル、 前 述の方法で製造した蒸麦 (大麦として 7トン) を加えて 11日間の発酵(2段目の発 酵) に付した。 発酵温度は 1次仕込み、 2次仕込みとも 25°Cとした。 上記 2段目の 発酵を終えた 2次もろみを常法により単式蒸留に付し、 大麦焼酎 10キロリットル と大麦焼酎蒸留残液 15キロリットルを得た。得られた大麦焼酎蒸留残液を以下の 実験 1乃至実験 14に用いた。 In the first preparation, add 3.6 ml of water and lkg (wet weight) of cultured cells of shochu yeast as yeast to the barley koji (3 tons as barley) produced by the method described above to obtain primary mash. The obtained primary moromi was subjected to 5 days of fermentation (1st stage fermentation). Next, in the secondary charging, 11.4 kiloliters of water and 7% ton of steamed barley (7 tons of barley) produced by the method described above were added to the primary mash that had been subjected to the first stage fermentation. (Stage fermentation). The fermentation temperature was 25 ° C for both the first and second charge. The second mash after the second stage fermentation was subjected to simple distillation by a conventional method to obtain 10 kiloliters of barley shochu and 15 kiloliters of barley shochu distillation residue. The obtained barley shochu distillation residue was Used for Experiment 1 to Experiment 14.
実験 1  Experiment 1
上記「大麦焼酎及び大麦焼酎蒸'留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 の Br ixを 10に調整し、 この BrixlOに調整した液体分 1Lに、 終濃度が 75容量%にな るようにエタノールを加え、 8000rpm、 lOminの条件で遠心分離して有機溶媒(ェ タノ一ル) に不溶の画分を分取し、得られた画分を凍結乾燥に付すことにより凍 結乾燥物 11. 8gを得た。  From the barley shochu distillation residue obtained in the above-mentioned “Production of barley shochu and barley shochu steamed residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, the Brix of the obtained liquid component is adjusted to 10, and the liquid component adjusted to BrixlO is adjusted to 1 L. Ethanol is added so that the concentration becomes 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin to collect a fraction insoluble in an organic solvent (ethanol). The obtained fraction is lyophilized. 11.8 g of a freeze-dried product was obtained.
実験 2  Experiment 2
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分画した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を Br ixlOに調整後、 この Br ixlOに調整した液体分 1Lを、 500ml容量のオルガノ ( 株) 製アンバーライト IRC76 (弱酸性陽イオン交換樹脂) を充填したカラムに通 して、前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Br ix60に調 整後、 終濃度 75容量%になるようにエタノールを加え、 8000ι·ρπι、 lOminの条件で 遠心分離して前記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分 を凍結乾燥に付すことにより凍結乾燥物 7. lgを得た。  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged at 8000 rpm and lOmin to obtain a liquid component. After adjusting the liquid component to BrixlO, 1 ml of the liquid component adjusted to BrixlO is stored in a volume of 500 ml. The fraction not adsorbed on the ion exchange resin was fractionated through a column packed with Amberlite IRC76 (weakly acidic cation exchange resin) manufactured by Organo Co., Ltd., and the obtained fraction was converted to Brix60. After the adjustment, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged under the conditions of 8000ι · ρπι and lOmin, and the fraction insoluble in the organic solvent (ethanol) was collected. Was subjected to lyophilization to obtain 7. lg of lyophilized product.
実験 3  Experiment 3
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を Br ixl Oに調整後、 この Br ixlOに調整した液体分 1Lを、 500ml容量のオルガノ ( 株) 製アンバーライト IRA67 (弱酸性陰イオン交換樹脂) を充填したカラムに通 して、 前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Br ix60に調 整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で 遠心分離して前記有機溶媒(エタノール) に不溶の画分を分取し、 得られた画分 を凍結乾燥に付すことにより凍結乾燥物 8. 2gを得た。 From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component. After adjusting the obtained liquid component to Brixl O, 1 ml of the liquid component adjusted to BrixlO was added to 500 ml. Through a column packed with Amberlite IRA67 (weakly acidic anion exchange resin) manufactured by Organo Co., Ltd., fractions not adsorbed on the ion exchange resin were collected, and the obtained fractions were combined with Brix60. To After the preparation, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged at 8000 rpm and lOmin to collect a fraction insoluble in the organic solvent (ethanol), and the obtained fraction was lyophilized. The freeze-dried product 8.2g was obtained.
実験 4  Experiment 4
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を BrixlOに調整後、 この BrixlOに調整した液体分 1Lを、 500ml容量のオルガノ ( 株) 製アンバーライト IR120B (強酸性陽イオン交換樹脂) を充填したカラムに通 して、前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Brix60に調 整後、 終濃度 75容量%になるようにエタノールを加え、 8000n)m、 lOminの条件で 遠心分離して前記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分 を凍結乾燥に付すことにより凍結乾燥物 7. 6gを得た。  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component. After the liquid component thus obtained is adjusted to BrixlO, 1 L of the liquid component adjusted to BrixlO is added to a 500 ml organopolyester. Pass through a column packed with Amberlite IR120B (Strongly Acidic Cation Exchange Resin) manufactured by Co., Ltd., fractionate that is not adsorbed on the ion exchange resin, and adjust the resulting fraction to Brix60 Add ethanol to a final concentration of 75% by volume, centrifuge at 8000n) m, lOmin, fractionate the fraction insoluble in the organic solvent (ethanol), and freeze-dry the obtained fraction To give 7.6 g of lyophilized product.
実験 5  Experiment 5
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を BrixlOに調整後、 この BrixlOに調整した液体分 1Lを、 500ml容量のオルガノ ( 株) 製アンバーライト 200CT (強酸性陽イオン交換樹脂) を充填したカラムに通 して、前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Brix60に調 整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で 遠心分離して前記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分 を凍結乾燥に付すことにより凍結乾燥物 5. 5gを得た。  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component. After the liquid component thus obtained is adjusted to BrixlO, 1 L of the liquid component adjusted to BrixlO is added to a 500 ml organopolyester. Pass through a column packed with Amberlite 200CT (Strongly Acidic Cation Exchange Resin), and collect fractions not adsorbed on the ion exchange resin, and adjust the resulting fractions to Brix60. Add ethanol to a final concentration of 75% by volume, centrifuge at 8000 rpm and lOmin to collect the fraction insoluble in the organic solvent (ethanol), and subject the resulting fraction to lyophilization. As a result, 5.5 g of a lyophilized product was obtained.
実験 6  Experiment 6
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を BrixlOに調整後、 この BrixlOに調整した液体分 1Lを、 500ml容量のオルガノ ( 株)製アンパ一ライト IRA402BL (最強塩基性陰イオン交換樹脂) を充填したカラ ムに通して、 前記イオン交換樹脂に非吸着の画分を分取し、 得られた画分を Brix60に調整後、終濃度 75容量%になるようにエタノールを加え、 8000n)m、 lOmin の条件で遠心分離して前記有機溶媒 (エタノール) に不溶の画分を分取し、 得ら れた画分を凍結乾燥に付'すことにより凍結乾燥物 3. 2gを得た。 From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley ware 酎 Centrifugation was performed at 8000 rpm and lOmin to obtain a liquid component. After adjusting the resulting liquid component to BrixlO, 1 L of the liquid component adjusted to BrixlO was added to 500 ml capacity Ampo Co., Ltd. Pass through a column filled with Ilite IRA402BL (the strongest basic anion exchange resin) to fractionate the non-adsorbed fraction on the ion exchange resin, adjust the resulting fraction to Brix60, and obtain a final concentration of 75 Ethanol is added so that the volume% is reached, and the mixture is centrifuged at 8000 n) m and lOmin to fractionate the fraction insoluble in the organic solvent (ethanol), and the resulting fraction is subjected to lyophilization. As a result, 3.2 g of a lyophilized product was obtained.
実験 7  Experiment 7
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 を BrixlOに調整後、 この BrixlOに調整した液体分 1Lを、 350ml容量のオルガノ ( 株) 製アンバーライト IRC76 (弱酸性陽イオン交換樹脂) と 150ml容量のオルガノ (株) 製アンバ一ライト IRA67 (弱塩基性陰イオン交換樹脂) を混合することに より得た混床ィォン交換樹脂を充填したカラムに通して、前記混床ィォン交換樹 脂に非吸着の画分を分取し、 得られた画分を Brix60に調整後、 終濃度 75容量%に なるようにエタノールを加え、 8000i"pm、 lOminの条件で遠心分離して前記有機溶 媒 (エタノール) に不溶の画分を分取し、 得られた画分を凍結乾燥に付すことに より凍結乾燥物 2. 5gを得た。  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component. After adjusting the liquid component to BrixlO, 1 L of the liquid component adjusted to BrixlO Mixed bed ion exchange resin obtained by mixing Amberlite IRC76 (weakly acidic cation exchange resin) and 150 ml capacity Organolite IRA67 (weakly basic anion exchange resin) The non-adsorbed fraction was fractionated into the mixed bed ion exchange resin through a column packed with, and the resulting fraction was adjusted to Brix 60, and ethanol was added to a final concentration of 75% by volume, Centrifugation was performed at 8000 i "pm and lOmin to fractionate the fraction insoluble in the organic solvent (ethanol), and the resulting fraction was freeze-dried to obtain 2.5 g of a lyophilized product. It was.
[NK細胞活性の測定]  [Measurement of NK cell activity]
実験 1乃至実験 7で得たそれぞれの有機溶媒に不溶の画分(凍結乾燥物) につい て、 後述の実施例において記載したのと同一の方法により NK細胞活性 (即ち、 NK 細胞に対する賦活化作用) を測定した。  For the fractions (lyophilized product) insoluble in each organic solvent obtained in Experiments 1 to 7, NK cell activity (ie, activation effect on NK cells) was performed in the same manner as described in the Examples below. ) Was measured.
実験 1乃至実験 7で得たそれぞれの有機溶媒に不溶の画分(凍結乾燥物) を添加 して培養した NK細胞が示す NK細胞活性の測定結果から以下の事実が判明じた。即 ち、有機溶媒に不溶の画分を添加しない対照と比較して、 実験 1乃至実験 7で得た 有機溶媒に不溶の画分(凍結乾燥物) のそれぞれを別々に添加して培養した全て の NK細胞の NK細胞活性が上昇し、 K562細胞に対する細胞傷害活性が上昇した。 こ の中で、 前記実験 5で得た有機溶媒に不溶の画分 (凍結乾燥物) を添加して培養 した NK細胞が示す NK細胞活性が最も高い値を示した。 一方、 実験 1で得た有機溶 媒に不溶の画分(凍結乾燥物) を添加して培養した NK細胞が示す NK細胞活性が最 も低い値を示した。 The following facts were found from the measurement results of NK cell activity exhibited by NK cells cultured by adding the insoluble fraction (lyophilized product) to each organic solvent obtained in Experiments 1 to 7. That is, it was obtained in Experiment 1 to Experiment 7 compared to the control in which no fraction insoluble in organic solvent was added. The NK cell activity of all NK cells cultured with each of the fractions (lyophilized product) insoluble in organic solvent added increased, and the cytotoxic activity against K562 cells increased. Among them, the NK cell activity exhibited by the NK cells cultured with the fraction (lyophilized product) insoluble in the organic solvent obtained in Experiment 5 was the highest. On the other hand, the NK cell activity exhibited by the NK cells cultured with the insoluble fraction (lyophilized product) added to the organic solvent obtained in Experiment 1 was the lowest.
次に、本発明者らは、大麦を原料とする焼酎製造において副生する大麦焼酎蒸 留残液を固液分離して液体分を得、該液体分に有機溶媒(好ましくはエタノール )を添加することにより分取した前記有機溶媒に不溶の画分の主たる成分の 1つ として多糖類が含まれていることに鑑み、該有機溶媒に不溶の画分に含まれる多 糖類が M細胞の賦活化に関与しているか否かを明らかにするために実験を介し て更に検討を行った。即ち、前記有機溶媒に不溶の画分に含まれる多糖類以外の 成分である、 アミノ酸、 ペプチド、 タンパク質、 有機酸、 或いは大麦由来のポリ フエノール等を除去することを目的として以下の実験を行った。具体的には、大 麦焼酎蒸留残液の液体分に含まれる大麦由来のポリフエノール等を除去するこ とを目的として、大麦焼酎蒸留残液を固液分離することにより得た液体分を合成 吸着剤を使用した吸着分離処理に付して前記合成吸着剤に非吸着の画分を分取 し、 次に、 分取したこの合成吸着剤に非吸着の画分に含まれるアミノ酸、 ぺプチ ド、 タンパク質及び有機酸を除去することを目的として、前記合成吸着剤に非吸 着の画分を種々のイオン交換樹脂を使用したイオン交換処理に付すことによつ てそれらのィォン交換樹脂に非吸着の画分を個々に分取し、得られたィォン交換 樹脂に非吸着の画分のそれぞれについて、有機溶媒を添加することにより前記有 機溶媒に不溶の画分を分取し、得られた有機溶媒に不溶の画分が NK細胞に対して どのような賦活化作用を有するかを明らかにするために以下の実験を行った。 実験 8  Next, the present inventors obtain a liquid component by solid-liquid separation of the barley shochu distillation residual liquid by-produced in the production of shochu using barley as a raw material, and add an organic solvent (preferably ethanol) to the liquid component. In view of the fact that polysaccharides are included as one of the main components in the fraction insoluble in the organic solvent fractionated, the polysaccharides contained in the fraction insoluble in the organic solvent activate M cells. Further studies were conducted through experiments to clarify whether or not they are involved in the process. That is, the following experiments were conducted for the purpose of removing amino acids, peptides, proteins, organic acids, polyphenols derived from barley, etc., which are components other than polysaccharides contained in the fraction insoluble in the organic solvent. . Specifically, the liquid content obtained by solid-liquid separation of the barley shochu distillation residue was synthesized for the purpose of removing polyphenol derived from barley contained in the liquid content of the barley shochu distillation residue. A fraction that is not adsorbed to the synthetic adsorbent is separated by an adsorption separation process using an adsorbent, and then the amino acids and peptides contained in the fraction that is not adsorbed to the synthesized adsorbent. In order to remove proteins, proteins and organic acids, the ion-exchange resin is obtained by subjecting the non-adsorbed fraction to the synthetic adsorbent to ion exchange treatment using various ion-exchange resins. Individual fractions of non-adsorbed fractions were obtained, and fractions insoluble in the organic solvent were fractionated by adding an organic solvent to each of the non-adsorbed fractions obtained in the ion-exchange resin. Fractions insoluble in organic solvents The following experiments were conducted in order to determine with the activating effects such as. Experiment 8
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶な画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 の Br ixを 10に調整し、 この BrixlOに調整した液体分 1Lに、 終濃度が 75容量%にな るようにエタノールを加え、 8000rpm、 lOminの条件で遠心分離して前記有機溶媒 (エタノール) に不溶の画分を分取し、得られた画分を凍結乾燥に付すことによ り凍結乾燥物 11. 8 gを得た。 Barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” above From the above, a fraction insoluble in an organic solvent was collected by the method shown below. That is, the barley shochu distillation residue is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, the Brix of the obtained liquid component is adjusted to 10, and the liquid component adjusted to BrixlO is adjusted to 1 L. Ethanol is added so that the concentration is 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin to collect a fraction insoluble in the organic solvent (ethanol), and the resulting fraction is freeze-dried. As a result, 11.8 g of a freeze-dried product was obtained.
実験 9  Experiment 9
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンバ一ライト XAD- 16を充填したカラムに通し て吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を BrixlOに調整し、 この BrixlOに調整した前記画分 1Lを、 500ml容量のオルガノ ( 株) 製アンバーライト IRC76 (弱酸性陽イオン交換樹脂) を充填したカラムに通 し、前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Brix60に調整 後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で遠 心分離して前記有機溶媒(エタノール) に不溶の画分を分取し、 得られた画分を 凍結乾燥に付すことにより凍結乾燥物 5. 3 gを得た  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was packed with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. The fraction that was not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability with respect to the synthetic adsorbent of the column was fractionated. The obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column packed with 500 ml of Amberlite IRC76 (weakly acidic cation exchange resin) manufactured by Organo Corporation. The fraction not adsorbed on the ion exchange resin is collected, and the resulting fraction is adjusted to Brix60. Ethanol is added to a final concentration of 75% by volume, followed by centrifugal separation under the conditions of 8000 rpm and lOmin. A fraction insoluble in an organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 5.3 g of a lyophilized product.
実験 1 0  Experiment 1 0
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンパーライ卜 XAD- 16を充填したカラムに通し て咴着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を BrixlOに調整し、 この Br ixlOに調整した画分 1Lを、 500ml容量のオルガノ (株) 製アンバ一ライト IRA67 (弱酸性陰イオン交換樹脂) を充填したカラムに通し、 前記イオン交換樹脂に非吸着の画分を分取し、 得られた画分を Br ix60に調整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で遠心分 離して前記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分を凍結 乾燥に付すことにより凍結乾燥物 5. 9 gを得た。 From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was placed in a column packed with Synthetic Adsorbent Amperai® XAD-16 manufactured by Organo Corporation. The fraction adsorbed on the synthetic adsorbent consisting of a flow-through liquid exhibiting non-adsorbability to the synthetic adsorbent of the column was fractionated by subjecting it to an adhesion separation treatment. The obtained fraction Adjust to BrixlO, and pass 1 L of this adjusted fraction to BrixlO through a column packed with 500 ml of Amberlite IRA67 (weakly acidic anion exchange resin) manufactured by Organo Corp. After the fraction was adjusted to Brix60, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged at 8000 rpm and lOmin to obtain the organic solvent (ethanol). The insoluble fraction was collected, and the obtained fraction was freeze-dried to obtain 5.9 g of a freeze-dried product.
実験 1 1  Experiment 1 1
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 力、ら以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000ΠΜΙ、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンバーライト XAD-16を充填したカラムに通し て吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を Br ixlOに調整し、 この Br ixlOに調整した画分 1Lを、 500ml容量のオルガノ (株) 製アンバーライト IR120B (強酸性陽イオン交換樹脂) を充填したカラムに通し、 前記イオン交換樹脂に非吸着の画分を分取し、 得られた画分を Br ix60に調整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で遠心分 離して前記有機溶媒(エタノール) に不溶の画分を分取し、 得られた画分を凍結 乾燥に付すことにより凍結乾燥物 5. 6 gを得た。  The barley shochu distillation residue obtained in the above-mentioned “Production of barley shochu and barley shochu distillation residue” fractions insoluble in an organic solvent were collected by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 kg, lOmin to obtain a liquid component, and the obtained liquid component was applied to a column packed with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated. The obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite IR120B (strongly acidic cation exchange resin) manufactured by Organo Corporation. Fraction that is not adsorbed on the ion exchange resin is collected, and the resulting fraction is adjusted to Brix 60. Ethanol is added to a final concentration of 75% by volume, followed by centrifugation at 8000 rpm and lOmin. A fraction insoluble in an organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 5.6 g of a freeze-dried product.
実験 1 2  Experiment 1 2
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンバーライト XAD- 16を充填したカラムに通し て吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を BrixlOに調整し、 この BrixlOに調整した画分 1Lを、 500ml容量のオルガノ (株) 製アンバーライト 200CT (強酸性陽イオン交換樹脂) を充填したカラムに通し、 前記イオン交換樹脂に非吸着の画分を分取し、 得られた画分を Br ix60に調整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で遠心分 離して前記有機溶媒(エタノール) に不溶の画分を分取し、 得られた画分を凍結 乾燥に付すことにより凍結乾燥物 4. 1 gを得た。 From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was applied to a column filled with synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated. The obtained fraction The fraction 1 L adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corp., and the fraction not adsorbed to the ion exchange resin. After fractionation, the fraction obtained was adjusted to Brix 60, ethanol was added to a final concentration of 75% by volume, and the mixture was centrifuged at 8000 rpm and lOmin, and insoluble in the organic solvent (ethanol). The fraction was collected, and the obtained fraction was freeze-dried to obtain 4.1 g of a freeze-dried product.
実験 1 3  Experiment 1 3
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000n>m、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンバーライト XAD- 16を充填したカラムに通し て吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を BrixlOに調整し、 この BrixlOに調整した画分 1Lを、 500ml容量のオルガノ (株) 製アンバーライト IRA402BL (最強塩基性陰イオン交換樹脂) を充填したカラムに 通し、 前記イオン交換樹脂に非吸着の画分を分取し、得られた画分を Brix60に調 整後、 終濃度 75容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で 遠心分離して前記有機溶媒(エタノール) に不溶の画分を分取し、 得られた画分 を凍結乾燥に付すことにより凍結乾燥物 2. 3 gを得た。  From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged under the conditions of 8000 n> m and lOmin to obtain a liquid, and the resulting liquid was filled with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. By passing through a column and subjecting to an adsorption separation treatment, a fraction that was not adsorbed to the synthetic adsorbent consisting of a flow-through liquid that showed non-adsorbability to the synthetic adsorbent of the column was fractionated. The obtained fraction was adjusted to BrixlO, and 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite IRA402BL (strongest basic anion exchange resin) manufactured by Organo Corp. Fraction that is not adsorbed on the exchange resin, the resulting fraction is adjusted to Brix60, ethanol is added to a final concentration of 75% by volume, and the organic material is centrifuged at 8000 rpm and lOmin. The fraction insoluble in the solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 2.3 g of a freeze-dried product.
実験 1 4  Experiment 1 4
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 から以下に示す方法により有機溶媒に不溶の画分を分取した。即ち、前記大麦焼 酎蒸留残液を 8000rpm、 lOminの条件で遠心分離して液体分を得、得られた液体分 をオルガノ (株)製の合成吸着剤アンバーライト XAD-16を充填したカラムに通し て吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を示 す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分を Br ixlOに調整し、 この Br ixl Oに調整した画分 1Lを、 350ml容量のオルガノ (株) 製アンバーライト IRC76 (弱酸性陽イオン交換樹脂) と 150ml容量のオルガノ (株 ) 製アンバーライト IRA67 (弱塩基性陰イオン交換樹脂) を混合することにより 得た混床ィォン交換樹脂を充填したカラムに通し、前記混床ィォン交換樹脂に非 吸着の画分を分取し、 得られた画分を Brix60に調整後、 終濃度 75容量 こなるよ うにエタノールを加え、 8000rpiii、 lOminの条件で遠心分離して前記有機溶媒 (ェ タノ一ル) に不溶の画分を分取し、得られた画分を凍結乾燥に付すことにより凍 結乾燥物 1. 9 gを得た。 From the barley shochu distillation residue obtained in “Manufacturing barley shochu and barley shochu distillation residue”, a fraction insoluble in an organic solvent was fractionated by the following method. That is, the barley shochu distillation residue was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the resulting liquid component was applied to a column filled with synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation. Through the adsorption separation process, fractions that were not adsorbed to the synthetic adsorbent consisting of a flow-through solution exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated. The obtained fraction The fraction 1 L adjusted to Br ixlO was adjusted to 350 ml of Amberlite IRC76 (weakly acidic cation exchange resin) by Organo Co., Ltd. and 150 ml of Amberlite IRA67 (organo Co., Ltd.) A weakly basic anion exchange resin) is passed through a column packed with a mixed bed ion exchange resin, and a fraction not adsorbed on the mixed bed ion exchange resin is collected. After adjustment to Brix60, ethanol was added to a final concentration of 75 volumes, and the mixture was centrifuged under the conditions of 8000 rpiii, lOmin, and the fraction insoluble in the organic solvent (ethanol) was collected. By subjecting the portion to freeze-drying, 1.9 g of a freeze-dried product was obtained.
[NK細胞活性の測定] [Measurement of NK cell activity]
実験 8乃至実験 14で得た有機溶媒に不溶の画分 (凍結乾燥物) のそれぞれにつ いて、 後述の実施例において記載したのと同一の方法により NK細胞活性 (即ち、 M細胞に対する賦活作用) を測定した。  For each of the fractions (lyophilized product) insoluble in the organic solvent obtained in Experiments 8 to 14, the NK cell activity (ie, the activation action on M cells) was performed in the same manner as described in the Examples below. ) Was measured.
実験 8乃至実験 14で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物) を添 加して培養した NK細胞が示す NK細胞活性の測定結果から以下の事実が判明した。 即ち、 いずれの有機溶媒に不溶の画分も添加しない対照と比較して、 実験 8乃至 実験 14で得た有機溶媒に不溶の画分(凍結乾燥物) のそれぞれを個々に添加して 培養した全ての NK細胞の NK細胞活性が上昇し、 K562細胞に対する細胞傷害活性が 上昇した。 この中で、 実験 12で得た有機溶媒に不溶の画分 (凍結乾燥物) を添加 して培養した NK細胞が示す NK細胞活性が最も高い値を示した。 一方、 実験 8で得 た有機溶媒に不溶な画分(凍結乾燥物) を添加して培養した NK細胞が示す NK細胞 活性が最も低い値を示した。  The following facts were found from the measurement results of NK cell activity exhibited by NK cells cultured with the insoluble fraction (lyophilized product) added to each organic solvent obtained in Experiment 8 to Experiment 14. That is, compared with the control in which no fraction insoluble in any organic solvent was added, each of the fractions (lyophilized product) insoluble in the organic solvent obtained in Experiment 8 to Experiment 14 was added and cultured. All NK cells had increased NK cell activity and increased cytotoxic activity against K562 cells. Among them, the NK cell activity exhibited by the NK cells cultured by adding the insoluble fraction (lyophilized product) to the organic solvent obtained in Experiment 12 was the highest. On the other hand, the NK cell activity exhibited by the NK cells cultured with the fraction (lyophilized product) insoluble in the organic solvent obtained in Experiment 8 was the lowest.
[多糖類含量の測定] [Measurement of polysaccharide content]
(多糖類由来のァラビノース及びキシロースの合計含量の測定)  (Measurement of total content of arabinose and xylose derived from polysaccharides)
実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物) につ いて、多糖類含量、及び多糖類由来のァラビノース及びキシロースの合計含量を 以下の方法により測定した。 即ち、 実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物 ) 0. 05gにイオン交換水 lmlを加えて溶解し、 これに濃塩酸 200 lを加えて、 95 °C、 4時間の条件で加水分解を行い、 0. 80 mのメンブランフィルタ一で濾過して 濾液を得、 得られた濾液を高速液体クロマトグラフに注入して、 実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分(凍結乾燥物) に含まれる多糖類の含 量、及び多糖類由来のァラビノース及びキシロースの合計含量を求めた。高速液 体クロマトグラフ分析は、 Waters製 Waters600を用い、 検出器に昭和電工株式会 社製示差屈折計 RI-71を使用し、 カラムは BioRad社製 Aminex HPX-87H (300mm X 7. 8删)を使用した。 カラム温度は 60°Cとし、 移動相には 5mM硫酸を用い、 流量は 0. 5ml/min、 試料注入量は 20 ^ 1とした。 For the fractions (lyophilized product) insoluble in each organic solvent obtained in Experiment 1 to Experiment 14, the polysaccharide content and the total content of arabinose and xylose derived from the polysaccharide were measured by the following methods. That is, the fraction insoluble in each organic solvent obtained in Experiment 1 to Experiment 14 (lyophilized product) was dissolved by adding 0.5 ml of ion-exchanged water to 0.05 g, and 200 l of concentrated hydrochloric acid was added thereto to obtain 95 ° C. C. Hydrolysis was performed for 4 hours, filtered through a 0.80 m membrane filter to obtain a filtrate, and the obtained filtrate was injected into a high performance liquid chromatograph, and obtained in Experiment 1 to Experiment 14. The content of the polysaccharide contained in the fraction insoluble in each organic solvent (lyophilized product) and the total content of arabinose and xylose derived from the polysaccharide were determined. For high-speed liquid chromatographic analysis, Waters600 manufactured by Waters is used, a differential refractometer RI-71 manufactured by Showa Denko KK is used as the detector, and the column is Aminex HPX-87H (300 mm X 7.8 mm) manufactured by BioRad. It was used. The column temperature was 60 ° C, the mobile phase was 5mM sulfuric acid, the flow rate was 0.5ml / min, and the sample injection volume was 20 ^ 1.
実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分の多糖類含量の測定 結果、並びに、該多糖類由来のァラビノース及びキシロースの合計含量の測定結 果から以下の事実が判明した。 即ち、 前記実験 5及び前記実験 12で得た有機溶媒 に不溶の画分(凍結乾燥物) の多糖類含量並びに該多糖類由来のァラビノース及 びキシロースの合計含量が特に高い値を示した。一方、実験 1及び実験 8で得た有 機溶媒に不溶の画分(凍結乾燥物) の多糖類含量並びに該多糖類由来のァラピノ —ス及びキシロースの合計含量がそれぞれ最も低い値を示した。  The following facts were found from the measurement results of the polysaccharide content of the fractions insoluble in each organic solvent obtained in Experiments 1 to 14 and the measurement results of the total content of arabinose and xylose derived from the polysaccharide. That is, the polysaccharide content of the fraction insoluble in the organic solvent (lyophilized product) obtained in Experiment 5 and Experiment 12 and the total content of arabinose and xylose derived from the polysaccharide showed particularly high values. On the other hand, the polysaccharide content of the fraction insoluble in the organic solvent (lyophilized product) obtained in Experiment 1 and Experiment 8 and the total content of alapinose and xylose derived from the polysaccharide showed the lowest values.
更に、 実験 1乃至実験 14で得た有機溶媒に不溶の画分 (凍結乾燥物) のそれぞ れを別々に添加して培養した NK細胞が示す M細胞活性は、該有機溶媒に不溶の画 分に含まれる多糖類由来のァラビノース及びキシロースの合計含量に比例して 高くなつていることが明らかになった。そして、 NK細胞活性と多糖類由来のァラ ビノース及びキシ口ースの合計含量との相関係数は 0· 961であることが判明した。 以上の結果から、 実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分 ( 凍結乾燥物)が有する NK細胞賦活化作用は、該有機溶媒に不溶の画分に含まれる 、ァラビノース及びキシロースを主たる構成要素とする多糖類に由来している可 能性が極めて高いことが明らかになった。 [分子量分布の測定] Furthermore, the M cell activity exhibited by NK cells cultured separately by adding each of the fractions (lyophilized product) insoluble in the organic solvent obtained in Experiment 1 to Experiment 14 is the fraction insoluble in the organic solvent. It was revealed that the content was increased in proportion to the total content of arabinose and xylose derived from the polysaccharide contained in the minute. The correlation coefficient between the NK cell activity and the total content of arabinose and xylose derived from polysaccharide was found to be 0 · 961. From the above results, the NK cell activation action of the fractions (lyophilized product) insoluble in each organic solvent obtained in Experiment 1 to Experiment 14 is contained in the fraction insoluble in the organic solvent, arabinose and It was found that the possibility of being derived from a polysaccharide mainly composed of xylose is very high. [Measurement of molecular weight distribution]
実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物) に含 まれる、ァラピノ一ス及びキシロースを主たる構成要素とする多糖類の分子量を 明らかにするために、それぞれの有機溶媒に不溶の画分が有する分子量分布を測 定した。  In order to clarify the molecular weight of polysaccharides mainly composed of alapinose and xylose contained in the fractions (lyophilized product) insoluble in each organic solvent obtained in Experiment 1 to Experiment 14, respectively. The molecular weight distribution of the fraction insoluble in the organic solvent was measured.
即ち、 昭和電工株式会社製の Shodex s tandard P-82 (分子量 1300乃至 1660000 ) 、 及びマルトトリオース (分子量 504) から成る分子量標準品をそれぞれ別々 に O. lmol /L硝酸ナトリウム溶液に溶解して 0. 05W/V 農度の標準液を得、 該標準 液を高速液体クロマトグラフに注入して検量線を作成した。 次に、 前記実験 1乃 至実験 で得たそれぞれの有機溶媒に不溶の画分(凍結乾燥物) 0. 02gを用意し、 これに O. lmol/L硝酸ナトリウム溶液 10ml を加え、 室温でー晚放置した後、 孔径 0. 45 mのメンブランフィルターでろ過してろ液を得、 該ろ液を高速液体クロマ トグラフに注入して、 システムインスツルメンッ株式会社製 480デ一タステ一シ ョン GPCプログラムを用いて分子量分布を求めた。 高速液体クロマトグラフ分析 は、 昭和電工株式会社製 Shodex GPC SYSTEM- 21 を用い、 検出器に昭和電工株式 会社製示差屈折計 RI- 71 Sを使用し、 カラムは東ソ一株式会社製 TSKge l GMPWXL ( φ 7. 8mmX 300mm)を 2本連結して使用した。 カラム温度は 40°Cとし、 移動相には O. lmol/L硝酸ナトリウム溶液を用い、 流量は 1. 0ml/min、 試料注入量は 100 1と した。  Specifically, Shodex standard P-82 (molecular weight 1300 to 1660000) and maltotriose (molecular weight 504) manufactured by Showa Denko Co., Ltd. were separately dissolved in O. lmol / L sodium nitrate solution. A standard solution of 0.05 W / V agricultural power was obtained, and the standard solution was injected into a high performance liquid chromatograph to prepare a calibration curve. Next, prepare 0.02 g of the fraction insoluble in each organic solvent (lyophilized product) obtained in Experiment 1 to Experiment 10, and add 10 ml of O. lmol / L sodium nitrate solution at room temperature.晚 After standing, filter through a 0.45 m membrane filter to obtain a filtrate, inject the filtrate into a high-speed liquid chromatograph, and make a 480-meter system manufactured by System Instruments Co., Ltd. The molecular weight distribution was determined using the GPC program. For high-performance liquid chromatographic analysis, Shodex GPC SYSTEM-21 made by Showa Denko Co., Ltd. is used, and a differential refractometer RI-71S made by Showa Denko Co., Ltd. is used as the detector. Two (φ7.8 mm × 300 mm) were connected and used. The column temperature was 40 ° C, O. lmol / L sodium nitrate solution was used as the mobile phase, the flow rate was 1.0 ml / min, and the sample injection volume was 100 1.
上記方法により実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分につ いてそれぞれの分子量分布を測定した結果、 有機溶媒に不溶の画分に含まれる、 多糖類由来のァラビノース及びキシロースの合計含量が高いほど、 分子量 3000 乃至 10万の範囲に分子量分布を有する画分の割合が髙まることが判明した。 こうしたことから、本発明者らは、大麦焼酎蒸留残液から上述した方法で分取 した有機溶媒に不溶の画分に含まれる、ァラビノース及びキシロースを主たる構 成要素とする NK田胞活性化能を有した多糖類は、主として 3000乃至 10万の範囲の 分子量分布を有しているのではないかと推測し、限外濾過を用いた濃縮精製を検 討した。 As a result of measuring the molecular weight distribution of the fractions insoluble in the organic solvents obtained in Experiments 1 to 14 by the above method, the arabinose and xylose derived from polysaccharides contained in the fractions insoluble in the organic solvents. It was found that the higher the total content of, the higher the fraction with a molecular weight distribution in the molecular weight range of 3000 to 100,000. For these reasons, the present inventors have the ability to activate NK rice field, comprising arabinose and xylose as the main constituents contained in the fraction insoluble in the organic solvent fractionated from the barley shochu distillation residue. Polysaccharides with a major range of 3000 to 100,000 Presuming that it has a molecular weight distribution, we examined concentration and purification using ultrafiltration.
[限外濾過による濃縮精製]  [Concentration purification by ultrafiltration]
実験 1乃至実験 14で得たそれぞれの有機溶媒に不溶の画分について、 上記方法 により分子量分布を測定した結果、 実験 5及び実験 12で得たそれぞれの有機溶媒 に不溶の画分 (凍結乾燥物) が、 分子量 3000乃至 10万の範囲に分子量分布を有す る画分の割合が非常に高く、しかも多糖類由来のァラビノース及びキシロースの 合計含量も非常に高いことが判明した。 そこで、 以下に示す手順により、 限外濾 過処理を介した濃縮精製を行った。  As a result of measuring the molecular weight distribution of the fractions insoluble in each organic solvent obtained in Experiment 1 to Experiment 14 by the above method, the fraction insoluble in each organic solvent obtained in Experiment 5 and Experiment 12 (lyophilized product). However, it was found that the fraction having a molecular weight distribution in the molecular weight range of 3000 to 100,000 was very high, and the total content of arabinose and xylose derived from polysaccharides was also very high. Therefore, concentration and purification through ultrafiltration was performed according to the following procedure.
即ち、 第一に、 上記 「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得られ た大麦焼酎蒸留残液を、 8000rpm、 lOminの条件で遠心分離して液体分を得、 得ら れた液体分を Br ixl Oに調整後、 この Br ixl Oに調整した液体分 1Lを、 500ml容量の オルガノ (株) 製アンバーライト 200CT (強酸性陽イオン交換樹脂) を充填した カラムに通して、 前記イオン交換樹脂に非吸着の画分を得、 得られた画分を A/G テクノロジ一社製の限外濾過膜 UFP- 30- E- 4MA (分画分子量 3万) による濃縮処理 に付して濃縮液を得、 得られた濃縮液を Br ix20に調整後、 終濃度 75容量%になる ようにエタノールを加え、 8000rpm、 lOminの条件で遠心分離して前記有機溶媒 ( エタノール) に不溶の画分を分取し、得られた画分を凍結乾燥に付すことにより 凍結乾燥物 2. 5gを得た。  That is, first, the barley shochu distillation residue obtained in the above-mentioned “Manufacture of barley shochu and barley shochu distillation residue” was centrifuged at 8000 rpm and lOmin to obtain a liquid component, and the liquid obtained After adjusting the volume to Brixl O, 1 L of the liquid volume adjusted to Brixl O was passed through a column packed with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation. Fraction that is not adsorbed on the exchange resin is obtained, and the obtained fraction is subjected to concentration treatment with an ultrafiltration membrane UFP-30-E-4MA (fraction molecular weight 30,000) manufactured by A / G Technology. After the concentrate is adjusted to Brix20, ethanol is added to a final concentration of 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin, and is insoluble in the organic solvent (ethanol). Fractionate the fraction and freeze-dry the resulting fraction to obtain 2.5 g of lyophilized product. .
得られた有機溶媒に不溶の画分 (凍結乾燥物) について、 上記 「多糖類含量の 測定」 に記載の方法により、多糖類由来のァラビノース及びキシロースの合計含 量を測定した。その結果、多糖類由来のァラビノース及びキシロースの合計含量 は約 54. 4重量 ¾にまで高まっていることが判明した。 また、 前記有機溶媒に不溶 の画分 (凍結乾燥物) について、 上記 「分子量分布の測定」 に記載の方法により 分子量分布の測定を行つたところ、該有機溶媒に不溶の画分の分子量分布は、 10 万以上が 5%、 3万乃至 10万が 18%、 1万乃至 3万が 23%、 3, 000乃至 1万が 31%、 1 , 000 乃至 3, 000が 11%、 500乃至 1 , 000が 3%、 500以下が 9%であることが判明した。 そ して、得られたクロマトグラムの結果から、該有機溶媒に不溶の画分のクロマト グラムは分子量 3, 000乃至 10, 000の範囲に最も高いピークを有することが明らか になった。 For the obtained fraction insoluble in organic solvent (lyophilized product), the total content of polysaccharide-derived arabinose and xylose was measured by the method described in “Measurement of Polysaccharide Content” above. As a result, it was found that the total content of polysaccharide-derived arabinose and xylose increased to about 54.4 wt. Further, when the molecular weight distribution of the fraction insoluble in the organic solvent (lyophilized product) was measured by the method described in “Measurement of molecular weight distribution” above, the molecular weight distribution of the fraction insoluble in the organic solvent was 100,000 to 5%, 30,000 to 100,000 are 18%, 10,000 to 30,000 are 23%, 3,000 to 10,000 are 31%, 1,000 From 3,000 to 11%, 500 to 1,000 was found to be 3%, and 500 or less was found to be 9%. From the results of the chromatogram obtained, it was revealed that the chromatogram of the fraction insoluble in the organic solvent had the highest peak in the molecular weight range of 3,000 to 10,000.
そこで、後述の実施例に記載の方法により、該有機溶媒に不溶の画分を添加し て培養した NK細胞の NK細胞活性を測定した。その結果、該有機溶媒に不溶の画分 が有する NK細胞賦活化作用は極めて強力なものであり、 しかも、 ポジティブコン トロールの IL-2に匹敵する程度のものであった。  Therefore, the NK cell activity of NK cells cultured by adding a fraction insoluble in the organic solvent was measured by the method described in the Examples below. As a result, the NK cell activation action of the fraction insoluble in the organic solvent was extremely strong, and was comparable to the positive control IL-2.
以上の実験結果から、大麦焼酎蒸留残液の液体分から分取した有機溶媒に不溶 の画分が有する NK細胞賦活化作用は、該有機溶媒に不溶の画分に含まれる、 ァラ ビノース及びキシロースを主たる構成要素とする多糖類に由来し、こうしたァラ ビノース及びキシロースを主たる構成要素とする多糖類を著量含有する組成物 は、大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分離し て液体分を得、該液体分をイオン交換樹脂を使用するイオン交換処理に付して前 記イオン交換樹脂に非吸着の画分を分取し、得られたイオン交換樹脂に非吸着の 画分を限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得、該濃 縮液に有機溶媒を添加することにより前記有機溶媒に不溶の画分として分取で きることが判明した。 そして、 該有機溶媒に不溶の画分は、 成分分析の結果、 多 糖類を約 84. 1重量%、 粗タンパクを約 4. 2重量%、 有機酸を約 0. 3重量 °ん 遊離糖類 を約 1. 2重量 %含有し、該画分は多糖類を主たる成分として含有することが判つた 次に、 上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得られた大麦焼 酎蒸留残液を、 8000rpm、 lOminの条件で遠心分離して液体分を得、 得られた液体 分をオルガノ (株)製の合成吸着剤アンバーライト XAD-16を充填したカラムに通 して吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸着性を 示す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られた画分 を Br ixl Oに調整した後、 この Br ixlOに調整した画分 1Lを、 500ml容量のオルガノ (株) 製アンバーライト 200CT (強酸性陽イオン交換樹脂) を充填したカラムに 通し、 前記イオン交換樹脂に非吸着の画分を分取し、 得られた画分を A/Gテクノ ロジ一社製の限外濾過膜 UFP- 30- E- 4MA (分画分子量 3万) による濃縮処理に付し て濃縮液を得、 得られた濃縮液を Br ix20に調整後、 終濃度 75容量%になるように エタノールを加え、 8000n)m、 lOminの条件で遠心分離して前記有機溶媒 (ェタノ ール) に不溶の画分を分取し、得られた画分を凍結乾燥に付すことにより凍結乾 燥物 1. 3 gを得た。 From the above experimental results, the NK cell activation action of the fraction insoluble in the organic solvent fractionated from the liquid fraction of the barley shochu distillation residue is contained in the fraction insoluble in the organic solvent, arabinose and xylose. A composition containing a significant amount of such polysaccharides mainly composed of arabinose and xylose is derived from a polysaccharide mainly composed of arabinose. The liquid is subjected to solid-liquid separation to obtain a liquid component, which is subjected to an ion exchange treatment using an ion exchange resin to fractionate a fraction not adsorbed on the ion exchange resin, and the resulting ion exchange is obtained. A fraction that is not adsorbed to the resin is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrate, and an organic solvent is added to the concentrate to obtain a fraction insoluble in the organic solvent. It was found that it can be sorted as . As a result of component analysis, the fraction insoluble in the organic solvent contains about 84.1% by weight of polysaccharide, about 4.2% by weight of crude protein, and about 0.3% by weight of organic acid. About 1.2% by weight The fraction was found to contain polysaccharides as the main component. Next, the barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” above was used. The liquid is centrifuged under the conditions of 8000 rpm and lOmin to obtain a liquid component, and the obtained liquid component is passed through a column filled with a synthetic adsorbent Amberlite XAD-16 manufactured by Organo Corporation for adsorption separation treatment. As a result, fractions that had not been adsorbed to the synthetic adsorbent consisting of a flow-through liquid exhibiting non-adsorbability to the synthetic adsorbent of the column were fractionated. Obtained fraction Was adjusted to Brixl O, and then 1 L of the fraction adjusted to BrixlO was passed through a column filled with 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation. Fractionated non-adsorbed fraction is subjected to concentration treatment with ultrafiltration membrane UFP-30-E-4MA (fractional molecular weight 30,000) manufactured by A / G Technology. The resulting concentrate is adjusted to Brix20, ethanol is added to a final concentration of 75% by volume, and the mixture is centrifuged at 8000 n) m and lOmin, and the organic solvent (ethanol) is obtained. Fraction-insoluble fraction was collected, and the obtained fraction was freeze-dried to obtain 1.3 g of a freeze-dried product.
得られた有機溶媒に不溶の画分 (凍結乾燥物) について、 上記 「多糖類含量の 測定」 に記載の方法により、多糖類由来のァラビノース及びキシロースの合計含 量を測定した。その結果、多糖類由来のァラビノース及びキシロースの合計含量 は約 58. 6重量%にまで高まっていることが判明した。 また、 得られた有機溶媒に 不溶の画分 (凍結乾燥物) について、 上記 「分子量分布の測定」 に記載の方法に より分子量分布の測定を行つたところ、該有機溶媒に不溶の画分の分子量分布は 、 100, 000以上が 11%、 30, 000乃至 100, 000が 29%、 10, 000乃至 30, 000が 24%、 3, 000 乃至 10, 000が 21%、 1, 000乃至 3, 000が 6%、 500乃至 1 , 000が 2%、 500以下が 7%である ことが判明した。 そして、 得られたクロマトグラムの結果から、 該有機溶媒に不 溶の画分のクロマトグラムは、 分子量 30, 000乃至 100, 000の範囲に最も高いピ一 クを有することが明らかになった。 そこで、 後述の実施例に記載の方法により、 該有機溶媒に不溶の画分を添加して培養した NK細胞の NK細胞活性を測定した。そ の結果、該有機溶媒に不溶の画分が有する NK細胞賦活化作用は極めて顕著であり 、 しかも、 ポジティブコントロールの IL-2に匹敵する程度のものであった。 以上の実験結果から、大麦焼酎蒸留残液の液体分から上述した方法で分取した 有機溶媒に不溶の画分が有する NK細胞賦活化作用は、該有機溶媒に不溶の画分に 含まれる、ァラビノース及びキシロースを主たる構成要素とする多糖類に由来す ることが判明した。 また、 このようにァラビノース及びキシロースを主たる構成 要素とする多糖類を著量含有する組成物は、大麦を原料とする焼酎製造において 副生する大麦焼酎蒸留残液を固液分離して液体分を得、該液体分を合成吸着剤を 使用する吸着分離処理に付して前記合成吸着剤に非吸着の画分を得、得られた画 分をイオン交換樹脂を使用するイオン交換処理に付して前記イオン交換樹脂に 非吸着の画分を得、得られたイオン交換樹脂に非吸着の画分を限外濾過膜を使用 する限外濾過による濃縮処理に付して濃縮液を得、該濃縮液に有機溶媒を添加す ることにより前記有機溶媒に不溶の画分として分取できることが判明した。そし て、 該有機溶媒に不溶の画分は、 成分分析の結果、 多糖類を約 78. 5重量 %、 粗夕 ンパクを約 3. 3重量%、 有機酸を約 0. 2重量 %、 遊離糖類を約 1. 5重量 %含有し、 該画 分は多糖類を主たる成分として含有することが判った。 For the obtained fraction insoluble in organic solvent (lyophilized product), the total content of polysaccharide-derived arabinose and xylose was measured by the method described in “Measurement of Polysaccharide Content” above. As a result, it was found that the total content of arabinose and xylose derived from polysaccharides increased to about 58.6% by weight. In addition, when the molecular weight distribution of the fraction (lyophilized product) insoluble in the obtained organic solvent was measured by the method described in “Measurement of molecular weight distribution” above, the fraction insoluble in the organic solvent was obtained. The molecular weight distribution is 11% for 100,000 or more, 29% for 30,000 to 100,000, 24% for 10,000 to 30,000, 21% for 3,000 to 10,000, 1,000 to 3 , 000 was found to be 6%, 500 to 1,000 was 2%, and 500 or less was 7%. From the results of the obtained chromatogram, it was revealed that the chromatogram of the fraction insoluble in the organic solvent had the highest peak in the molecular weight range of 30,000 to 100,000. Therefore, the NK cell activity of NK cells cultured by adding a fraction insoluble in the organic solvent was measured by the method described in Examples below. As a result, the NK cell activation action of the fraction insoluble in the organic solvent was extremely remarkable, and was comparable to that of IL-2 as a positive control. From the above experimental results, the NK cell activation action of the fraction insoluble in the organic solvent fractionated from the liquid content of the barley shochu distillation residue by the above-described method is the arabinose contained in the fraction insoluble in the organic solvent In addition, it was found to be derived from a polysaccharide mainly composed of xylose. In addition, the main composition of arabinose and xylose in this way A composition containing a significant amount of polysaccharide as an element is obtained by solid-liquid separation of the barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and this liquid is used as a synthetic adsorbent. A fraction that is non-adsorbed on the synthetic adsorbent is obtained by subjecting it to an adsorption separation treatment, and the obtained fraction is subjected to an ion exchange treatment using an ion exchange resin to obtain a fraction that is not adsorbed on the ion exchange resin. By subjecting the non-adsorbed fraction to the obtained ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrate, and adding an organic solvent to the concentrate It was found that it can be fractionated as a fraction insoluble in the organic solvent. As a result of component analysis, the fraction insoluble in the organic solvent is about 78.5% by weight of polysaccharide, about 3.3% by weight of crude protein, about 0.2% by weight of organic acid, and free. It was found that the saccharide contained about 1.5% by weight, and the fraction contained polysaccharide as a main component.
ところで、 特許文献 1に記載のへミセルロ一スは、 主たる構成要素がキシ口一 ス及びァラビノースである点において、本発明の NK細胞を賦活化する作用を有す る組成物に類似するところはあるものの、前記へミセルロースは平均分子量が 55 万又は 60万であることから本発明の NK細胞を賦活化する作用を有する組成物と は明らかに別異のものである。  Incidentally, the hemicellulos described in Patent Document 1 is similar to the composition having the action of activating NK cells of the present invention in that the main constituents are xylose and arabinose. However, since the hemicellulose has an average molecular weight of 550,000 or 600,000, it is clearly different from the composition having an action of activating NK cells of the present invention.
特許文献 2に記載の免疫力増強物質は、 主たる構成要素がキシロース及びァラ ビノースである点において、本発明の M細胞を賦活化する作用を有する組成物に 類似するところはあるものの、 前記免疫力増強物質は平均分子量が 60万又は 65 万であることから本発明の NK細胞を賦活化する作用を有する組成物とは明らか に別異のものである。  The immunity enhancing substance described in Patent Document 2 is similar to the composition having an action of activating M cells of the present invention in that the main components are xylose and arabinose. Since the force-enhancing substance has an average molecular weight of 600,000 or 650,000, it is clearly different from the composition having the action of activating NK cells of the present invention.
特許文献 3には、 米を原料とし発酵のみを介して製造される清酒製造において 副生する酒粕の水抽出液が NK細胞活性化作用を有することが記載されている。し かしながら、 特許文献 3には、 前記水抽出液の成分組成については全く記載され ておらず、また前記 NK細胞活性化作用に関与する成分についても具体的記載はな レ^  Patent Document 3 describes that an aqueous extract of sake lees produced as a by-product in sake production produced using rice as a raw material only through fermentation has an NK cell activation effect. However, Patent Document 3 does not describe the component composition of the aqueous extract at all, and does not specifically describe the component involved in the NK cell activation action.
特許文献 4には、 米糠の水抽出物であって、 分子量 3万乃至 4万程度の画分から なる抽出物を含有してなる免疫賦活用組成物が、マイトジェン活性及び優れた NK 細胞の活性化作用を有することが記載されている。 しかしながら、 特許文献 4に は、前記免疫賦活用組成物の成分組成については全く記載されておらず、 またそ の免疫賦活作用に関与する成分についても具体的に記載するところはない。 特許文献 5には、 「セルエース」 の商品名で市販されている、 トウモロコシ外 皮から澱粉質及び蛋白質を除去した残部をアルカリ抽出することにより得られ るへミセルロースをキシラナ一ゼで処理することにより得られるへミセルロー スの部分分解物が記載され、 該へミセルロースの部分分解物を投与した co 1 on26 担癌マウスにおいて、 NK細胞活性が有意に上昇し、 更にサイトカイン (IL-2及び iNF- r ) 産生能も有意に上昇することが記載されている。 非特許文献 1には、 特 許文献 5に記載の 「セルエース」 (トウモロコシ外皮から得られたへミセルロー スの部分分解物) が、 キシロース、 ァラビノース、 ゥロン酸、 ガラク I ス、 及 びグルコースを含有するものであることが記載されている。 よって、 特許文献 5 と非特許文献 1は、 同じ 「トウモロコシ外皮から得られたへミセルロースの部分 分解物」 、 即ち市販の 「セルエース」 に係るものである。 一方、 本発明の NK細胞 を賦活化する作用を有する組成物は、大麦を原料として大麦麹及び蒸麦を製造し 、得られた大麦麹及び蒸麦中に含まれるでんぷんを前記大麦麹の麹により糖化し 、次いで酵母によるアルコール発酵に付して焼酎熟成もろみを得、得られた焼酎 熟成もろみを蒸留に付して焼酎を製造する際に副生する蒸留残渣、即ち、大麦焼 酎蒸留残液から得られるものである。即ち、本発明の NK細胞を賦活化する作用を 有する組成物の取得源は、 大麦焼酎蒸留残液である。 一方、 特許文献 5に記載の へミセルロースの部分分解物 「セルエース」 の取得源は、 トウモロコシ外皮、 即 ち、 トウモロコシ穀粒を精白する際に除かれるトウモロコシ穀粒の外皮である。 このように、 両者の取得源は全く異なる。 しかも、 本発明の NK細胞を賦活化する 作用を有する組成物は、 特許文献 5に記載のへミセルロースの部分分解物の製造 方法とは全く異なる製造方法で得られるものである。そして、本発明の NK細胞を 賦活化する作用を有する組成物は、 ァラビノース、キシロース及びグルコースを 含有するもののゥロン酸を実質的に含有しない。 一方、 特許文献 5に記載のへミ セルロースの部分分解物は比較的多量のゥロン酸を含有する。この点でも両者はPatent Document 4 describes an aqueous extract of rice bran from a fraction having a molecular weight of about 30,000 to 40,000. It is described that the composition for immunostimulation comprising the extract as described above has mitogenic activity and excellent NK cell activation action. However, Patent Document 4 does not describe the component composition of the immunostimulatory composition at all, and does not specifically describe the component involved in the immunostimulatory action. Patent Document 5 discloses that hemicellulose obtained by alkali extraction of the residue obtained by removing starch and protein from corn hull, which is marketed under the name of “Cel Ace”, is treated with xylanase. In the co 1 on26 tumor-bearing mice administered with the partial degradation product of hemicellulose, NK cell activity was significantly increased, and cytokines (IL-2 and iNF) were obtained. -r) It is described that the production ability is also significantly increased. Non-Patent Document 1 includes “Celace” (partially decomposed hemicellulose obtained from corn hulls) described in Patent Document 5 containing xylose, arabinose, uronic acid, galactose, and glucose. It is described that it is. Therefore, Patent Document 5 and Non-Patent Document 1 relate to the same “partially decomposed product of hemicellulose obtained from corn hulls”, that is, commercially available “Cell Ace”. On the other hand, the composition having an action of activating NK cells of the present invention produces barley koji and steamed barley using barley as a raw material, and the starch contained in the obtained barley koji and steamed barley is added to the barley koji. Saccharified, and then subjected to alcoholic fermentation with yeast to obtain shochu-ripened mash, and the resulting shochu-ripened mash is subjected to distillation to produce shochu, that is, a by-product distillation residue, that is, barley shochu mash distillation residue It is obtained from the liquid. That is, the source for obtaining the composition having the effect of activating NK cells of the present invention is barley shochu distillation residue. On the other hand, the acquisition source of “cell ace”, a partial degradation product of hemicellulose described in Patent Document 5, is corn hull, that is, hull of corn kernel that is removed when corn kernel is refined. In this way, both sources are completely different. Moreover, the composition having the action of activating NK cells of the present invention is obtained by a production method completely different from the method for producing a partially decomposed product of hemicellulose described in Patent Document 5. And the NK cells of the present invention The composition having an activating effect contains arabinose, xylose and glucose, but does not substantially contain uronic acid. On the other hand, the partially decomposed product of hemicellulose described in Patent Document 5 contains a relatively large amount of uronic acid. In this respect both
、 全く異なる。 よって、 本発明の M細胞を賦活化する作用を有する組成物は、 特 許文献 5に記載のトウモロコシ外皮から得られたへミセルロースの部分分解物 ( 商品名セルエース) から明確に区別される別異のものであることは明白である。 尚、 特許文献 5には、 へミセルロースの部分分解物の平均分子量が 2万乃至 20 万であることが好ましく、 2万乃至 10万であることがより好ましく、 2万乃至 4万 であることが最も好ましい旨記載されているが、当該平均分子量を決定づけるに 至った実験データは全く記載されておらず、 しかも、 こうした平均分子量を有す るへミセルロースの部分分解物を取得した具体例は全く記載されていない。 そこで、 本発明者らは、 特許文献 5において、 へミセルロースの部分分解物が 商品名 「セルエース」 (日本食品化工株式会社製) として市販されていることが 記載されていることから、 当該 「セルエース」 を入手し、 先に述べた 「分子量分 布の測定」 に記載の方法により該セルエースの分子量分布を測定した。その結果 、 該セルエースの分子量分布は、 100万以上が 1%、 30万乃至 100万が 9%、 10万乃至 30万が 30%、 3万乃至 10万が 30%、 1万乃至 3万が 11%、 3000乃至 1万が 4%、 1000乃至 3000が 2%、 1000以下が 13%であり、 そのクロマトグラムにおいて認められる最も 高いピークは分子量 10万乃至 30万の範囲に存在し、その重量平均分子量 (Mw)は 15 万であることが判明した。 従って、 特許文献 5に記載のトウモロコシ外皮から得 られたへミセルロースの部分分解物は、 特許文献 5に記載されているように、 市 販の 「セルエース」 に該当するものであると理解される。 , Completely different. Therefore, the composition having the effect of activating the M cells of the present invention is clearly distinguished from the partially decomposed product of hemicellulose (trade name Cellace) obtained from corn hull described in Patent Document 5. Obviously it is different. In Patent Document 5, the average molecular weight of the partially degraded hemicellulose is preferably 20,000 to 200,000, more preferably 20,000 to 100,000, and 20,000 to 40,000. However, the experimental data that led to the determination of the average molecular weight is not described at all, and a specific example of obtaining a partially decomposed product of hemicellulose having such an average molecular weight is as follows. It is not described at all. Therefore, the inventors described in Patent Document 5 that a partially decomposed product of hemicellulose is marketed under the trade name “Cel Ace” (manufactured by Nippon Shokuhin Kako Co., Ltd.). Cellace ”was obtained, and the molecular weight distribution of Cellace was measured by the method described in“ Measurement of molecular weight distribution ”described above. As a result, the molecular weight distribution of Cell Ace is 1% for 1 million or more, 9% for 300,000 to 1 million, 30% for 100,000 to 300,000, 30% for 30,000 to 100,000, and 10,000 to 30,000. 11%, 3000 to 10,000 is 4%, 1000 to 3000 is 2%, 1000 or less is 13%, and the highest peak observed in the chromatogram is in the molecular weight range of 100,000 to 300,000. The average molecular weight (Mw) was found to be 150,000. Therefore, it is understood that the partial degradation product of hemicellulose obtained from the corn hull described in Patent Document 5 falls under the category of “Cell Ace” marketed as described in Patent Document 5. .
一方、 上述したように、本発明の M細胞を賦活化する作用を有する組成物の分 子量分布は、 10万以上が僅か 5%又は 11%にすぎず、分子量 3, 000乃至 10万の範囲に 分子量分布を有する成分が全体の 72%又は 74%を占めている。 しかも、 クロマトグ ラムにおいて認められる最も高いピークは、 それぞれ分子量 3, 000乃至 10, 000又 は分子量 30, 000乃至 100, 000の範囲に存在している。 On the other hand, as described above, the molecular weight distribution of the composition having the effect of activating the M cells of the present invention is only 5% or 11% of 100,000 or more, and has a molecular weight of 3,000 to 100,000. Components with molecular weight distribution in the range account for 72% or 74% of the total. In addition, the highest peaks observed in the chromatogram are molecular weights of 3,000 to 10,000, respectively. Is present in the molecular weight range of 30,000 to 100,000.
従って、本発明の NK細胞を陚活化する作用を有する組成物が有する分子量分布 は、 「セルェ一ス」 、 即ち、 トウモロコシ外皮から得られたへミセルロースの部 分分解物からなる組成物が有する分子量分布とは全く異なる。 よって、本発明の NK細胞を賦活化する作用を有する組成物は、 特許文献 5に記載のへミセルロース の部分分解物から明確に区別される別異のものであることは明白である。  Accordingly, the molecular weight distribution of the composition having the action of stimulating NK cells of the present invention is “cell suspension”, that is, a composition comprising a partial degradation product of hemicellulose obtained from corn hulls. It is completely different from the molecular weight distribution. Therefore, it is clear that the composition having the effect of activating NK cells of the present invention is different from the partial degradation product of hemicellulose described in Patent Document 5.
特許文献 6には、 大麦焼酎蒸留残液から分取した脂肪月干抑制作用を有する組成 物が記載されている。 この脂肪肝抑制作用を有する組成物の取得源は、本発明の NK細胞を賦活化する作用を有する組成物と同様に大麦焼酎蒸留残液であるが、脂 肪肝抑制作用と NK細胞を賦活化する作用とは別異のものである。 また、特許文献 6に記載の前記組成物の主たる成分は分子量 3000以下のものであり、 当該組成物 に含まれるへミセル口一スはキシロースを主たる構成要素とすることから、本発 明の NK細胞を賦活化する作用を有する組成物とは明確に区別される別異のもの である。  Patent Document 6 describes a composition having an action to suppress fat dryness from a barley shochu distillation residue. The source of the composition having an action to suppress fatty liver is barley shochu distillate as in the case of the composition having an action to activate NK cells of the present invention. It is different from the action to become. The main component of the composition described in Patent Document 6 has a molecular weight of 3000 or less, and the micelle mouth contained in the composition contains xylose as a main component. It is a distinct distinction from a composition that has the effect of activating cells.
本発明及びその好ましい態様の説明 DESCRIPTION OF THE INVENTION AND PREFERRED EMBODIMENTS
本発明の M細胞を賦活化する作用を有する組成物は以下のようにして製造さ れる。即ち、大麦を使用する蒸留酒の製造において副成する大麦焼酎蒸留残液を 固液分離して液体分を得る工程 A、得られた前記液体分をイオン交換樹脂を使用 するイオン交換処理に付して前記イオン交換樹脂に非吸着の画分を得る工程 B 1、得られた前記イオン交換樹脂に非吸着の画分を限外濾過膜を使用する限外濾 過による濃縮処理に付して濃縮液を得る工程 C、及び得られた前記濃縮液に有機 溶媒を添加することにより前記有機溶媒に不溶の画分を分取する工程 Dを順次 行うことにより製造される。  The composition having the effect of activating the M cells of the present invention is produced as follows. That is, Step A to obtain a liquid component by solid-liquid separation of the barley shochu distillation residue that is a by-product in the production of distilled liquor using barley, and the obtained liquid component is subjected to an ion exchange treatment using an ion exchange resin. Step B 1 for obtaining a non-adsorbed fraction on the ion exchange resin, and subjecting the obtained non-adsorbed fraction to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane. It is produced by sequentially performing Step C for obtaining a concentrated solution and Step D for fractionating a fraction insoluble in the organic solvent by adding an organic solvent to the obtained concentrated solution.
この他、本発明の NK細胞を賦活化する作用を有する組成物は以下のようにして 製造される。即ち、大麦を使用する蒸留酒の製造において副成する大麦焼酎蒸留 残液を固液分離して液体分を得る工程 A、得られた前記液体分を合成吸着剤を使 用する吸着分離処理に付して前記合成吸着剤に非吸着の画分を得る工程 E、得ら れた前記合成吸着剤に非吸着の画分をイオン交換樹脂を使用するイオン交換処 理に付して前記イオン交換樹脂に非吸着の画分を得る工程 B 2、得られた前記ィ オン交換樹脂に非吸着の画分を限外濾過膜を使用する限外濾過による濃縮処理 に付して濃縮液を得る工程 C、及び得られた前記濃縮液に有機溶媒を添加するこ とにより前記有機溶媒に不溶の画分を分取する工程 Dを順次行うことにより製 造される。 In addition, the composition having an action of activating NK cells of the present invention is produced as follows. That is, Step A to obtain a liquid component by solid-liquid separation of a barley shochu distillation residue, which is a by-product in the production of distilled liquor using barley, and the obtained liquid component using a synthetic adsorbent. Step E to obtain a fraction that is not adsorbed to the synthetic adsorbent by subjecting it to an adsorption separation treatment, and the fraction that is not adsorbed to the synthetic adsorbent thus obtained is subjected to an ion exchange treatment using an ion exchange resin. Step B 2 for obtaining a non-adsorbed fraction on the ion exchange resin, and subjecting the obtained non-adsorbed fraction to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane. Thus, the step C is obtained by sequentially performing the step C for obtaining a concentrated liquid and the step D for fractionating a fraction insoluble in the organic solvent by adding an organic solvent to the obtained concentrated liquid.
以下に、本発明の該製造方法を実施する際に使用する、大麦を原料とする焼酎 の製造において副成する大麦焼酎蒸留残液、 及び各工程について詳述する。 本発明において使用する大麦焼酎蒸留残液は、代表的には、大麦又は精白大麦 を原料として大麦麹及び蒸麦を製造し、得られた大麦麹及び蒸麦中に含まれるで んぷんを該大麦麹の麹により糖化し、それらを酵母によるアルコ一ル発酵に付し て焼酎熟成もろみを得、得られた焼酎熟成もろみを減圧蒸留または常圧蒸留等の 単式蒸留装置を用いて蒸留する際に蒸留残渣として副生するもの、即ち、大麦焼 酎の蒸留残液を意味する。  Below, the barley shochu distillation residual liquid by-produced in the production of shochu using barley as a raw material and the respective steps used in carrying out the production method of the present invention will be described in detail. The barley shochu distillation residue used in the present invention typically comprises barley koji and steamed barley using barley or polished barley as a raw material, and the starch contained in the barley koji and steamed barley obtained is When saccharifying with barley koji, subjecting them to alcoholic fermentation with yeast to obtain shochu-ripened mash, and distilling the obtained shochu-ripened mash with a single distillation apparatus such as vacuum distillation or atmospheric distillation Means a by-product as a distillation residue, that is, a distillation residue of barley shochu.
本発明において、大麦焼酎蒸留残液を得るに際して、大麦焼酎の製造に用いる 大麦麹は、通常の大麦焼酎製造において行われている製麹条件で製造すればよく In the present invention, when the barley shochu distillation residue is obtained, the barley koji used for the production of barley shochu may be produced under the koji-making conditions used in normal barley shochu production.
、用いる麹菌株としては、一般的に大麦焼酎製造で使用する白麹菌(Aspergi l lus kawachi i)が好ましい。或いは泡盛製造で使用する黒麹菌(Aspergi l lus awamori ) 及び清酒製造等で使用する黄麹(Aspergi l lus oryzae) などの Aspergi l lus属の 菌株を用いることもできる。 また大麦焼酎の製造に用いる酵母は、 一般的に焼酎 製造の際に使用する各種の焼酎醸造用酵母を使用することができる。 As a koji mold to be used, the Aspergillus kawachi i generally used in the production of barley shochu is preferable. Alternatively, Aspergi lus genus strains such as Aspergillus awamori used in awamori manufacture and Aspergi lus oryzae used in sake production and the like can also be used. In addition, various yeasts for brewing shochu can be used as the yeast used in the production of barley shochu.
本発明において、大麦焼酎の製造における蒸留工程で得られた大麦焼酎蒸留残 液を固液分離して液体分を得る工程 Aは、大麦焼酎蒸留残液から原料大麦、 ある いは大麦麹由来の水不溶性の発酵残渣等の SS分を除去することを目的として行 うものである。 この工程 Aにおける当該固液分離は、 スクリュープレス方式や口 —ラープレス方式の固液分離方法によるか、或いはろ過圧搾式の固液分離機を用 いて予備分離を行い、 次いで遠心分離機、 ケイソゥ土ろ過装置、 セラミックろ過 装置、或いはろ過圧搾機等を用いて本発明により実施できる本固液分離処理を行 ラ。 In the present invention, the step A for obtaining a liquid component by solid-liquid separation of the barley shochu distillation residue obtained in the distillation step in the production of barley shochu is made from raw barley or barley koji derived from the barley shochu distillation residue. The purpose is to remove SS components such as water-insoluble fermentation residues. The solid-liquid separation in step A can be performed by screw press or -Preliminary separation is performed by a solid-liquid separation method using the Ler press method or using a filter-press type solid-liquid separator, and then using a centrifuge, a diatomaceous earth filter, a ceramic filter, or a filter-press The solid-liquid separation process that can be performed according to the present invention is performed.
前記工程 Aで得られた大麦焼酎蒸留残液の液体分を合成吸着剤を使用する吸 着分離処理に付すことにより前記合成吸着剤に非吸着の画分を得る工程 Eは、大 麦焼酎蒸留残液の液体分に含まれているポリフエノール等の成分を除去するこ とを目的として行うものである。工程 Eで使用する合成吸着剤としては、芳香族 系、 芳香族系修飾型、 或いはメ夕クリル系の合成吸着剤を用いることができる。 当該工程 Eで使用する合成吸着剤の好適な具体例としては、 オルガノ (株) 製の アンバーライ卜 XAD-4、 アンバーライ卜 XAD- 16、 アンバーライト XAD- 1180及びァ ンパ一ライト XAD-2000、 三菱化学 (株) 製のセパビーズ SP850及びダイヤイオン HP20等の芳香族系 (又はスチレン系とも言う) 合成吸着剤、 オルガノ (株) 製の アンパーライト XAD- 7及び三菱化学(株)製のダイヤイオン HP2MG等のメタクリル 系 (又はアクリル系とも言う) 合成吸着剤を挙げることができる。 これらの他、 場合によっては三菱化学 (株) 製のセパピーズ SP207等の芳香族系修飾型合成吸 着剤を用いることができる。  The step E of obtaining a non-adsorbed fraction on the synthetic adsorbent by subjecting the liquid content of the barley shochu distillation residue obtained in the step A to an adsorption separation process using a synthetic adsorbent is a barley shochu distillation The purpose is to remove components such as polyphenol contained in the liquid content of the residual liquid. As the synthetic adsorbent used in Step E, an aromatic, aromatic modified, or methacrylic synthetic adsorbent can be used. Preferable specific examples of the synthetic adsorbent used in Step E include Amberlay XAD-4, Amberlay XAD-16, Amberlite XAD-1180 and Amperlite XAD-2000 manufactured by Organo Corporation. Aromatic (or styrene) synthetic adsorbents such as Sepabeads SP850 and Diaion HP20 manufactured by Mitsubishi Chemical Co., Ltd. Amperlite XAD-7 manufactured by Organo Co., Ltd. and Diamond manufactured by Mitsubishi Chemical Co., Ltd. Examples include methacrylic (or acrylic) synthetic adsorbents such as Ion HP2MG. In addition to these, aromatic modified synthetic adsorbents such as Sepapies SP207 manufactured by Mitsubishi Chemical Corporation may be used in some cases.
前記工程 Aで得られた大麦焼酎蒸留残液の液体分をイオン交換樹脂を使用す るイオン交換処理に付して前記イオン交換樹脂に非吸着の画分を得る工程 B 1、 或は前記工程 Eで得られた合成吸着剤に非吸着の画分をイオン交換樹脂を使用 するイオン交換処理に付して前記イオン交換樹脂に非吸着の画分を得る工程 B 2においては、上記液体分又は前記合成吸着剤に非吸着の画分に含まれる上述し た多糖類以外の成分、 即ち、 アミノ酸、 ペプチド、 タンパク質、 有機酸、 或いは 大麦由来のポリフエノール等を、イオン交換樹脂を用いて除去することを目的と して行うものである。当該工程 B 1及び工程 B 2で使用するイオン交換樹脂とし ては、 陽イオン交換樹脂、 陰イオン交換樹脂、 或いは両者を混合した混床イオン 交換樹脂を使用することができる。陽イオン交換樹脂の場合、強酸性陽イオン交 換樹脂及び弱酸性陽イオン交換樹脂のいずれであっても使用することができ、陰 イオン交換樹脂の場合、強塩基性陰イオン交換樹脂及び弱塩基性陰イオン交換榭 脂のいずれであっても使用することができる。また混床ィォン交換樹脂の場合に は、上述した陽ィォン交換樹脂と陰ィォン交換樹脂を自由に組み合わせて所定の 割合で混合して使用することができる。こうしたイオン交換樹脂の好適な具体例 としては、 オルガノ (株) 製のアンバ一ライト 200CT及びアンバーライト IR120B 等の強酸性陽イオン交換樹脂、 アンバーライ MRC76等の弱酸性陽イオン交換樹 脂、 アンパーライト IRA402BL等の最強塩基性陰イオン交換樹脂、 アンバーライト IRA67等の弱塩基性陰イオン交換測旨、 或いは、 前記弱酸性陽イオン交換樹脂と 前記弱塩基性陰ィォン交換樹脂の両者を所定の割合で混合することにより得ら れる混床型イオン交換樹脂等を用いることができる。 これらのうち、上記液体分 又は上記合成吸着剤に非吸着の画分に含まれているアミノ酸やべプチド等を除 去する観点においては、 前記弱酸性陽イオン交換樹脂アンバーライト IRC76と前 記弱塩基性陰イオン交換榭脂アンパ一ライ卜 IRA67の両者を所定の割合で混合す ることにより得られる混床型イオン交換樹脂、或いは、強酸性陽イオン交換樹脂 アンバーライト 200CTを使用することが特に好ましい。 The step B 1 of obtaining a non-adsorbed fraction on the ion exchange resin by subjecting the liquid content of the barley shochu distillation residue obtained in the step A to an ion exchange treatment using an ion exchange resin In step B2, in which the fraction adsorbed on the synthetic adsorbent obtained in E is subjected to an ion exchange treatment using an ion exchange resin to obtain a fraction not adsorbed on the ion exchange resin, the liquid fraction or Components other than the above-mentioned polysaccharides contained in the non-adsorbed fraction of the synthetic adsorbent, that is, amino acids, peptides, proteins, organic acids, or barley-derived polyphenols are removed using an ion exchange resin. This is done for the purpose. The ion exchange resin used in Step B1 and Step B2 includes a cation exchange resin, an anion exchange resin, or a mixed bed ion in which both are mixed. Exchange resins can be used. In the case of a cation exchange resin, either a strong acid cation exchange resin or a weak acid cation exchange resin can be used. In the case of an anion exchange resin, a strong base anion exchange resin and a weak base are used. Any sex anion exchange resin can be used. In the case of a mixed bed ion exchange resin, the above-described cation exchange resin and anion exchange resin can be freely combined and used at a predetermined ratio. Specific examples of such ion exchange resins include strong acid cation exchange resins such as Amberlite 200CT and Amberlite IR120B manufactured by Organo Corp., weak acid cation exchange resins such as Amberly MRC76, and amperite. Strongest basic anion exchange resin such as IRA402BL, weak basic anion exchange measurement such as Amberlite IRA67, or both the weak acid cation exchange resin and the weak basic anion exchange resin at a predetermined ratio A mixed bed type ion exchange resin obtained by mixing can be used. Among these, from the viewpoint of removing amino acids and peptides contained in the liquid or the fraction not adsorbed to the synthetic adsorbent, the weak acid cation exchange resin Amberlite IRC76 and the above-mentioned weak It is particularly preferable to use a mixed bed type ion exchange resin obtained by mixing both basic anion exchange resin ampere lye IRA67 at a predetermined ratio, or Amberlite 200CT, a strongly acidic cation exchange resin. preferable.
前記工程 B 1及び前記工程 B 2で得られた上記イオン交換樹脂に非吸着の画 分を限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得る工程 Cにおいては、 NK細胞に対する賦活化作用に関与する成分である、 ァラビノース 及ぴキシロースを主たる構成要素とする多糖類を限外濾過膜を用いて濃縮する ことを目的として行うものである。 当該工程 Cで使用する限外濾過膜としては、 いかなる膜材質及び膜モジュール型式のものであっても使用することができ、分 画分子量は、好ましくは 3000以上、特に好ましくは 1万乃至 5万のものを使用する ことができる。 更に、 限外ろ過の濃縮倍率を、 好ましくは 2倍以上、 特に好まし くは 5倍以上にすることによって、 ァラビノース及びキシロースからなる多糖類 を著量含有する本発明の M細胞を賦活化する作用を有する組成物を得ることが できる。 In the step C of obtaining a concentrated solution by subjecting the non-adsorbed fraction obtained in the step B 1 and the step B 2 to a concentration treatment by ultrafiltration using an ultrafiltration membrane, The purpose is to concentrate a polysaccharide mainly composed of arabinose and xylose, which are components involved in NK cell activation, using an ultrafiltration membrane. As the ultrafiltration membrane used in Step C, any membrane material and membrane module type can be used, and the molecular weight cut-off is preferably 3000 or more, particularly preferably 10,000 to 50,000. Can be used. Furthermore, by increasing the concentration rate of ultrafiltration to preferably 2 times or more, particularly preferably 5 times or more, a polysaccharide composed of arabinose and xylose. Thus, a composition having an effect of activating the M cells of the present invention containing a significant amount of can be obtained.
前記工程 Cで得られた濃縮液に有機溶媒を添加することにより前記有機溶媒 に不溶の画分を分取する工程 Dにおいては、適宜の有機溶媒を所定の終濃度にな るまで添加する。 この場合、 有機溶媒はエタノールが至適であるが、 これに限定 されるものではない。有機溶媒の終濃度は成分の生産効率に影響し、該有機溶媒 の最適終濃度は、 好ましくは 5容量 ¾以上、 より好ましくは、 30乃至 75容量 %であ る。  In step D, in which an organic solvent is added to the concentrate obtained in step C to fractionate a fraction insoluble in the organic solvent, an appropriate organic solvent is added until a predetermined final concentration is reached. In this case, ethanol is optimal as the organic solvent, but the organic solvent is not limited to this. The final concentration of the organic solvent affects the production efficiency of the components, and the optimum final concentration of the organic solvent is preferably 5 volume% or more, more preferably 30 to 75 volume%.
このようにして得られる、本発明の NK細胞を賦活化する作用を有する組成物は 後述の実施例における試験例の結果から明らかなように、そのまま経口的に投与 する場合は勿論のこと、 該組成物を生理的食塩水等の適当な担体に分散せしめ、 静脈注射により患者に投与することによつても所望の NK細胞賦活効果を得るこ とができる。 また、 本発明は、 前記 NK細胞を賦活化する作用を有する組成物で賦 活化した NK細胞を含有する組成物(以下、賦活化した NK細胞含有組成物と呼称す る) を提供する。該賦活化した NK細胞含有組成物は、 白血病等の罹患者から血液 を採血し、得られた血液を NK細胞等の免疫細胞からなるリンパ球と血清に分離し 、該リンパ球に前記 NK細胞を賦活化する作用を有する組成物を混合して所定期間 の培養に付すことにより得られるものであって、このようにして得られる賦活化 した NK細胞含有組成物は、 洗浄後、 点滴用生理食塩水に浮遊させ、 点滴により静 脈から投与することができる。こうした賦活化した NK細胞含有組成物は K562細胞 を壊死する作用を有する。従って、 該賦活化した NK細胞含有組成物は、 (骨髄性 ) 白血病の治療薬剤として使用することができる。  The composition having the action of activating NK cells of the present invention obtained as described above is obviously of course administered directly as it is, as is apparent from the results of test examples in the examples described later. The desired NK cell activation effect can also be obtained by dispersing the composition in a suitable carrier such as physiological saline and administering it to a patient by intravenous injection. The present invention also provides a composition containing NK cells activated with the composition having an action of activating NK cells (hereinafter referred to as an activated NK cell-containing composition). The activated NK cell-containing composition collects blood from an affected person such as leukemia, separates the obtained blood into lymphocytes and serum composed of immune cells such as NK cells, and the lymphocytes are separated into the NK cells. It is obtained by mixing a composition having an action of activating and subjecting it to culturing for a predetermined period. The activated NK cell-containing composition obtained in this way is washed with a drip physiology Can be suspended in saline and administered via intravenous infusion. Such activated NK cell-containing composition has the effect of necrotizing K562 cells. Therefore, the activated NK cell-containing composition can be used as a therapeutic agent for (myeloid) leukemia.
以下に実施例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例 によって何ら限定されるものではない。  EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples.
実施例 1  Example 1
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 を 8000rpm、 lOminの条件で遠心分離して液体分を得、 得られた液体分を Br ixlO に調整後、 この Br ixlOに調整した液体分 1Lを、 500ml容量のオルガノ (株) 製ァ ンバ一ライト 200CT (強酸性陽イオン交換樹脂) を充填したカラムに通して、 前 記イオン交換樹脂に非吸着の画分を得、得られたイオン交換樹脂に非吸着の画分 を A/Gテクノロジ一社製の限外濾過膜 UFP- 30-E- 4MA (分画分子量 3万) による濃 縮処理に付して濃縮液を得、 得られた濃縮液を Br ix20に調整後、 終濃度 75容量% になるようにエタノールを加え、 8000rpm、 lOminの条件で遠心分離して前記有機 溶媒 (エタノール) に不溶の画分を分取し、 得られた画分を凍結乾燥に付すこと により凍結乾燥物 2. 5gを得た。該凍結乾燥物を粉碎し灰白色で無味無臭の組成物 を得た。 Barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” above Centrifugation was performed at 8000 rpm and lOmin to obtain a liquid component. After the obtained liquid component was adjusted to Br ixlO, 1 L of the liquid component adjusted to Br ixlO was added to a 500 ml volume of Organo Corporation Pass through a column packed with Wright 200CT (strongly acidic cation exchange resin) to obtain a fraction that is not adsorbed to the ion exchange resin, and the fraction that is not adsorbed to the obtained ion exchange resin Concentrated with UFP-30-E-4MA (fractional molecular weight 30,000) manufactured by the company to obtain a concentrated solution. The resulting concentrated solution is adjusted to Brix20, and the final concentration is 75 volumes. Ethanol was added so that the concentration of the lyophilized product was 10%. Centrifugation was performed at 8000 rpm and lOmin, and a fraction insoluble in the organic solvent (ethanol) was collected. 2. 5g was obtained. The lyophilized product was powdered to obtain a grayish white, tasteless and odorless composition.
実施例 2  Example 2
上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 を 8000rpm、 lOminの条件で遠心分離して大麦焼酎蒸留残液の液体分を得、得られ た液体分をオルガノ (株)製の合成吸着剤アンパ一ライト XAD-16を充填したカラ ムに通して吸着分離処理に付すことにより、該カラムの合成吸着剤に対して非吸 着性を示す素通り液からなる前記合成吸着剤に非吸着の画分を分取した。得られ た合成吸着剤に非吸着の画分を Br ixlOに調整し、 この Br ixlOに調整した画分 1L を、 500ml容量のオルガノ (株) 製アンバーライト 200CT (強酸性陽イオン交換樹 脂) を充填したカラムに通し、 前記イオン交換樹脂に非吸着の画分を得、 得られ た画分を A/Gテクノロジ一社製の限外濾過膜 UFP - 30-E-4MA (分画分子量 3万) に よる濃縮処理に付して濃縮液を得、得られた濃縮液を Br ix20に調整後、終濃度 75 容量%になるようにエタノールを加え、 8000rpm、 lOminの条件で遠心分離して前 記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分を凍結乾燥に付 すことにより凍結乾燥物 1. 3 gを得た。 該凍結乾燥物を粉枠し灰白色で無味無臭 の組成物を得た。  The barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” was centrifuged at 8000 rpm and lOmin to obtain a liquid content of the barley shochu distillation residue. By passing through a column filled with a synthetic adsorbent amperite XAD-16 manufactured by Co., Ltd. and subjecting it to an adsorption separation treatment, the above-mentioned flow-through liquid that exhibits non-adsorbability to the synthetic adsorbent of the column is used. The fraction not adsorbed on the synthetic adsorbent was collected. The fraction that was not adsorbed to the resulting synthetic adsorbent was adjusted to Br ixlO, and 1 L of the fraction adjusted to Br ixlO was added to 500 ml of Amberlite 200CT (strongly acidic cation exchange resin) manufactured by Organo Corporation. A fraction that is not adsorbed to the ion exchange resin is obtained, and the obtained fraction is filtered with an ultrafiltration membrane UFP-30-E-4MA manufactured by A / G Technology (fractionated molecular weight 3 The resulting concentrate is adjusted to Brix20, ethanol is added to a final concentration of 75% by volume, and the mixture is centrifuged at 8000 rpm and lOmin. A fraction insoluble in the organic solvent (ethanol) was collected, and the obtained fraction was freeze-dried to obtain 1.3 g of a lyophilized product. The freeze-dried product was powdered to obtain an off-white, tasteless and odorless composition.
比較例 1 上記「大麦焼酎及び大麦焼酎蒸留残液の製造」 において得た大麦焼酎蒸留残液 を 8000rpm、 l Ominの条件で遠心分離して液体分を得、 該液体分 1Lに終濃度が 75 容量%になるようにエタノールを加え、 8000Π 、 l Ominの条件で遠心分離して前 記有機溶媒 (エタノール) に不溶の画分を分取し、 得られた画分を真空凍結乾燥 機を用いて凍結乾燥に付し、 凍結乾燥物 1 1. 8gを得た。 該凍結乾燥物を粉枠し灰 白色で無味無臭の組成物を得た。 Comparative Example 1 The barley shochu distillation residue obtained in “Manufacture of barley shochu and barley shochu distillation residue” was centrifuged at 8000 rpm and l Omin to obtain a liquid, and the final concentration was 75% by volume in 1 L of the liquid. Ethanol was added, and the mixture was centrifuged at 8000Π and l Omin to separate the fraction insoluble in the organic solvent (ethanol). The obtained fraction was freeze-dried using a vacuum freeze dryer. To give 11.8 g of lyophilized product. The freeze-dried product was powdered to obtain a grayish white and tasteless and odorless composition.
試験例 1  Test example 1
実施例 実施例 2及び比較例 1で得た組成物が NK細胞に対する賦活化作用を有 するものであるか否かを明らかにするために以下の試験例 1を行った。  Examples In order to clarify whether the compositions obtained in Example 2 and Comparative Example 1 have an activating effect on NK cells, the following Test Example 1 was performed.
即ち、 ヒト健常人からへパリン加末梢血を採取して生理食塩液を用いて 2倍に 希釈し、 希釈した血液をリンホセパール I ( (株) 免疫生物研究所製) に重層し 、 室温で、 1500ΠΜ、 30分間の遠心分離に付した後、 ピペットを用いて血漿を除 去することにより末梢血単核細胞(per ipheral b l ood mononuc l ear eel I s :匪 C ) 画分を得た。 次に、 得られた PBMC画分を S t emSep (ベリタス社製)に付すことによ り NK細胞画分を得、 得られた NK細胞画分を 5%C02雰囲気下、 37°Cで培養し、 NK細 胞培養液を得た。 得られた M細胞培養液を 1000rpm、 5分間の遠心分離に付し NK 細胞を捕集した。 それぞれの捕集した NK細胞の細胞数を 10%FCS添加 RPMI- 1640培 地を用いて I X 個/ mlに調整して NK細胞懸濁液を得た。 一方、 継代培養に付す ことにより得た K562細胞(慢性骨髄性白血病細胞) の培養液を遠心分離に付して K562細胞を分取し、 PBS (Phosphat e-buf f ered sal ine)で 2回洗浄し、次いで 10%FCS 添加 RPMI-1640培地で更に洗浄して K562細胞からなる標的細胞を得た。 That is, heparin-added peripheral blood was collected from healthy humans, diluted twice with physiological saline, and the diluted blood was overlaid on Lymphosepar I (manufactured by Immune Biology Laboratories) at room temperature. After centrifugation at 1500ΠΜ for 30 minutes, the plasma was removed using a pipette to obtain a fraction of peripheral blood mononuclear cells (匪 C). Next, the PBMC fraction obtained to obtain a S t emSep NK cell fraction Ri by the subjecting (manufactured by Veritas), the NK cell fraction obtained 5% C0 2 atmosphere at 37 ° C for Culture was performed to obtain a NK cell culture solution. The obtained M cell culture solution was centrifuged at 1000 rpm for 5 minutes to collect NK cells. The number of NK cells collected was adjusted to IX cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain an NK cell suspension. On the other hand, K562 cells (chronic myeloid leukemia cells) obtained by subculture are centrifuged to separate the K562 cells, which are then washed with PBS (Phosphat e-bufered saline). The cells were washed twice and then further washed with RPMI-1640 medium supplemented with 10% FCS to obtain target cells consisting of K562 cells.
次に、 3つの前記 NK細胞懸濁液 100 1のそれぞれに対して、 実施例し 実施例 2 及び比較例 1で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物) の濃度を前 記10^ 3添加11^11-1640培地を用ぃて11^/1111に調製した溶液をそれぞれ11 1ず つ添加し、 5¾C02雰囲気下、 37°Cで 72時間培養して NK細胞培養液を得た。 また、 コントロールとして別の NK細胞懸濁液 100 1に対して、 前記 10%FCS添加 RPMI- 1640培地 11 lを添加したものについても同様の処理に付した。更に、ポジ ティブコントロールとして更に別の NK細胞懸濁液 100 1に対して、 IL- 2の濃度を 前記 10%FCS添加 RPMI- 1640培地を用いて lmg/mlに調製した溶液をそれぞれ 11 1 添加したものについても同様の処理に付した。 Next, for each of the three NK cell suspensions 100 1, the concentration of the fraction insoluble in each organic solvent (lyophilized product) obtained in Example 2 and Comparative Example 1 was previously determined. serial 10 ^ 3 added 11 ^ 11-1640 medium solution prepared use Ite 11 ^ / 1111 was added One not a respectively 11 1, 5¾C0 2 atmosphere, 72 hours of culture to NK cell culture medium at 37 ° C for Got. In addition, 10% FCS was added to another NK cell suspension 100 1 as a control. The same treatment was applied to the addition of 11 l of RPMI-1640 medium. Furthermore, as a positive control, 11 1 each of solutions prepared to 1 mg / ml of IL-2 concentration using RPMI-1640 medium with 10% FCS added to another NK cell suspension 100 1 The same process was applied to the above.
このようにして得たそれぞれの NK細胞培養液を、 1000rpm、 5分間の遠心分離に 付し NK細胞を捕集した。 それぞれの捕集した NK細胞の細胞数を 10%FCS添加 RPMI- 1640培地を用いて I X 個/ mlに調整して効果細胞を得た。  Each NK cell culture solution thus obtained was centrifuged at 1000 rpm for 5 minutes to collect NK cells. The number of NK cells collected was adjusted to IX cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain effect cells.
次に、 至適濃度に調整した前記標的細胞を 96穴 V底プレートに 100 1づっ分注 し、 これに前記効果細胞を づっ別々に混合した。前記効果細胞と前記標的 細胞を混合したプレートは、 800rpm、 2分間の遠心分離に付し、 5%C02雰囲気下、 37°Cで 4時間培養後、 各培養液 100 1をそれぞれ採取し、 Ce l lTi ter- Glo Luminescent Cel 1 Vi ab i 1 i ty Assayキット (プロメガ社製) を用いて ΑΊΤ量を測 定し、下記の計算式により K562細胞の生存率を調べ、 各サンプルの NK細胞活性化 能の指標とした。 Next, the target cells adjusted to the optimum concentration were dispensed 100 1 into a 96-well V-bottom plate, and the effector cells were mixed separately. Plate mixing said target cell and said effector cells are, 800 rpm, centrifuged for 2 minutes, 5% C0 2 atmosphere, after 4 hours at 37 ° C, each culture 100 1 were taken, respectively, Measure the K562 cell viability using the following formula, using the CeilTiter-Glo Luminescent Cel 1 Vi ab i 1 i Assay Assay kit (Promega), and determine the NK cells of each sample. It was used as an index of activation ability.
K562細胞生存率 (%) = { ( [各サンプルで処理した NK細胞 + K562細胞]の発光量)一 (NK細胞のみの発光量) } / (PBSで処理した K562細胞の発光量) X 100 K562 cell viability (%) = {(Luminescence of [NK cells + K562 cells treated with each sample]) 1 (Luminescence of NK cells only)} / (Luminescence of K562 cells treated with PBS) X 100
[評価 1 ]  [Evaluation 1]
K562細胞に対する NK細胞活性の測定結果を表 1に示す。表 1に示す結果から以下 の事実が判明した。 即ち、 比較例 1で得た組成物の所定量を添加して培養に付す ことにより得た NK細胞は、該所定量の IL- 2を添加して培養に付すことにより得た NK細胞よりもやや低い NK細胞活性を示した。一方、 実施例 1及び実施例 2で得た組 成物の所定量を添加して培養に付すことにより得た NK細胞は、 該所定量の IL - 2 を添加して培養に付すことにより得た M細胞に匹敵する極めて顕著な NK細胞活 性化能を示すことが判明した。  Table 1 shows the measurement results of NK cell activity against K562 cells. The following facts were found from the results shown in Table 1. That is, NK cells obtained by adding a predetermined amount of the composition obtained in Comparative Example 1 and subjecting it to culture are more than NK cells obtained by adding the predetermined amount of IL-2 and subjecting it to culture. Slightly low NK cell activity was shown. On the other hand, NK cells obtained by adding a predetermined amount of the composition obtained in Example 1 and Example 2 and subjecting them to culture are obtained by adding the predetermined amount of IL-2 and subjecting them to culture. It was revealed that the cells have extremely remarkable NK cell activation ability comparable to that of M cells.
試験例 2  Test example 2
ところで、悪性腫瘍等の罹患者においては、 NK細胞の活性が低下しているため 、 該 NK細胞によってもたらされる腫瘍細胞に対する細胞傷害活性も著しく低い。 そこで、上記有機溶媒に不溶の画分による NK細胞賦活化と、それによつてもたら される腫瘍細胞に対する細胞傷害活性をより実際的に評価する目的で以下の試 験を行った。 By the way, in afflicted patients such as malignant tumors, the activity of NK cells is reduced. The cytotoxic activity against tumor cells caused by the NK cells is also extremely low. Therefore, the following tests were conducted for the purpose of more practically evaluating the NK cell activation by the fraction insoluble in the organic solvent and the resulting cytotoxic activity against tumor cells.
即ち、 ヒト健常人からへパリン加末梢血を採取して生理食塩液を用いて 2倍に 希釈し、 希釈した血液をリンホセパール I ( (株) 免疫生物研究所製) に重層し 、 室温で、 1500rpm、 30分間の遠心分離に付した後、 ピペットを用いて血漿を除 去することにより末梢血単核細胞(per ipheral b l ood mononuc l ear eel I s :匪 C ) 画分を得た。 次に、 得られた: PBMC画分を StemSep (ベリタス社製)に付すことによ り NK細胞画分を得、 得られた NK細胞画分を 5%C02雰囲気下、 37°Cで培養し、 NK細 胞培養液を得た。 得られた NK細胞培養液を 1000rpm、 5分間の遠心分離に付し NK 細胞を捕集した。 それぞれの捕集した NK細胞の細胞数を 10%FCS添加 RPMI- 1640培 地を用いて I X 106個/ mlに調整して NK細胞懸濁液を得た。 一方、 継代培養に付す ことにより得た K562細胞(慢性骨髄性白血病細胞) の培養液を遠心分離に付して K562細胞を分取し、 PBS (Phosphate-buf fered sal ine)で 2回洗浄し、次いで薩 CS 添加 RPMI-1640培地で更に洗浄して K562細胞からなる標的細胞を得た。 That is, heparin-added peripheral blood was collected from healthy humans, diluted twice with physiological saline, and the diluted blood was overlaid on Lymphosepar I (manufactured by Immune Biology Laboratories) at room temperature. After centrifugation at 1500 rpm for 30 minutes, plasma was removed using a pipette to obtain a fraction of peripheral blood mononuclear cells (IC). Then, the resulting: PBMC fraction to obtain a StemSep NK cell fraction Ri by the subjecting (manufactured by Veritas), and the NK cell fraction obtained 5% C0 2 atmosphere, the culture at 37 ° C for The NK cell culture solution was obtained. The obtained NK cell culture solution was centrifuged at 1000 rpm for 5 minutes to collect NK cells. The number of cells of each collected NK cell was adjusted to IX 10 6 cells / ml using RPMI-1640 medium supplemented with 10% FCS to obtain an NK cell suspension. On the other hand, K562 cells (chronic myeloid leukemia cells) obtained by subculture are centrifuged to separate the K562 cells and washed twice with PBS (Phosphate-buf fered saline). Subsequently, the cells were further washed with RPMI-1640 medium supplemented with CS, to obtain target cells consisting of K562 cells.
次に、 前記 NK細胞懸濁液を 96穴 V底プレートに 100 1づっ分注し、 これに至適 濃度に調整した前記標的細胞を 100 Uづっ添加し、 次いで、 実施例し 実施例 2 及び比較例 1で得たそれぞれの有機溶媒に不溶の画分 (凍結乾燥物) の濃度を前 記 10%FCS添加 RPMI-1640培地を用いて lmg/mlに調製した溶液をそれぞれ 22 1ず つ添加し、 5%C02雰囲気下、 37°Cで 4時間培養した。 これとは別に、 コントロール として、別の M細胞懸濁液 100 1に対して、至適濃度に調整した前記標的細胞 100 lを添加し、 次いで、 前記 10%FCS添加 RPMI- 1640培地 22 μ 1を添加したものにつ いても同様の処理に付した。 更に、 ポジティブコントロールとして、 更に別の ΝΚ 細胞懸濁液 100 1に対して、 至適濃度に調整した前記標的細胞 100 χ Ιを添加し、 次いで、 前記 10%FCS添加 RPMI- 1640培地を用いて lmg/mlの濃度に調製した IL- 2水 溶液を 22 1添加したものについても同様の処理に付した。 次に各培養液 100 1 をそれぞれ採取し、 Cel lTi ter-Glo Luminescent Ce l l Vi abi l i ty Assayキット ( プロメガ社製) を用いて ATP量を測定し、 下記の計算式により K562細胞の生存率 を調べ、 各サンプルの NK細胞活性化能の指標とした。 Next, the NK cell suspension was dispensed into a 96-well V-bottom plate at a rate of 1001, and the target cells adjusted to the optimum concentration were added at a rate of 100 U. Add each of the solutions prepared to 1 mg / ml using RPMI-1640 medium with 10% FCS added to the concentration of the fraction insoluble in each organic solvent (lyophilized product) obtained in Comparative Example 1. Then, the cells were cultured for 4 hours at 37 ° C. in a 5% CO 2 atmosphere. Separately, as a control, 100 L of the target cells adjusted to the optimal concentration was added to another M cell suspension 100 1, and then the RPMI-1640 medium with 10% FCS was added to 22 μ1. The same treatment was applied to the material to which the slag was added. Further, as a positive control, the target cell 100 χ 調整 adjusted to the optimal concentration was added to another ΝΚ cell suspension 100 1, and then the RPMI-1640 medium supplemented with 10% FCS was used. IL-2 water prepared to a concentration of lmg / ml The same treatment was applied to the solution to which 22 1 was added. Next, 100 1 of each culture was collected, and the amount of ATP was measured using CelTiter-Glo Luminescent Cell Viability Assay Kit (Promega), and the survival rate of K562 cells was calculated using the following formula. Was used as an index of NK cell activation ability of each sample.
K562細胞生存率 (%) = { ( [各サンプルで処理した NK細胞 + K562細胞]の発光量)―K562 cell viability (%) = {([Luminescence of [NK cells + K562 cells treated in each sample])]
(NK細胞のみの発光量) } / (PBSで処理した K562細胞の発光量) X 100 (Luminescence of NK cells only)} / (Luminescence of K562 cells treated with PBS) X 100
[評価 2 ]  [Evaluation 2]
M細胞と K562細胞の混合物に比較例 1で得た凍結乾燥物を添加した場合の細胞 傷害活性の測定結果を表 2に示す。表 2に示す結果から以下の事実が判明した。即 ち、 NK細胞と K562細胞の混合物に比較例 1で得た凍結乾燥物を前記所定量にて添 加した場合には、該混合物に前記所定量の IL- 2を添加した場合よりも明らかに低 い細胞傷害活性を示した。 一方、 NK細胞と K562細胞の混合物に実施例 1及び実施 例 2で得た凍結乾燥物の前記所定量を添加した場合には、 該混合物に前記所定量 の IL-2を添加した場合に匹敵する極めて強力な細胞傷害活性を示すことが判明 した。  Table 2 shows the measurement results of the cytotoxic activity when the lyophilized product obtained in Comparative Example 1 was added to the mixture of M cells and K562 cells. The following facts were found from the results shown in Table 2. That is, when the lyophilized product obtained in Comparative Example 1 was added to the mixture of NK cells and K562 cells in the predetermined amount, it was clearer than the case where the predetermined amount of IL-2 was added to the mixture. Showed low cytotoxic activity. On the other hand, when the predetermined amount of the lyophilized product obtained in Example 1 and Example 2 was added to the mixture of NK cells and K562 cells, it was comparable to the case where the predetermined amount of IL-2 was added to the mixture. It was found to exhibit extremely strong cytotoxic activity.
即ち、実施例 1及び実施例 2の凍結乾燥物を NK細胞と K562細胞の混合物に添加し た場合には、 NK細胞を著しく賦活化するだけでなく、該 K562細胞の増殖をも抑制 することから、 優れた白血病治療効果を奏することが明らかになった。  That is, when the lyophilized product of Example 1 and Example 2 is added to a mixture of NK cells and K562 cells, it not only significantly activates NK cells but also suppresses the proliferation of K562 cells. From the above, it was revealed that there is an excellent leukemia treatment effect.
試験例 3  Test example 3
実施例 1及び実施例 2で得た有機溶媒に不溶の画分の凍結乾燥物が有する in vivoにおける NK細胞賦活化作用を明らかにするために以下の試験を行った。即ち 、 C57BL/6マウス ( 、 3週齢、 1群 10匹) に、 本発明の NK細胞を賦活化する作用 を有する組成物を含まない食餌 (対照群) と、 実施例 1で得た有機溶媒に不溶の 画分の凍結乾燥物を 0. 5%及び 1. 0%含む食餌 (試験群 1) 、 並びに、 実施例 2で得た 有機溶媒に不溶の画分の凍結乾燥物を 0. 5%及び 1. 0%含む食餌 (試験群 2) を摂取 させ、 5週間後に両群のマウスから脾臓を摘出し、 細胞数を計測すると共に NK細 胞活性を以下のように測定した。 In order to clarify the in vivo NK cell activation action of the freeze-dried fraction insoluble in the organic solvent obtained in Example 1 and Example 2, the following test was performed. That is, C57BL / 6 mice (3 weeks old, 10 mice per group) were fed with a diet (control group) that did not contain the composition having the effect of activating NK cells of the present invention, and the organic obtained in Example 1 Diet containing 0.5% and 1.0% of lyophilized fraction insoluble in solvent (test group 1), and lyophilized fraction insoluble in organic solvent obtained in Example 2 of 0. 5% and 1.0% diet (Test group 2) was ingested, and after 5 weeks, the spleens were removed from both groups of mice, the number of cells was counted and NK fine Cell activity was measured as follows.
即ち、 脾細胞を C- RMI培地に浮遊させ、 フルォレセインイソチオシァネート ( FITC)結合抗マウス IL- 2 /3受容体抗体とフィコエリトリン 0PE)結合抗マウス CD3 抗体にて細胞標識し、 フローサイトメ一夕一にて NK細胞分画を測定し、 CD3-IL-2 ιδ +分画を M細胞と同定した。 '  That is, spleen cells were suspended in C-RMI medium, and cell-labeled with fluorescein isothiocyanate (FITC) -conjugated anti-mouse IL-2 / 3 receptor antibody and phycoerythrin 0PE) -conjugated anti-mouse CD3 antibody, The NK cell fraction was measured by flow cytometry, and the CD3-IL-2 ιδ + fraction was identified as M cells. '
マウスリンパ腫細胞株 YAC- 1を51 04を用いて標識して標的細胞とし、 脾細胞: 標的細胞 = 100 : 1の割合で 6時間混合浮遊させ、 その上澄み液中の51 Crの放射活性 をァ-シンチレーションカウンタ一で測定し、 NK細胞活性 (%)を以下の式から算出 した。 Mouse lymphoma cell line YAC-1 was labeled with 51 0 4 as target cells, splenocytes: target cells = 100: 1, mixed and suspended for 6 hours, and the radioactivity of 51 Cr in the supernatant was determined. NK cell activity (%) was calculated from the following formula using a scintillation counter.
NK細胞活性 (%) = [ (実験遊離-自然遊離) / (最大遊離-自然遊離) ] X 100 NK cell activity (%) = [(experimental release-spontaneous release) / (maximum release-spontaneous release)] X 100
[評価 3 ]  [Evaluation 3]
脾細胞数、 NK細胞分画及び脾細胞由来 NK細胞活性の測定結果を表 3に示す。表 3 に示す結果から以下の事実が判明した。 即ち、 実施例 1で得た NK細胞を賦活化す る作用を有する組成物を 0. 5%及び 1. 0%含む食餌を摂取した試験群 1、 並びに、 上 記実施例 2で得た有機溶媒に不溶の画分の凍結乾燥物を 0. 5%及び 1. 0%含む食餌を 摂取した試験群 2の脾細胞由来 NK細胞活性は、 対照群と比較して、 それぞれ有意 に増加していることが判明した。 一方、 脾細胞数、 及び NK細胞分画に関しては、 試験群 1、試験群 2及び対照群からなる 3つの群間で相互に有意差は認めなかった。 これらの結果から、本発明の NK細胞を賦活化する作用を有する組成物は、 in vivo においても NK細胞を賦活化することが明白となつた。  Table 3 shows the results of measurement of the number of spleen cells, NK cell fraction, and spleen cell-derived NK cell activity. The following facts were found from the results shown in Table 3. That is, test group 1 ingesting a diet containing 0.5% and 1.0% of the composition having the effect of activating NK cells obtained in Example 1, and the organic solvent obtained in Example 2 above. The spleen cell-derived NK cell activity in test group 2 that received diets containing 0.5% and 1.0% lyophilized fractions insoluble in erythrocyte significantly increased compared to the control group, respectively. It has been found. On the other hand, regarding the number of spleen cells and NK cell fraction, there was no significant difference between the three groups consisting of test group 1, test group 2 and control group. From these results, it became clear that the composition having an action of activating NK cells of the present invention activates NK cells even in vivo.
以上の試験例 1乃至試験例 3の結果から明らかなように、大麦焼酎蒸留残液から 得られる、ァラピノ一ス及びキシロースからなる多糖類を主たる成分とする本発 明の M細胞を賦活化する作用を有する組成物は、極めて優れた NK細胞に対する賦 活化作用を有することが判明した。  As is clear from the results of Test Example 1 to Test Example 3 above, the M cells of the present invention, which are mainly composed of polysaccharides consisting of alapinose and xylose, obtained from the barley shochu distillation residue, are activated. It has been found that a composition having an action has an excellent activation effect on NK cells.
本発明の NK細胞を賦活化する作用を有する組成物は、公知の NK細胞陚活化剤で ある IL- 2に匹敵する極めて顕著な NK細胞賦活化作用を有するので、白血病をはじ めとするガンの治療に極めて好適である。 The composition having the effect of activating NK cells of the present invention has a very remarkable NK cell activation effect comparable to IL-2, which is a known NK cell activator, so leukemia is repelled. It is extremely suitable for the treatment of cancer.
表 1  table 1
コントロール IL-2 実施例 1 実施例 2 比較例 1 Control IL-2 Example 1 Example 2 Comparative Example 1
K562細胞生存率 (¾〉 84.7 38.7 48.4 42.6 68.3 表 2 コントロール 1L-2 実施例 1 実施例 2 比較例 1K562 cell viability (¾) 84.7 38.7 48.4 42.6 68.3 Table 2 Control 1L-2 Example 1 Example 2 Comparative Example 1
K562細胞生存率 (%〉 79.4 30.2 37.6 33.1 62.7 表 3 コ g jL 実脑 1の雄乾燥物 実施例 2の凍結乾燥物 K562 cell viability (%) 79.4 30.2 37.6 33.1 62.7 Table 3 Dried male g jL fruit 1 Lyophilized product of Example 2
5^ 11 0.5¾ 1.0¾5 ^ 1 1 0.5¾ 1.0¾
NK細胞活性 (¾) 2.70±0.25 18.8±2.97 21.6±5.18 20.2±4.31 22.8±3.75 fl卑細胞数(x10a個) 1.17±0.31 1.18±0.16 1.08+0.61 1.22±0.38 1.09±0.45 NK細胞分画 ( .81 ±0.14 62±0.71 4.43±0.29 4,29±0.87 4.58±1.27 NK cell activity (¾) 2.70 ± 0.25 18.8 ± 2.97 21.6 ± 5.18 20.2 ± 4.31 22.8 ± 3.75 fl Number of base cells (x10 a ) 1.17 ± 0.31 1.18 ± 0.16 1.08 + 0.61 1.22 ± 0.38 1.09 ± 0.45 NK cell fraction ( .81 ± 0.14 62 ± 0.71 4.43 ± 0.29 4,29 ± 0.87 4.58 ± 1.27
I I

Claims

1. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分離1. Solid-liquid separation of barley shochu distillation residue produced as a by-product in shochu production using barley
' して液体分を得、該液体分をイオン交換樹脂を使用するイオン交換処理に付して 前記イオン交換榭脂に非吸着百一の画分を分取し、分取した前記画分を限外濾過膜を 主冃 'To obtain a liquid fraction, and subject the liquid fraction to an ion exchange treatment using an ion exchange resin to fractionate a non-adsorbed fraction on the ion exchange resin, Leading ultrafiltration membranes
使用する限外濾過による濃縮処理に付して濃縮液を得、該濃縮液に有機溶媒を添 加することにより分取した、 ゥロン酸を実質的に含有せず、 キシロース、 ァラビ ノース及びグルコースからなる多糖類を含有する前記有機溶媒に不溶の画分か らなる、 ナチュラルキラ一細胞を賦活化する作用を有する組成物。  Concentrated by ultrafiltration to be used to obtain a concentrated solution, which was fractionated by adding an organic solvent to the concentrated solution, substantially free of uronic acid, from xylose, arabinose and glucose A composition having a function of activating natural killer cells, comprising a fraction insoluble in the organic solvent containing the polysaccharide.
 Surrounding
2. 前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 1に記載の組成物。  2. The composition according to claim 1, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布:  Molecular weight distribution:
100, 000以上 5%  100,000 or more 5%
30, 000乃至 100, 000 18%  30,000 to 100, 000 18%
10, 000乃至 30, 000 23%  10,000 to 30,000 23%
3, 000乃至 10, 000 31%  3,000 to 10,000 31%
1 , 000乃至 3, 000 11%  1 000 to 3,000 11%
500乃至 1, 000 3%  500 to 1,000 3%
500以下 9%  500 or less 9%
3. 前記有機溶媒に不溶の画分は、 多糖類が約 84. 1重量 %、 多糖類由来のァラビ ノース及びキシロースの合計含量が約 54. 4重量 %、 粗タンパクが約 4. 2重量%、 有 機酸が約 0. 3重量%、及び遊離糖類が約 1. 2重量 %からなる成分組成を有するもので ある請求項 1に記載の組成物。  3. The fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of the total content of arabinose and xylose derived from polysaccharide, and about 4.2% by weight of crude protein. The composition according to claim 1, which has a component composition comprising about 0.3% by weight of organic acid and about 1.2% by weight of free sugars.
4. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分離 して液体分を得、該液体分を合成吸着剤を使用する吸着分離処理に付して前記合 成吸着剤に非吸着の第一の画分を分取し、前記第一の画分をイオン交換樹脂を使 用するイオン交換処理に付して前記イオン交換樹脂に非吸着の第二の画分を分 取し、前記第二の画分を限外濾過膜を使用する限外濾過による濃縮処理に付して 濃縮液を得、該濃縮液に有機溶媒を添加することにより分取した、 ゥロン酸を実 質的に含有せず、キシロース、 ァラビノース及びグルコースからなる多糖類を含 有する前記有機溶媒に不溶の画分からなる、ナチュラルキラー細胞を賦活化する 作用を有する組成物。 4. The barley shochu distillation residue obtained as a by-product in the production of shochu using barley as a raw material is subjected to solid-liquid separation to obtain a liquid, and the liquid is subjected to an adsorption separation process using a synthetic adsorbent to perform the synthetic adsorption. Fractionate the first fraction that is not adsorbed on the agent, and use the ion exchange resin for the first fraction. The second fraction that is not adsorbed on the ion exchange resin is fractionated, and the second fraction is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane. Thus, a concentrated solution was obtained and fractionated by adding an organic solvent to the concentrated solution, which did not substantially contain uronic acid and was insoluble in the organic solvent containing a polysaccharide consisting of xylose, arabinose and glucose. A composition comprising a fraction and having an action of activating natural killer cells.
5. 前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 4に記載の組成物。  5. The composition according to claim 4, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 100,000 or more
30, 000乃至 100, 000  30,000 to 100, 000
10, 000乃至 30, 000  10,000 to 30,000
3, 000乃至 10, 000  3,000 to 10,000
1 , 000乃至 3, 000  1, 000 to 3,000
500乃至 1, 000  500 to 1,000
500以下  500 or less
6.前記有機溶媒に不溶の画分は、 多糖類が約 78. 5重量 %、 多糖類由来のァラビ ノース及びキシロースの合計含量が約 58. 6重量%、 粗タンパクが約 3. 3重量%、 有 機酸が約 0. 2重量%、及び遊離糖類が約 1. 5重量 ¾からなる成分組成を有するもので ある請求項 4に記載の組成物。  6. The fraction insoluble in the organic solvent is about 78.5% by weight of polysaccharide, about 58.6% by weight of the total content of arabinose and xylose derived from polysaccharide, and about 3.3% by weight of crude protein. 5. The composition according to claim 4, which has a component composition consisting of about 0.2% by weight of organic acid and about 1.5% by weight of free sugars.
7. 前記有機溶媒に不溶の画分は、 粉末形態のものである請求項 1乃至請求項 6 のレ ^ずれかに記載の組成物。  7. The composition according to any one of claims 1 to 6, wherein the fraction insoluble in the organic solvent is in a powder form.
8. 医薬品として使用する請求項 1乃至請求項 6のいずれかに記載の組成物。 8. The composition according to any one of claims 1 to 6, which is used as a medicine.
9. 前記合成吸着剤は、 芳香族系合成吸着剤又はメタクリル系合成吸着剤であ る請求項 4に記載の組成物。 9. The composition according to claim 4, wherein the synthetic adsorbent is an aromatic synthetic adsorbent or a methacrylic synthetic adsorbent.
10. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得る工程、該液体分をイオン交換樹脂を使用するイオン交換処理 に付して前記イオン交換樹脂に非吸着の画分を分取する工程、分取した前記ィォ ン交換樹脂に非吸着の画分を限外濾過膜を使用する限外濾過による濃縮処理に 付して濃縮液を得る工程、該濃縮液に有機溶媒を添加することにより、 ゥロン酸 を実質的に含有せず、 キシロース、 ァラビノース及びグルコースからなる多糖類 を含有する前記有機溶媒に不溶の画分を分取する工程を含むことを特徴とする、 ナチュラルキラー細胞を賦活化する作用を有する前記有機溶媒に不溶の画分か らなる組成物の製造方法。 10. The barley shochu distillation residue that is by-produced in the production of shochu using barley as a raw material Separating the liquid component, subjecting the liquid component to an ion exchange treatment using an ion exchange resin, and fractionating a non-adsorbed fraction on the ion exchange resin, and separating the ion exchange resin. The non-adsorbed fraction is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution, and an organic solvent is added to the concentrated solution to substantially contain uronic acid. Insoluble in the organic solvent having an action of activating natural killer cells, comprising a step of fractionating a fraction insoluble in the organic solvent containing a polysaccharide consisting of xylose, arabinose and glucose A method for producing a composition comprising the following fractions:
11.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 10に記載の組成物の製造方法。  11. The method for producing a composition according to claim 10, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 5%  100,000 or more 5%
30, 000乃至 100, 000 18%  30,000 to 100,000 18%
10, 000乃至 30, 000 23%  10,000 to 30,000 23%
3, 000乃至 10, 000 31%  3,000 to 10,000 31%
1, 000乃至 3, 000 11%  1,000 to 3,000 11%
500乃至 1 , 000 3%  500 to 1, 000 3%
500以下 9%  500 or less 9%
12. 前記有機溶媒に不溶の画分は、 多糖類が約 84. 1重量%、 多糖類由来のァラ ピノ一ス及びキシロースの合計含量が約 54. 4重量%、 粗タンパクが約 4. 2重量%、 有機酸が約 0. 3重量%、及び遊離糖類が約 1. 2重量 %からなる成分組成を有するもの である請求項 10に記載の組成物の製造方法。  12. The fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of the total content of arapinose and xylose derived from polysaccharide, and about 4. 11. The method for producing a composition according to claim 10, wherein the composition comprises 2% by weight, organic acid is about 0.3% by weight, and free saccharide is about 1.2% by weight.
13. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得る工程、前記液体分を合成吸着剤を使用する吸着分離処理に付 して前記合成吸着剤に非吸着の画分を分取する工程、分取した前記合成吸着剤に 非吸着の画分をイオン交換樹脂を使用するイオン交換処理に付して前記イオン 交換樹脂に非吸着の画分を分取する工程、分取した前記イオン交換樹脂に非吸着 の画分を限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得る 工程、前記濃縮液に有機溶媒を添加することにより、 ゥロン酸を実質的に含有せ ず、 キシロース、 ァラビノース及びグルコースからなる多糖類を含有する前記有 機溶媒に不溶の画分を分取する工程を含むことを特徴とする、ナチュラルキラ一 細胞を賦活化する作用を有する前記有機溶媒に不溶の画分からなる組成物の製 造方法。 13. A step of obtaining a liquid component by separating a barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and subjecting the liquid to an adsorption separation process using a synthetic adsorbent. A step of separating a non-adsorbed fraction into an agent, and subjecting the collected non-adsorbed fraction to an ion exchange treatment using an ion exchange resin to the ion A step of fractionating a non-adsorbed fraction on the exchange resin, and a step of subjecting the non-adsorbed fraction to the collected ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution Adding an organic solvent to the concentrated solution to fractionate a fraction that is substantially free of uronic acid and insoluble in the organic solvent containing a polysaccharide consisting of xylose, arabinose, and glucose. A method for producing a composition comprising a fraction insoluble in the organic solvent having an action of activating natural killer cells, comprising:
14.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 13に記載の組成物の製造方法。  14. The method for producing a composition according to claim 13, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 11%  100,000 or more 11%
30, 000乃至 100, 000 29%  30,000 to 100, 000 29%
10, 000乃至 30, 000 24%  10,000 to 30,000 24%
3, 000乃至 10, 000 21%  3,000 to 10,000 21%
1, 000乃至 3, 000 6%  1,000 to 3,000 6%
500乃至 1 , 000 2%  500 to 1, 000 2%
500以下 7%  500 or less 7%
15. 前記有機溶媒に不溶の画分は、 多糖類が約 78. 5重量%、 多糖類由来のァラ ビノース及びキシロースの合計含量が約 58. 6重量%、 粗タンパクが約 3. 3重量%、 有機酸が約 0. 2重量%、及び遊離糖類が約 1. 5重量 %からなる成分組成を有するもの である請求項 13に記載の組成物の製造方法。  15. The fraction insoluble in the organic solvent is about 78.5% by weight of polysaccharide, about 58.6% by weight of the total content of arabinose and xylose derived from polysaccharide, and about 3.3% of crude protein. 14. The method for producing a composition according to claim 13, wherein the composition has a component composition comprising about 0.2% by weight of organic acid, about 0.2% by weight of organic acid, and about 1.5% by weight of free sugars.
16. 前記有機溶媒に不溶の画分を凍結乾燥する工程を更に有する請求項 10乃 至請求項 15のいずれかに記載の組成物の製造方法。  16. The method for producing a composition according to any one of claims 10 to 15, further comprising a step of freeze-drying a fraction insoluble in the organic solvent.
17. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得、該液体分をイオン交換樹脂を使用するイオン交換処理に付し て前記イオン交換樹脂に非吸着の画分を分取し、分取した前記画分を限外濾過膜 を使用する限外濾過による濃縮処理に付して濃縮液を得、該濃縮液に有機溶媒を 添加することにより分取した、 ゥロン酸を実質的に含有せず、 キシロース、 ァラ ピノ一ス及びグルコースからなる多糖類を含有し、ナチュラルキラ一細胞を陚活 化する作用を有する前記有機溶媒に不溶の画分を用いて賦活化したナチュラル キラ一細胞を含有することを特徴とする賦活化したナチュラルキラー細胞含有 組成物。 17. A barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material is separated into solid and liquid to obtain a liquid, and the liquid is subjected to an ion exchange treatment using an ion exchange resin. The non-adsorbed fraction is fractionated into the ultrafiltration membrane. Concentrated by ultrafiltration using a solution to obtain a concentrated solution, and fractionated by adding an organic solvent to the concentrated solution, substantially free of uronic acid, xylose, arapinose And a natural killer cell activated using a fraction insoluble in the organic solvent, which contains a polysaccharide consisting of glucose and glucose and has an action of activating natural killer cells. Natural killer cell-containing composition.
18.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 17に記載の賦活化したナチュラルキラ一細胞含有組成物。  18. The activated natural killer cell-containing composition according to claim 17, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 0Q0以上 5%  100, 0Q0 or more 5%
30, 000乃至 100, 000 18%  30,000 to 100, 000 18%
10, 000乃至 30, 000 23%  10,000 to 30,000 23%
3, 000乃至 10, 000 31%  3,000 to 10,000 31%
1, 000乃至 3, 000 11%  1,000 to 3,000 11%
500乃至 1, 000 3%  500 to 1,000 3%
500以下 9%  500 or less 9%
19. 前記有機溶媒に不溶の画分は、 多糖類が約 84. 1重量%、 多糖類由来のァラ ビノース及びキシロースの合計含量が約 54. 4重量%、 粗タンパクが約 4. 2重量%、 有機酸が約 0. 3重量 %、及び遊離糖類が約 1. 2重量 %からなる成分組成を有するもの である請求項 17に記載の賦活化したナチュラルキラー細胞含有組成物。  19. The fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of the total content of arabinose and xylose derived from polysaccharide, and about 4.2% by weight of crude protein. 18. The activated natural killer cell-containing composition according to claim 17, which has a component composition consisting of about 0.3% by weight, about 0.3% by weight of organic acid, and about 1.2% by weight of free sugars.
20. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得、該液体分を合成吸着剤を使用する吸着分離処理に付して前記 合成吸着剤に非吸着の画分を分取し、分取した前記画分を限外濾過膜を使用する 限外濾過による濃縮処理に付して濃縮液を得、該濃縮液に有機溶媒を添加するこ とにより分取した、 ゥロン酸を実質的に含有せず、 キシロース、 ァラビノース及 びグルコースからなる多糖類を含有し、ナチュラルキラー細胞を賦活化する作用 を有する前記有機溶媒に不溶の画分を用いて賦活化したナチュラルキラー細胞 を含有することを特徴とする陚活化したナチュラルキラ一細胞含有組成物。 20. The barley shochu distillation residue obtained as a by-product in the production of shochu using barley as a raw material is separated into solid and liquid to obtain a liquid, and the liquid is subjected to an adsorption separation process using a synthetic adsorbent. The non-adsorbed fraction is collected on the sample, and the collected fraction is subjected to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution, and an organic solvent is added to the concentrated solution. That is substantially free of uronic acid and contains polysaccharides consisting of xylose, arabinose and glucose, and activates natural killer cells. A natural killer cell-containing composition activated by using a natural killer cell activated using a fraction insoluble in the organic solvent.
21.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 20に記載の賦活化したナチュラルキラー細胞含有組成物。  21. The activated natural killer cell-containing composition according to claim 20, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 11%  100, 000 or more 11%
30, 000乃至 100, 000 29%  30,000 to 100, 000 29%
10, 000乃至 30, 000 24%  10,000 to 30,000 24%
3, 000乃至 10, 000 21¾  3,000 to 10,000 21¾
1 , 000乃至 3, 000 6%  1, 000 to 3,000 6%
500乃至 1, 000 2%  500 to 1,000 2%
500以下 7%  500 or less 7%
22. 前記有機溶媒に不溶の画分は、 多糖類が約 78. 5重量 %、 多糖類由来のァラ ピノース及びキシロースの合計含量が約 58. 6重量%、 粗タンパクが約 3. 3重量^ 有機酸が約 0. 2重量 %、及び遊離糖類が約 1. 5重量 %からなる成分組成を有するもの である請求項 20に記載の賦活化したナチュラルキラ一細胞含有組成物。  22. The fraction insoluble in the organic solvent is approximately 78.5% by weight of polysaccharide, approximately 58.6% by weight of the total content of arapinose and xylose derived from polysaccharide, and approximately 3.3% by weight of crude protein. 21. The activated natural killer cell-containing composition according to claim 20, wherein the composition comprises an organic acid in an amount of about 0.2% by weight and a free saccharide in an amount of about 1.5% by weight.
23. 骨髄性白血病の治療薬剤として使用する請求項 17乃至請求項 22のいずれ かに記載の賦活化したナチュラルキラ一細胞含有組成物。  23. The activated natural killer cell-containing composition according to any one of claims 17 to 22, which is used as a therapeutic agent for myeloid leukemia.
24. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得る工程、前記液体分をイオン交換樹脂を使用するイオン交換処 理に付して前記イオン交換樹脂に非吸着の画分を分取する工程、分取した前記画 分を限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得る工程、 前記濃縮液に有機溶媒を添加することにより、 ゥロン酸を実質的に含有せず、 キ シロース、 ァラビノース及びグルコースからなる多糖類を含有し、 ナチュラルキ ラー細胞を賦活化する作用を有する前記有機溶媒に不溶の画分を分取する工程、 分取した該有機溶媒に不溶の画分とナチュラルキラ一細胞を混合して培養する ことにより前記ナチュラルキラー細胞を賦活化する工程を含むことを特徴とす る賦活化したナチュラルキラー細胞含有組成物の製造方法。 24. A step of obtaining a liquid component by separating a barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and subjecting the liquid to an ion exchange treatment using an ion exchange resin. A step of fractionating a non-adsorbed fraction on the exchange resin, a step of subjecting the fractionated fraction to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrate, and an organic solvent in the concentrate Is added to the organic solvent, which is substantially free of uronic acid, contains polysaccharides consisting of xylose, arabinose and glucose, and has the action of activating natural killer cells. The fractionation step, the fraction that is insoluble in the fractionated organic solvent and natural killer cells are mixed and cultured The manufacturing method of the activated natural killer cell containing composition characterized by including the process of activating the said natural killer cell by this.
25.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 24に記載の賦活化したナチュラルキラー細胞含有組成物の製造方法。  25. The method for producing an activated natural killer cell-containing composition according to claim 24, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 5%  100, 000 or more 5%
30, 000乃至 100, 000 18%  30,000 to 100, 000 18%
10, 000乃至 30, 000 23%  10,000 to 30,000 23%
3, 000乃至 10, 000 31%  3,000 to 10,000 31%
1, 000乃至 3, 000 11%  1,000 to 3,000 11%
500乃至 1 , 000 3%  500 to 1, 000 3%
500以下 9%  500 or less 9%
26. 前記有機溶媒に不溶の画分は、 多糖類が約 84. 1重量%、 多糖類由来のァラ ピノ一ス及びキシロースの合計含量が約 54. 4重量%、 粗タンパクが約 4. 2重量 ¾、 有機酸が約 0. 3重量 %、及び遊離糖類が約 1. 2重量 %からなる成分組成を有するもの である請求項 24に記載の賦活化したナチュラルキラー細胞含有組成物の製造方 法。  26. The fraction insoluble in the organic solvent is about 84.1% by weight of polysaccharide, about 54.4% by weight of the total content of arapinose and xylose derived from polysaccharide, and about 4. 25. The production of an activated natural killer cell-containing composition according to claim 24, having a composition comprising 2 wt. ¾, an organic acid of about 0.3 wt.%, And a free saccharide of about 1.2 wt. Method.
• 27. 大麦を原料とする焼酎製造において副生する大麦焼酎蒸留残液を固液分 離して液体分を得る工程、前記液体分を合成吸着剤を使用する吸着分離処理に付 して前記合成吸着剤に非吸着の画分を分取する工程、分取した前記合成吸着剤に 非吸着の画分をイオン交換樹脂を使用するイオン交換処理に付して前記イオン 交換樹脂に非吸着の画分を分取する工程、分取した前記イオン交換樹脂に非吸着 の画分を限外濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得る 工程、前記濃縮液に有機溶媒を添力 [?することにより、 ゥロン酸を実質的に含有せ ず、 キシ口一ス、 ァラビノース及びグルコースからなる多糖類を含有し、 ナチュ ラルキラー細胞を賦活化する作用を有する前記有機溶媒に不溶の画分を分取す る工程、分取した該有機溶媒に不溶の画分とナチュラルキラー細胞を混合して培 養することにより前記ナチュラルキラー細胞を賦活化する工程を含むことを特 徴とする賦活化したナチュラルキラー細胞含有組成物の製造方法。 • 27. A process for obtaining a liquid component by separating a barley shochu distillation residue produced as a by-product in the production of shochu using barley as a raw material, and subjecting the liquid to an adsorption separation process using a synthetic adsorbent. A step of fractionating a non-adsorbed fraction on the adsorbent, and subjecting the fractionated non-adsorbed fraction to the synthetic adsorbent to an ion exchange treatment using an ion exchange resin, A step of fractionating, a step of subjecting the fraction that has not been adsorbed to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrate, and an organic solvent in the concentrate Helping [? Thus, a fraction that is substantially free of uronic acid, contains a polysaccharide composed of xylose, arabinose, and glucose and has an action of activating natural killer cells is separated. Take Activated natural killer cells, characterized in that it comprises a step of activating the natural killer cells by mixing and culturing a fraction that is insoluble in the collected organic solvent and natural killer cells. The manufacturing method of a containing composition.
28.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 27に記載の賦活化したナチュラルキラ一細胞含有組成物の製造方法。  28. The method for producing an activated natural glitter single cell-containing composition according to claim 27, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 11%  100,000 or more 11%
30, 000乃至 100, 000 29%  30,000 to 100, 000 29%
10, 000乃至 30, 000 24%  10,000 to 30,000 24%
3, 000乃至 10, 000 21%  3,000 to 10,000 21%
1 , 000乃至 3, 000 6%  1,000 to 3,000 6%
500乃至 1,000 2%  500 to 1,000 2%
500以下 7%  500 or less 7%
29. 前記有機溶媒に不溶の画分は、 多糖類が約 78. 5重量%、 多糖類由来のァラ ピノ一ス及びキシロースの合計含量が約 58. 6重量%、 粗タンパクが約 3. 3重量 ¾、 有機酸が約 0. 2重量 %、及び遊離糖類が約 1. 5重量からなる成分組成を有するもの である請求項 27に記載の賦活化したナチュラルキラ一細胞含有組成物の製造方 法。  29. The fraction insoluble in the organic solvent is about 78.5% by weight of polysaccharide, about 58.6% by weight of the total content of arapinose and xylose derived from polysaccharide, and about 3. 28. The production of an activated natural killer cell-containing composition according to claim 27, having a composition comprising 3 wt. ¾, organic acid of about 0.2 wt%, and free saccharide of about 1.5 wt. Method.
30. 玄麦大麦又は精白大麦を原料にして製造した大麦麹と焼酎用酵母とを発 酵に付して熟成もろみを作製し、該熟成もろみを蒸留に付して大麦焼酎を製造す る工程 (A) 、 及び前記工程 (A) において前記大麦焼酎を製造する際に蒸留残渣 として副成する大麦焼酎蒸留残液を処理する工程 (B) からなり、 前記工程 (B ) においては、 大麦焼酎蒸留残液を固液分離して液体分を得る工程、 前記液体分 をイオン交換樹脂を使用するイオン交換処理に付して前記イオン交換樹脂に非 吸着の画分を分取する工程、分取した前記イオン交換樹脂に非吸着の画分を限外 濾過膜を使用する限外濾過による濃縮処理に付して濃縮液を得る工程、及び前記 濃縮液に有機溶媒を添加することにより、 ゥロン酸を実質的に含有せず、 キシロ ース、 ァラビノース及びグルコースからなる多糖類を含有し、 ナチュラルキラー 細胞を陚活化する作用を有する前記有機溶媒に不溶の画分を分取する工程を順 次行うことにより前記ナチュラルキラー細胞を賦活化する作用を有する画分か らなる組成物を製造し、 前記工程 (A) 及び前記工程 (B) を連続して行うことを 特徴とする前記大麦焼酎及び前記ナチュラルキラー細胞を賦活化する作用を有 する画分からなる組成物を連続して製造する方法。 30. A step of fermenting barley koji and shochu yeast produced from brown barley or polished barley as raw materials to produce ripened mash, and subjecting the ripened mash to distillation to produce barley shochu ( A), and the step (B) of treating the barley shochu distillation residual liquid as a distillation residue when producing the barley shochu in the step (A), and in the step (B), the barley shochu distillation A step of obtaining a liquid component by solid-liquid separation of the residual liquid, a step of subjecting the liquid component to an ion exchange treatment using an ion exchange resin, and fractionating a fraction not adsorbed on the ion exchange resin, Subjecting the non-adsorbed fraction to the ion exchange resin to a concentration treatment by ultrafiltration using an ultrafiltration membrane to obtain a concentrated solution; and By adding an organic solvent to the concentrate, it contains substantially no uronic acid, contains a polysaccharide consisting of xylose, arabinose, and glucose, and has the above-mentioned effect of stimulating natural killer cells. A composition comprising a fraction having an action of activating the natural killer cells is produced by sequentially performing a process of fractionating an insoluble fraction, and the process (A) and the process (B) are continuously performed. A method for continuously producing a composition comprising the barley shochu and a fraction having an action of activating the natural killer cells.
31.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 30に記載の方法。  31. The method according to claim 30, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 100,000 or more
30, 000乃至 100, 000  30,000 to 100,000
10, 000乃至 30, 000  10,000 to 30,000
3, 000乃至 10, 000  3,000 to 10,000
1, 000乃至 3, 000  1,000 to 3,000
500乃至 1,000  500 to 1,000
500以下  500 or less
32. 前記有機溶媒に不溶の画分は、 多糖類が約 84. 1重量 %、 多糖類由来のァラ ピノース及びキシロースの合計含量が約 54. 4重量%、 粗夕ンパクが約 4. 2重量%、 有機酸が約 0. 3重量%、及び遊離糖類が約 1. 2重量 %からなる成分組成を有するもの である請求項 30に記載の方法。  32. The fraction insoluble in the organic solvent was about 84.1% by weight of polysaccharide, about 54.4% by weight of the total content of arapinose and xylose derived from polysaccharide, and about 4.2% of crude protein. 31. The method of claim 30, having a component composition comprising, by weight, about 0.3% by weight organic acid, and about 1.2% by weight free sugars.
33. 玄麦大麦又は精白大麦を原料にして製造した大麦麹と焼酎用酵母とを発 酵に付して熟成もろみを作製し、該熟成もろみを蒸留に付して大麦焼酎を製造す る工程 (A) 、 及び前記工程 (A) において前記大麦焼酎を製造する際に蒸留残渣 として副成する大麦焼酎蒸留残液を処理する工程 (B) からなり、 前記工程 (B ) においては、 前記大麦焼酎蒸留残液を固液分離して液体分を得る工程、 前記液 体分を合成吸着剤を使用する吸着分離処理に付して前記合成吸着剤に非吸着の 画分を分取する工程、分取した前記合成吸着剤に非吸着の画分をイオン交換榭脂 を使用するイオン交換処理に付して前記イオン交換樹脂に非吸着の画分を分取 する工程、分取した前記イオン交換樹脂に非吸着の画分を限外濾過膜を使用する 限外濾過による濃縮処理に付して濃縮液を得る工程、及び前記濃縮液に有機溶媒 を添加することにより、 ゥロン酸を実質的に含有せず、 キシロース、 ァラビノー ス及びグルコースからなる多糖類を含有し、ナチュラルキラ一細胞を賦活化する 作用を有する前記有機溶媒に不溶の画分を分取する工程を順次行うことにより 前記ナチユラルキラ一細胞を賦活化する作用を有する画分からなる組成物を製 造し、 前記工程 (A) 及び前記工程 (B) を連続して行うことを特徴とする前記大 麦焼酎及び前記ナチュラルキラ一細胞を賦活化する作用を有する画分からなる 組成物を連続して製造する方法。 33. A process for producing barley shochu by subjecting barley koji produced using brown barley or polished barley as a raw material and yeast for shochu to fermentation, and subjecting the maturation mash to distillation. A) and the step (B) of treating the barley shochu distillation residual liquid as a distillation residue when producing the barley shochu in the step (A), and in the step (B), the barley shochu A step of solid-liquid separating the distillation residue to obtain a liquid component, the liquid A step of subjecting the body fraction to an adsorption separation process using a synthetic adsorbent to fractionate a fraction that is not adsorbed on the synthetic adsorbent; A step of fractionating a non-adsorbed fraction on the ion-exchange resin by subjecting the ion-exchange resin to a fraction, and using an ultrafiltration membrane to fractionate the non-adsorbed fraction on the fractionated ion-exchange resin. A step of obtaining a concentrated solution by subjecting to a concentration treatment by the above, and by adding an organic solvent to the concentrated solution, containing a polysaccharide substantially free of uronic acid and comprising xylose, arabinose and glucose, A composition comprising a fraction having an action of activating natural killer cells is produced by sequentially performing a step of fractionating a fraction insoluble in the organic solvent having an action of activating natural killer cells. The process (A) And a method of continuously producing a composition comprising the barley shochu and a fraction having an action of activating the natural killer cell, wherein the step (B) is continuously performed.
34.前記有機溶媒に不溶の画分は、 下記の分子量分布を有するものである請求 項 33に記載の方法。  34. The method according to claim 33, wherein the fraction insoluble in the organic solvent has the following molecular weight distribution.
分子量分布: Molecular weight distribution:
100, 000以上 100,000 or more
30, 000乃至 100, 000  30,000 to 100, 000
10, 000乃至 30, 000  10,000 to 30,000
3, 000乃至 10, 000  3,000 to 10,000
1, 000乃至 3, 000  1,000 to 3,000
500乃至 〖,000  500 to 〖, 000
500以下  500 or less
35. 前記有機溶媒に不溶の画分は、 多糖類が約 78. 5重量%、 多糖類由来のァラ ビノース及びキシロースの合計含量が約 58. 6重量%、 粗タンパクが約 3. 3重量 %、 有機酸が約 0. 2重量%、及び遊離糖類が約 1. 5重量 %からなる成分組成を有するもの である請求項 33に記載の方法。 35. The fraction insoluble in the organic solvent comprises about 78.5% by weight of polysaccharide, about 58.6% by weight of the total content of arabinose and xylose derived from polysaccharide, and about 3.3% of crude protein. 34. The method of claim 33, having a component composition consisting of about 0.2% organic acid, about 0.2% by weight organic acid, and about 1.5% by weight free sugars.
36. 前記工程 (A) において、 前記熟成もろみを得る際に、 別に用意した玄麦 大麦又は精白大麦を前記大麦麹及び前記焼酎用酵母と共に発酵に付すことを特 徴とする請求項 30又は請求項 33に記載の方法。 36. In the step (A), when obtaining the ripened mash, separately prepared brown barley or refined barley is subjected to fermentation together with the barley straw and the shochu yeast. The method according to 33.
37.前記合成吸着剤が、 芳香族系合成吸着剤又はメタクリル系合成吸着剤であ る請求項 33に記載の方法。  37. The method according to claim 33, wherein the synthetic adsorbent is an aromatic synthetic adsorbent or a methacrylic synthetic adsorbent.
PCT/JP2004/000003 2002-12-27 2004-01-05 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same WO2004061090A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005507954A JPWO2004061090A1 (en) 2002-12-27 2004-01-05 Composition having an action of activating natural killer cells and production method thereof, and composition containing natural killer cells activated using the composition and production method thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2002379486 2002-12-27
JP2002-379476 2002-12-27
JP2002379476 2002-12-27
JP2002-379486 2002-12-27
JP2003-429972 2003-12-25
JP2003429972A JP2005104957A (en) 2002-12-27 2003-12-25 Composition having activity for activating natural killer cell, method for producing the same, activated natural killer cell-containing composition and method for producing the same

Publications (1)

Publication Number Publication Date
WO2004061090A1 true WO2004061090A1 (en) 2004-07-22

Family

ID=32718766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/000003 WO2004061090A1 (en) 2002-12-27 2004-01-05 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same

Country Status (2)

Country Link
JP (2) JP2005104957A (en)
WO (1) WO2004061090A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006115826A (en) * 2004-10-25 2006-05-11 Yasunobu Kobayashi Method for promoting proliferation of natural killer cell and cultivation composition used therefor
WO2007034958A1 (en) * 2005-09-26 2007-03-29 Sanwa Shurui Co., Ltd. Anti-angiogenic composition comprising grain-derived component as active ingredient
IT201900006858A1 (en) * 2019-05-15 2020-11-15 Abresearch Srl Preparation of insoluble polysaccharides obtained from suspended plant cell cultures for the treatment of Clostridium difficile infections

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0923895A (en) * 1995-07-12 1997-01-28 Daiwa Yakuhin Kk Immunocompetence enhancing substance and its production
JPH10146166A (en) * 1996-11-18 1998-06-02 Nippon Shuzo Kumiai Chiyuuoukai Physiologically active composition
JP2001145472A (en) * 1999-09-07 2001-05-29 Sanwa Shiyurui Kk Composition having fatty liver-suppressing activity fractionated from residual liquid of barley shochu liquor distillation and production of the same composition
JP2001161339A (en) * 1999-12-03 2001-06-19 Asahi Kasei Corp Method for stabilization of secondary charging water
JP2002255843A (en) * 2001-03-02 2002-09-11 Oriza Yuka Kk Immunoactivating composition
JP2003073294A (en) * 2001-09-05 2003-03-12 Sanwa Shiyurui Kk Leukemic cell growth inhibitor and method for manufacturing the same
JP2003221342A (en) * 2001-11-21 2003-08-05 Sanwa Shiyurui Kk Composition having crisis inhibition action and cure action on hepatitis and production method for the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0923895A (en) * 1995-07-12 1997-01-28 Daiwa Yakuhin Kk Immunocompetence enhancing substance and its production
JPH10146166A (en) * 1996-11-18 1998-06-02 Nippon Shuzo Kumiai Chiyuuoukai Physiologically active composition
JP2001145472A (en) * 1999-09-07 2001-05-29 Sanwa Shiyurui Kk Composition having fatty liver-suppressing activity fractionated from residual liquid of barley shochu liquor distillation and production of the same composition
JP2001161339A (en) * 1999-12-03 2001-06-19 Asahi Kasei Corp Method for stabilization of secondary charging water
JP2002255843A (en) * 2001-03-02 2002-09-11 Oriza Yuka Kk Immunoactivating composition
JP2003073294A (en) * 2001-09-05 2003-03-12 Sanwa Shiyurui Kk Leukemic cell growth inhibitor and method for manufacturing the same
JP2003221342A (en) * 2001-11-21 2003-08-05 Sanwa Shiyurui Kk Composition having crisis inhibition action and cure action on hepatitis and production method for the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUKIZAKI MASATO: "Shochu joryu haieki jikomi no yoru shcho seizo no closed-ka ni kansuru kenkyu", MIYAZAKI-KEN KOGYO SHIKENJO KENKYU HOKOKU, vol. 32, 1987, pages 51 - 54, XP002982751 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006115826A (en) * 2004-10-25 2006-05-11 Yasunobu Kobayashi Method for promoting proliferation of natural killer cell and cultivation composition used therefor
JP4653465B2 (en) * 2004-10-25 2011-03-16 泰信 小林 Method for promoting natural killer cell proliferation and culture composition used therefor
WO2007034958A1 (en) * 2005-09-26 2007-03-29 Sanwa Shurui Co., Ltd. Anti-angiogenic composition comprising grain-derived component as active ingredient
IT201900006858A1 (en) * 2019-05-15 2020-11-15 Abresearch Srl Preparation of insoluble polysaccharides obtained from suspended plant cell cultures for the treatment of Clostridium difficile infections
WO2020230080A1 (en) * 2019-05-15 2020-11-19 Abresearch Srl Preparation of insoluble polysaccharides obtained from plant cell cultures in suspension for the treatment of clostridium difficile infections

Also Published As

Publication number Publication date
JP2005104957A (en) 2005-04-21
JPWO2004061090A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
JP4826696B2 (en) Angiogenesis inhibitors
KR101170998B1 (en) Glycoprotein fraction isolated from rice bran and method for producing the same
WO2004061090A1 (en) Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same
WO2015052849A1 (en) Novel derivative having collagen-producing activity, and method for producing same
CN114989258B (en) Application of plant extract composition in preparing product for treating constipation and reducing weight
JP4451100B2 (en) Immunostimulant and anticancer agent containing Tamogitake fruit body composition as active ingredient
CN117562893A (en) Expression of PD-L1 inhibition and PD1 enhanced expression
CN109998055B (en) Hemp seed antioxidant polypeptide chewable tablet and preparation method thereof
JP2003342188A (en) Anticancer agent
US8034386B2 (en) Extract from Agaricus blazei Murill capable of suppressing breast cancer
KR100506950B1 (en) Immune stimulative constituents of ginseng saponins
JP2004217928A (en) Production method for composition having activating action of natural killer cell and production method for activated natural killer cell-containing composition
EP1398036B1 (en) Ganoderma lucidum spores for treatment of systemic lupus erytrhomatosus (SLE)
JPH02134325A (en) Remedy for aids and production thereof
US20130022641A1 (en) Anti-Tumor Agent and Immunostimulating Agent
JPH11246427A (en) Agent for activating metabolism of saccharide and lipid
JP4524342B2 (en) Composition exhibiting a pharmacological action for improving memory learning ability taken from barley shochu distillation residue
WO2007034958A1 (en) Anti-angiogenic composition comprising grain-derived component as active ingredient
CN1171630C (en) LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same
JP7162542B2 (en) Food composition for promoting food factor sensing-related gene expression and food factor sensing-related gene expression promoter
JP5756270B2 (en) Cancer peptide vaccine therapy effect improving agent
WO2022158368A1 (en) Gls1 gene-inhibiting cosmetic material composition, gls1 gene inhibitor, cosmetic material composition for senescent cell removal, and senescent cell removing agent
Tran et al. Cirsium japonicum var. maackii fermented with Pediococcus pentosaceus induces immunostimulatory activity in RAW 264.7 cells, splenocytes and CTX-immunosuppressed mice
WO2004004748A1 (en) Agaricus blazei murill extract capable of preventing cancer induction or metastasis
JP4251866B2 (en) Composition having inhibitory action and curative action on alcoholic liver injury, and method for producing the composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005507954

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: GB0519678.7

Country of ref document: GB

122 Ep: pct application non-entry in european phase